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Resumo 
 
 
De forma a reduzir a transmissão de agentes patogénicos através do consumo 
de bivalves, devem ser desenvolvidas novas tecnologias a associar à 
depuração, tal como a terapia fágica. A eficácia da utilização de fagos para 
controlar infeções bacterianas tem sido relatada em diversos estudos. No 
entanto, relativamente à utilização da terapia fágica para inativar bactérias 
patogénicas durante a depuração de bivalves, existe apenas um estudo 
preliminar, feito sem circulação de água (contrariamente ao que acontece na 
depuração industrial). 
O sucesso da combinação destas duas tecnologias depende da compreensão 
detalhada da dinâmica sazonal e espacial da comunidade bacteriana total, 
incluindo bactérias associadas a doenças devido ao consumo de bivalves e 
indicadores de qualidade microbiológica da água, nas zonas de produção de 
bivalves. Durante o Verão, a comunidade bacteriana total apresentou uma 
maior complexidade e aumento da abundância dos principais grupos de 
bactérias patogénicas, indicando que deste pode ser um período crítico onde a 
terapia fágica deve ser aplicada. No entanto, devido ao impacto das fontes de 
poluição antropogénicas e outras fontes de contaminação, a terapia fágica 
poderá ter que ser aplicada também durante a estação fria. 
Cinco novos fagos foram isolados e caracterizados para controlar Salmonella 
Typhimurium (phSE-1, phSE-2 e phSE-5) e Escherichia coli (phT4A e EC2A), a 
fim de avaliar a sua potencial aplicação durante a depuração de bivalves. 
Os ensaios in vitro demonstraram que o uso de fagos individuais (phT4A e 
EC2A), pode ser uma alternativa eficaz para o controlo de E. coli, em 
particular, quando combinados em cocktail. A depuração num sistema estático 
com MOI 1 usando os fagos phT4A e EC2A, foi a condição em que se obteve 
melhores resultados (diminuição ~2.0 log CFU/g) em berbigões artificialmente 
contaminados. Quando berbigões naturalmente contaminados foram tratados 
em sistema estático com as suspensões de fagos individuais e cocktails de 
fagos, foram obtidas reduções semelhantes na concentração de E. coli 
(diminuição ~0.7 log UFC/g). Quando os berbigões naturalmente contaminados 
foram depurados com o fago phT4A com circulação de água, a concentração 
de bactéria foi reduzida mais rapidamente que na ausência de fagos.  
Os resultados dos ensaios in vitro mostraram igualmente que o controlo de S. 
Typhimurium com fagos phSE-5 e phSE-2 e o cocktail destes dois fagos foi 
eficiente. A aplicação do fago phSE-5 e cocktail (phSE-2/phSE-5) inativou 
eficazmente S. Typhimurium em berbigões contaminados artificialmente 
(redução de 1.7 UFC/g com o fago phSE-5 e 0.7 log UFC/g com o cocktail 
phSE-2/phSE-5) e em berbigões naturalmente contaminados (redução de 0.9 
log UFC/g para ambos para a suspensão simples e para o cocktail) durante a 
depuração em sistema estático, especialmente quando são usadas 
suspensões do fago phSE-5 a uma MOI baixa. Os berbigões artificialmente 
contaminados também foram mais eficazmente descontaminados durante a 
depuração com circulação de água na presença do fago phSE-5 que quando 
foi usada apenas depuração sem adição de fagos (i.e. o processo 
convencional de depuração). 
Este é o primeiro trabalho em que foi testado o uso de fagos durante a 
depuração de berbigões naturalmente contaminados e contaminados 
artificialmente em sistemas com circulação de água, tal como acontece na 
depuração industrial de bivalves, provando assim que esta tecnologia poderá 
ser transposta para a indústria. Os resultados obtidos usando fagos de E. coli 
e de S. Typhimurium mostraram que a combinação da terapia fágica e 
depuração melhora a segurança microbiana dos bivalves para consumo 
humano, melhorando a eficiência de descontaminação. Além disso, esta 
abordagem também permite reduzir o tempo necessário para a depuração e 
consequentemente, os custos a ela associados. No entanto, a seleção e 
caracterização dos fagos e determinação da MOI mais adequado para ser 
utilizado durante a terapia fágica, é essencial para o sucesso da terapia fágica 
no controlo de bactérias patogénicas. 
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Abstract 
 
In order to reduce the infections by microbial pathogens through the 
consumption of bivalves, it is essential to develop alternative approaches to the 
conventional depuration practices. One new promising approaches is to 
combine the depuration of bivalves with phage therapy. The use of phages to 
control bacterial infections has been reported across numerous fields by many 
researchers. However, relatively the combination of depuration and phage 
therapy to eliminate pathogenic bacteria in bivalves there is only one study, and 
this study did not replicate industrial depuration procedures. 
The successful combination of those two technologies depends on a detailed 
understanding of the seasonal and spatial dynamics of the overall bacterial 
communities, including the bacteria implicated in bivalves-related illness and 
the indicators of microbiological water quality, in the harvesting areas. During 
the summer, the total bacterial community presented high complexity and an 
increase of abundance of the main pathogenic bacteria, indicating that this 
season is the critical time frame when phage therapy should be applied. 
However, due to the impact anthropogenic and other sources of contamination, 
phage therapy could be necessary also during the cold season. 
Five new phages were isolated and characterized to control Escherichia coli 
(phT4A and ECA2) and Salmonella Typhimurium (phSE-1, phSE-2 and phSE-
5) in order to evaluate their potential application during depuration. 
The in vitro assays indicated that the use of phages individually (phT4A and 
EC2A) or combined in cocktails (phT4A/EC2A), can be an effective alternative 
to control of E. coli, particularly if combined in a phage cocktail. Depuration in 
static seawater at MOI 1 with phage phT4A and ECA2 revealed to be the best 
condition (decreased of the 2.0 log CFU/g) in artificially contaminated cockles. 
When naturally contaminated cockles were treated in static seawater with 
single phage suspensions and the phage cocktail, similar decreases in the 
concentration of E. coli (decreased of the 0.7 log CFU/g) were achieved. When 
naturally contaminated cockles were depurated using conventional practices 
with phage phT4A, bacterial concentration was reduced sooner. 
The assays in vitro, demonstrated that the control S. Typhimurium with phages 
phSE-5 and phSE-2 and with these two phages combined in a cocktail was 
efficient, paving way for the in vivo studies. The efficiency of bacterial 
inactivation with single phage suspensions of phSE-5 and phSE-2 leaded to 
further in vivo studies to control of Salmonella in bivalves. The application of 
phage phSE-5 and phage cocktail phSE-2/phSE-5 can be successfully 
employed to inactivate S. Typhimurium (reduction of 1.7 log CFU/g for phSE-5 
and 0.7 log CFU/g for phSE-2/phSE-5 in artificially contaminated cockles and 
reduction of 0.9 log CFU/g for both in naturally contaminated cockles) during 
depuration in static system, especially if phSE-5 phage is used individually and 
if a low MOI is employed. Using conventional depuration practices in the 
presence of phage phSE-5, bacterial concentration is more quickly and 
efficiently reduced in artificially contaminated cockles. 
To our knowledge, this is the first report of a depuration trial using phages in 
the artificially and naturally contaminated cockles using industrial depuration 
procedures, proving that this technology can be ported into the bivalves 
industry. The obtained results using phages of E. coli and S. Typhimurium 
indicated that combining phage therapy with depuration procedures enhance 
bivalve microbial safety for human consumption by improving decontamination 
efficiency. Moreover, this approach also displays the advantage of reducing the 
time required for depuration and consequently its associated costs. However, 
the selection and characterization of appropriate phages and the most 
adequate multiplicity of infection to be used in phage therapy is a critical stage 
to achieve a successful phage-mediated control of pathogenic bacteria.  
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Thesis Outline  
 
The present work is focused on the potential use of phage therapy to inactivate 
bacterial implicated in seafood-related illness, during depuration of the bivalves. 
Production of bivalve shellfish had a fast economical growing and is an essential part of 
the diet of many populations. Bivalves are filter feeders that accumulate food particles and 
small organisms by circulating large volumes of seawater through their system; 
consequently, microorganisms, including human pathogens, become absorbed along with 
nutrients and accumulate in their bodies. Bivalves are consumed raw or lightly cooked; 
therefore, contaminated bivalves are potential vectors for human pathogens. Depuration is 
a method applied to eliminate human pathogens from live bivalves, but some pathogenic 
microorganisms are known to be resistant to this process and remain in bivalves after 
depuration. In order to reduce the risk of infections by microbial pathogens through the 
consumption of bivalves, it is essential to develop alternative approaches to conventional 
depuration practices. One of the most promising approaches is to combine bivalve 
depuration with phage therapy. 
 
This document is divided into seven chapters. Chapter 1 is an in-depth literature 
review serving as a basis for the following experimental work, described in following 
chapters (Chapters 2 - 6). Chapter 7 resumes the main conclusions of the experimental 
work performed and Chapter 8 lists the references used in the present document. 
 
Chapter 1 aims to provide a revision about depuration method and its limitations, 
applications of phage therapy and main aspects to consider for apply phage therapy during 
depuration. In the first part is presented a description of the bacteria implicated in seafood-
related illness and the preventive measures used to control microbial contamination. It is 
also introduced the limitations associated to the depuration method. In the second part, the 
application of an innovative treatment, phage therapy, to control bacterial contamination in 
aquaculture is described. The main aspects to be considered for the application of this new 
technology are enumerated, namely: the effect of the incidence and seasonal variation of 
bacterial implicated in seafood-related illness in phage therapy efficiency, the selection of 
appropriate bacteriophages and the most adequate multiplicity of infection to be applied in 
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phage therapy, the bacterial/phage interaction kinetics. Other aspects as the emergence of 
phage-resistant mutants are also considered in this chapter. 
Chapter 2 Evaluate the seasonal dynamics of the composition of bacterial 
communities, including the bacterial implicated in seafood-related illness, and the sanitary 
quality bacterial indicators, in the water of two differently classified (statutes B and C) 
harvesting zones at the Ria de Aveiro (Portugal). 
Chapter 3 Evaluate the efficiency of two new phages of E. coli (phT4A and ECA2), 
individually or combined in cocktails, to control E. coli using different MOIs (1 and 100) 
in vitro assays. Describes the isolation and characterization in terms of genome analysis, 
host range, latent period, burst size and adsorption to the host of the new phages. The 
development of phage-resistant mutants was also evaluated after exposition to single phage 
suspensions and to phage cocktails. 
Chapter 4 Describes the application of two new phages of E. coli (phT4A and 
ECA2), individually or combined in a cocktail, to control E. coli in natural and artificially 
contaminated cockles in static water and during depuration mimicking industrial 
procedures currently employed using naturally contaminated bivalves 
Chapter 5 Evaluates the efficiency of three new phages of S. Typhimurium (phSE-1, 
phSE-2 and phSE-5), individually or combined in cocktails of two or three phages, to 
control S. Typhimurium growth in in vitro assays. Describes the isolation and 
characterization in terms of genome analysis (phage phSE-2 and phSE-5), survival in 
marine environment, host range, latent period, burst size and adsorption to the host of the 
new phages. The development of phage-resistant mutants was also evaluated after 
exposition to single phage suspensions and to phage cocktails.  
Chapter 6 Describes the application of phSE-5 individually or combined in a 
cocktail (phSE-2/phSE-5), to control S. Typhimurium in natural and artificially 
contaminated cockles in static water and during depuration mimicking industrial 
procedures currently employed using artificially contaminated bivalves. 
Chapter 7 Describes the main conclusions obtained in the experimental work and 
perspectives for future work. 
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Objectives 
 
 The main objective of this study was to develop an effective alternative to 
decontaminate bivalves by combining two techniques, depuration and phage therapy. 
 
The specific objectives can be summarized as: 
 
 Evaluation of the seasonal and spatial dynamics of the overall bacterial 
communities, namely the bacterial implicated in seafood-related illness and the 
indicators of microbiological water quality, in harvesting areas. 
 Isolation and characterization of phages to control S. Typhimurium and E. coli 
(indicators of the depuration efficiency and bacterial implicated in seafood-related 
illness). 
 Selection of an optimal protocol for viral inactivation of bacteria under different 
conditions (different concentrations and single phage suspensions or phage 
cocktails). 
 Selection of appropriate phages individually or combined in a cocktail to control S. 
Typhimurium and E. coli during traditional depuration of bivalves. 
 Development of a protocol for control S. Typhimurium and E. coli in 
artificially/naturally contaminated cockles, using phages during depuration in static 
system. 
 Development of a protocol using phages during depuration mimicking industrial 
procedures currently employed, using artificially/naturally contaminated cockles. 
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1.1. Bivalves importance: economic and nutritional 
 
Bivalve shellfish are an essential part of the diet of many populations and their 
commercial value has risen dramatically worldwide (Oliveira et al., 2011a). The bivalves 
are still of great importance in the human diet, being a source of essential nutrients and 
providing a protein content of high biological quality (Bernardino, 2000; Fauconneau et 
al., 2002; Murchie et al., 2005; Sapkota et al., 2008), and their nutritional value varies 
among bivalve species (Oliveira et al., 2011a).  
The global tendency in the growth of human consumption of seafood and the need 
for its increased production will persist as the human populations expand. In recent years, 
the culture of bivalve molluscs has rapidly expanded and became more important for the 
aquaculture sector worldwide. Some bivalves are wild captured, while their majority is 
originated from aquaculture using seeds either produced from populations collected at 
natural breeding areas or from hatcheries of propagation production. However, the aquatic 
environment is becoming over-exploited and as a consequence of over-catching, the 
depletion of stocks is leading to the reduction of natural shellfish beds and to the need of 
human intervention in its production. The outcome is the development of artificial bivalve 
shellfish production and exploitation by the food industry (Hernroth et al., 2002). 
Aquaculture has been increasing exponentially and has became one of the fastest-growing 
food industries, especially in Asia (Defoirdt et al., 2004; FAO, 2006; Sapkota et al., 2008).  
Freshwater finfish represented half of global aquaculture production (54%) and 
molluscs were the second largest aquaculture product produced worldwide (24%) (FAO, 
2009). In 2010, global fish production by capture and aquaculture was 148 million tons of 
which 128 million tons were used for food. Bivalve molluscs represented almost 10% of 
the total world fishery production, but 24% in volume (on about 4.6 kg per capita, 
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subdivided into 1.7 kg of crustaceans, 0.5 kg of cephalopods and 2.4 kg of other molluscs) 
and 14% in value of the total world aquaculture production. The oysters culture, 
particularly Crassostrea gigas, dominates the global production of molluscs (FAO, 2006). 
The Manila clam (Ruditapes philippinarum), the Yesso scallop (Patinopecten yessoensis), 
the blue mussel (Mytilus edulis) and the blood cockle (Anadara granosa) are also widely 
produced species (Figure 1.1). Crustaceans come next in relevance, in terms of production, 
represented mostly by penaeid shrimps and grapsid crabs (FAO, 2009, 2006). 
 
Figure 1.1 World aquaculture production the bivalve molluscs (adapted from: FAO, 2009). 
 
1.2. General characteristics of bivalves 
Bivalvia, with about 7500 species, includes animals with two shell valves such as 
mussels, oysters, scallops and clams. The shell has several functions: it acts as a skeleton 
for the attachment of muscles, it protects against predators, and it helps to keep mud and 
sand out of the mantle cavity in burrowing species. Shell main component its calcium 
carbonate and is formed by the deposition of crystals of this salt in an organic matrix of the 
protein, conchiolin. Three layers make up the shell: (1) a thin outer periostracum of horny 
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conchiolin, often much reduced due to mechanical abrasion, fouling organisms, parasites 
or disease, (2) a middle prismatic layer of aragonite or calcite, a crystalline form of 
calcium carbonate, and (3) an inner calcareous (nacreous) layer, that is either of dull 
texture or iridescent mother-of-pearl, depending on the species (Gosling, 2003). 
The cockles (Cerastoderme edule) are filter feeders, using their gills to capture 
particulate food such as phytoplankton from the water. The cockles burrow into the 
protection offered by sand, mud or gravel using the foot. Contact is maintained with the 
surface by way of siphons that extend from the posterior end of the animal. The water 
flows in through the inhalant siphon, through the gills, where filtering of suspended food 
particles takes place, and exits through the exhalant siphon (Gosling, 2003) (Figure 1.2). 
 
 
Figure 1.2 C. edule in sediment (adapted from: http://www.gopi.org.nz/the-inlet/natural-
history/cockles-of-the-inlet/) 
 
The digestive tract of typical bivalves consists of an oesophagus, stomach, and 
intestine. A number of digestive glands open into the stomach, often via a pair of 
diverticula, secreting enzymes to digest food in the stomach and including cells that 
phagocytose food particles, digesting them intracellularly. In filter-feeding bivalves, an 
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elongated rod of solidified mucus referred to as the "crystalline style" projects into the 
stomach from an associated sac. Cilia in the sac cause the style to rotate, winding in a 
stream of food-containing mucus from the mouth, and churning the stomach contents. This 
constant motion propels food particles into a sorting region at the rear of the stomach, 
which distributes smaller particles into the digestive glands and heavier particles into the 
intestine. Waste material is consolidated in the rectum and voided as pellets into the 
exhalent water stream through an anal pore (Figure 1.3). Feeding and digestion are 
synchronized with diurnal and tidal cycle. 
 
 
Figure 1.3 Anatomy of a typical bivalve. (A) Cross section of the bivalve, (B) Water flow 
through bivalves.  
(adapted from: http://bio.classes.ucsc.edu/bioe122/molluscs/bivalve/bivalvia.html) 
 
1.3. Microbial contamination and human health 
Bivalve molluscan shellfish feed by filtering large volumes of seawater and 
accumulating food particles from their surrounding environment. When that environment 
is contaminated by sewage, shellfish will also accumulate human pathogenic bacteria and 
viruses during filter feeding and present a health risk when consumed raw or only lightly 
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cooked (WHO, 2010). The biological agents involved in seafood contamination consist of 
bacteria, viruses, parasites and microalgae (biotoxins producers) (Table 1.1), which can 
cause illnesses ranging from mild gastroenteritis to life-threatening diseases (Amagliani et 
al., 2012; Defossez and Hawkins, 1997; Dunphy et al., 2006; Huss et al., 2000; Lees, 2000; 
Oliveira et al., 2011a) . Foodborne disease is a public health problem which comprises a 
broad group of illnesses. Among them, gastroenteritis is the most frequent clinical 
syndrome which can be attributed to a wide range of microorganisms (Molnar et al., 2006). 
The risk of human intoxications is linked to the ingestion of bivalves contaminated with 
chemicals and biotoxins. The contaminants that are present in the environment and 
consequently are part of the normal biota can be considered natural causes for shellfish-
derived illnesses (Shumway and Rodrick, 2009) while others can be human-generated 
before or after shellfish harvesting. Pre-harvesting microbial contamination (occurring 
naturally or as a result of human activities) includes a wide variety of viruses and 
pathogenic bacteria (Huss et al., 2000; Lees, 2000). 
 
Table. 1.1 Hazards associated with bivalve mollusc consumption (FAO, 2008) 
Class of hazard Contaminant 
Infections 
Bacteria 
Salmonella spp., Shigella spp., Vibrio parahaemolyticus, Vibrio 
vulnificus, Vibrio cholerae, Campylobacter spp., Listeria  monocytogenes 
Viruses 
Noroviruses, Hepatitis A virus, Enteroviruses, Adenoviruses 
Intoxications 
Chemical 
Heavy metals: including Mercury (Hg), Cadmium (Cd), Lead (Pb). 
Organics: Dioxins, Polychlorinated Biphenyls (PCBs), Polycyclic 
Aromatic Hydrocarbons (PAHs), pesticides 
Biotoxin 
Paralytic shellfish poisoning (PSP), Diarrhetic shellfish poisoning (DSP), 
Amnesic shellfish poisoning (ASP), Neurotoxic shellfish poisoning 
(NSP) 
 
Pathogenic bacteria associated with seafood can be categorized into three general 
groups: bacteria which are normal components of the marine or estuarine environment 
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(indigenous bacteria), enteric bacteria which are present due to faecal contamination (non-
indigenous bacteria) and bacterial contamination during processing (Feldhusen, 2000; 
Reilly and Kaferstein, 1997). Examples of indigenous bacteria of the marine or estuarine 
environment are Vibrio cholerae, Vibrio parahaemolyticus, Vibrio vulnificus, Clostridium 
botulinum and Aeromonas hydrophila. In the case of non-indigenous enteric bacteria 
resulting from faecal contamination, Salmonella spp., pathogenic Escherichia coli, 
Shigella spp., and Campylobacter spp., and Yersinia enterocolitica can be found. 
Regarding bacteria introduced during processing, Bacillus cereus, Listeria monocytogenes, 
Staphylococcus aureus and Clostridium perfringens are some examples (Feldhusen, 2000). 
The majority of reported seafood associated illnesses has undefined etiologies and is often 
assumed to be viral. While viruses are frequently the cause of seafood-related infections, 
hospitalizations and deaths are especially and generally related with bacteria (Butt et al., 
2004; Potasman et al., 2002). Most of the infectious outbreaks cause acute symptoms and a 
few, generally associated with Noroviruses, Hepatitis A viruses and V. vulnificus 
infections, can be fatal (Mesquita et al., 2011; Potasman et al., 2002). Vibrio species 
account for 20% of all outbreaks of disease (Butt et al., 2004; Normanno et al., 2006; 
Ripabelli et al., 1999). Other bacteria pointed as the etiological agent of shellfish poisoning 
are Plesiomonas shigelloides, L. monocytogenes, E. coli and Campylobacter, Salmonella 
and Shigella species (Brands et al., 2005; Butt et al., 2004). Although these bacteria are 
commonly implicated in seafood diseases, they are only occasionally traced to seafood 
(Potasman et al., 2002). First, some of the bacteria are autochthones, existing in the fresh 
water and estuaries. Naturally occurring bacteria are the most often cited causative agents 
of disease and death related to shellfish consumption (Croci et al., 2002; Huss et al., 2000; 
Wittman and Flick, 1995). Indeed, contamination by autochthone bacteria represents an 
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additional challenge in achieving edible bivalves. Second, the most frequent clinical 
syndrome (self-limiting gastrointestinal symptoms as gastroenteritis) can be related to a 
wide range of etiological agents and their laboratory identification requires several 
laborious tests (Molnar et al., 2006). 
Shellfish-associated infections with Salmonella spp. used to be a significant problem 
in Europe and North America but occur less often now. Shellfish-associated 
gastrointestinal illness due to Shigella spp. and Campylobacter spp. has been reported from 
the USA but not from other countries. Illnesses due to L. monocytogenes have so far only 
been linked to the consumption of smoked bivalves (specifically mussels) and not those 
consumed live or cooked without being smoked (FAO, 2008). 
The increased consumption of bivalves worldwide has been accompanied by 
numerous reports of infectious seafood outbreaks from almost all continents. The most 
commonly implicated bivalves are oysters, followed by clams and mussels, since they are 
also the most consumed bivalves (Potasman et al., 2002). 
Viral diseases are usually associated with seafood such as bivalves. Adenoviruses, 
enteroviruses, noroviruses and hepatitis A viruses are the viruses that are more often linked 
to shellfish contamination (Lees, 2000; Muniain-Mujika et al., 2003) (Table 1.2). 
Chemical hazards (pesticides, heavy metals and drug-residues) are usually associated 
with bivalves caught from polluted waters but, in general, are uncommon in commercially 
harvested shellfish. (Huss et al., 2000). 
Biotoxins, produced by diatoms and dinoflagellates, also are a serious health 
problem. These toxins, usually linked to the unpredictable growth of those microalgae 
(microalgae blooms) are heat resistant, which means that even well-cooked bivalves might 
still present a risk to consumer safety. Accumulation of toxic marine algae in raw or light 
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cooked bivalve shellfish has been associated to Neurotoxic Shellfish Poisoning (NSP), 
Paralytic Shellfish Poisoning (PSP), Diarrhetic Shellfish Poisoning (DSP), Azaspiracid 
Poisoning (AZP) and Amnesic Shellfish Poisoning (ASP) occurrences (Botana, 2008; Huss 
et al., 2000).  
 
Table 1.2 Microbial causes of bivalve shellfish-associated illness (adapted from: Butt et al., 2004; 
Oliveira et al., 2011). 
Risk Ethiology 
Incubation 
period 
Illness, symptoms and signs 
Infection 
 
 
Bacteria 
Salmonella spp. 1-3 days 
Gastroenteritis and Enteric (typhoid) fever. 
Diarrhea, fever, vomiting, abdominal cramps. 
Shigella spp. 24-28h Diarrhea, fever, abdominal cramps. 
Enterotoxigenic 
Escherichia coli 
1-3 days Watery diarrhea, abdominal cramps, fever, vomiting. 
Campylobacter jejuni 
2-5 days 
Diarrhea, cramps, fever, vomiting 
Staphylococcus 
aureus 
1-6 h 
Nausea, vomiting, abdominal cramps, fever, vomiting 
Listeria 
monocytogenes 
9-48 h 
2-6 weeks 
Listeriosis, septicaemia, central nervous system 
infections (meningitis), gastroenteritis, endocarditis, 
arthritis, encephalitis, osteomyelitis, pulmonary 
infections. 
 
Fever, muscle aches, nausea, diarrhea, violent or 
bursting headache and convulsions. 
Vibrio vulnificus 1-7 days 
Wound infections, septicaemia, gastroenteritis. 
Vomiting, diarrhea, abdominal pain. 
Vibrio 
parahaemolyticus 
2-48h 
Wound infections, septicaemia, gastroenteritis. 
Nausea, abdominal cramps, watery diarrhea, vomiting 
Vibrio cholerae 24-72h 
Epidemic and non-epidemic gastroenteritis. 
Profuse watery diarrhea, vomiting and dehydration 
causing death with hours. 
 Aeromonas 
hydrophilla 
Unknown Gastroenteritis 
 Plesiomonas 
shigelloides 
20-24h Gastroenteritis 
 Clostridium 
botulinum  
12-72h 
Botulism, weakness, visual defects, death by respiratory 
paralysis, cardiac arrest 
 Clostridium 
perfringens 
 Diarrhoea, seldom lethal 
 Bacillus cereus  Vomiting, diarrhea 
 Yersinia 
enterocolitica 
 Diarrhoea, vomiting, fever 
Viruses Noroviruses 24-48h Nausea, vomiting, watery large-volume diarrhea 
Hepatitis A virus 15-50 days Diarrhea, dark urine, flu-like symptoms 
Enteroviruses 10-70 h 
Nausea, vomiting, abdominal pain, malaise, headache, 
fever. 
Adenoviruses 10-70h 
Nausea, vomiting, abdominal pain, malaise, headache, 
fever 
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1.4. Legislation for safeguarding consumers 
The microbiological safety of bivalves as well as the suitability of coastal areas for 
growing and harvesting shellfish is directly related to the quality of the water in which they 
grow (Son and Fleet, 1980). However, water quality does not necessarily reflect the 
sanitary quality of shellfish harvested (Burkhardt et al., 1992). 
Human health problems associated with bivalve shellfish are well recognized 
worldwide. The fact that outbreaks of infection continue to occur despite apparently 
adequate control measures highlights the role of microbial contamination of bivalves 
(Potasman et al., 2002). Numerous factors contribute to the existence of shellfish 
associated diseases outbreaks. Problems regarding monitoring shellfish growing areas and 
post-harvest contamination of the product (during handling storing, processing, labeling 
and shipping), as well as the lack of consumer education and public awareness are on the 
basis of diseases outbreaks (Potasman et al., 2002; WHO, 2010). The control of the risk of 
disease requires an integrated management and monitoring of the shellfish growing areas 
together with post- harvest product purification and processing (WHO, 2010). 
The microbiological safety of bivalves destined for human consumption in member 
states of the European Union (EU) is covered by Council Regulation 853/2004 and 
854/2004 (EC Regulations, 2004a). Briefly, capture/production areas for bivalves in the 
EU are ranked according to the levels of E. coli present in 100 g of flesh bivalve and intra-
valvular liquid (FIL) and quantified through a 5-tubes 3-dilution most probable number 
(MPN) test. Based on the classification it will be determined if the shellfish can be sent for 
direct consumption or must be treated before commercialization (Lees, 2000). The 
harvesting zones are grouped in four classes, from A through D (Table 1.3). Bivalves 
originating from an area classified as “A” display less than 230 MPN of E. coli per 100 g 
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of FIL. Consequently, these bivalves do not require any post-harvest treatment to reduce 
microbiological contamination. Bivalves originating from an area classified as “B” must 
not exceed in 90% of sampled specimens with 4600 MPN E. coli per 100 g of FIL, with 
the remaining 10% of specimens not exceeding 46000 MPN E. coli per 100 g of FIL. 
Bivalves originated from an area classified as “C” must not exceed the limits of MPN test 
of 46.000 E. coli per 100 g of FIL. These bivalves must be relayed or cooked by an 
approved method (EC Regulations, 2005, 2004a). Where E. coli concentrations exceed 
46.000 E. coli per 100 g of FIL (category D), harvesting is forbidden. 
 
Table 1.3 European classification of bivalves growing areas according of E. coli (Lees, 2000). 
Category MPN of E. coli per 
100g of seafood 
Treatment required 
A ≤ 230 Direct human consumption 
B ]230, 4600] Depuration or relaying, to meet category A 
C ]4600, 46000] Protracted relaying to meet category A 
Relaying to meet category B and depuration 
D > 46000 Harvesting prohibited 
 
The final product is sealed, labelled for traceability any commercialized giving 
distributors and consumers the confidence of a safe certified product (Lees, 2000; 
Shumway and Rodrick, 2009). 
 
1.5. Purification methods 
Sanitary regulations rely on bacterial indicators of sewage contamination to classify 
shellfish harvesting waters and to estimate the efficiency of purification methods (Murchie 
et al., 2005). These purification procedures, used to reduce anthropogenic or natural 
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microbial contamination of bivalve molluscs, have been used since the 1920s and are now 
extensively used worldwide (Lees, 2000). Unhealthy harvested bivalves purge 
contaminants when transferred into clean natural shellfish beds (relaying) or into tanks 
(depuration) (Shumway and Rodrick, 2009). Depuration systems now in use worldwide 
include processes where water is static or changed in batches through to systems where 
seawater is flashed through continually or recycled through a sterilizer (WHO, 2010). 
Depuration consists of a flow-through or recirculation system of chemically (chlorine, 
ozone, iodophores, and activated oxygen) or physically (UV irradiation) disinfected water 
to allow purification under controlled conditions (Otwell et al., 1991; Roderick and 
Schneider, 1994). The purification rate is positively related to body weight, clearance rates 
per individual are higher in bivalves with higher body weight (Troost et al., 2009). This 
process of depuration usually occurs in 2 days (Lees, 2000). Relaying consists of 
transferring contaminated harvested bivalves to cleaner areas allowing self-purification in 
the natural environment for longer periods, at least two months for category C shellfish, 
according to EU standards (Lees, 2000). Purification processes are based on the 
assumption that if by filtering polluted water shellfish can become contaminated, they may 
also purge the contaminants by filtering clean water. Thus, microbial depuration decreases 
the risk for potential infections due to shellfish consumption. However, it is already well 
documented that a number of pathogenic microorganisms still persist in depurated bivalves 
(FAO, 2008; Martínez et al., 2009; Rong et al., 2014). Depuration has been applied to most 
bivalve shellfish species sold live including oysters, clams, mussels, cockles and scallops 
(WHO, 2010). After depuration, bivalves may be destined for consumption if they have a 
level of less than 230 E. coli in 100 g of flesh bivalve and intra-valvular liquid (FIL), and 
absence of Salmonella sp. (FAO, 2008).  
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The efficiency of depuration is related, mainly, with bivalve’s size, siphoning 
activity, and physiological conditions (Jones et al., 1991; Richards, 1988). The type and 
quantity of initial contamination is also related with depuration efficiency, as more 
contaminated bivalves require longer depuration times and different microorganisms 
respond differently to the purification process. Artificially contaminated molluscs depurate 
more rapidly than naturally contaminated molluscs in the environment (Croci et al., 2002; 
Jones et al., 1991; Richards, 1988). Different rates of elimination also occur when bivalves 
are contaminated with individual or several bacteria (Son and Fleet, 1980). The design of 
the system, the quality of the seawater used, the way the system works combined with the 
work of the operator, and the provision of the right physiological conditions for the 
shellfish for depuration time are factors affecting the effectiveness of depuration. 
 
1.5.1. Depuration - practical considerations  
It is essential to create the correct physiological conditions for the shellfish 
depuration in order to allow normal filter-feeding and avoid mortalities. These conditions 
are outlined in the following sections. 
 
1.5.2. Water disinfection 
Water quality is a critical factor that influences the shellfish depuration process. The 
water should be filtered or disinfected by ultraviolet light, chlorine, chlorine-containing 
compounds, ozone or other means to prevent it from becoming a source of bacterial 
contamination. 
Filtration is a process of removing impurities, such as particles and bacteria, from 
water based on the pore size of membrane filters. Certain bacteria and viruses can persist in 
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seawater making it a source of contamination during shellfish depuration, particularly in a 
re-circulating system, if the water is not filtered or sterilized during the process. Both flow-
through and re-circulating depuration systems can be equipped with a filtration device 
(Bozianis, 2014). 
Chlorination was the first form of disinfection to be used in depuration systems in 
1914. The disinfection capability of chlorine is well known, although bacteria are more 
susceptible than enteric viruses (WHO, 2010). Chlorine can be added directly to seawater 
to eliminate or reduce populations of bacteria. However, the presence of chlorine in 
seawater may be unfavorable for the growth and affect the water-filtering activity of 
shellfish (Bozianis, 2014). 
Ozone has been used for many years in Europe for treating water for depuration 
processes, as this compound reacts rapidly with organic matter. Therefore, seawater 
intended to be used in combination with ozone for shellfish depuration, should be filtered 
first to remove most of the organic materials before being mixed with ozone to allow 
ozonated water to exhibit strong bactericidal properties (Bozianis, 2014). Unlike chlorine, 
ozone has the advantage of not imparting taste or odours to the shellfish neither affecting 
their appearance (WHO, 2010). 
Iodophor disinfections in depuration systems has been carried out in Italy. Re-
circulating systems using 0.1 to 0.4 mg iodophor/litre of tank water produced rapid 
reductions in the bacterial content of the shellfish without unduly affecting the activity of 
the shellfish or their organoleptic quality. However iodophors are not in common use in 
shellfish purification systems (WHO, 2010). 
Ultraviolet irradiation is the preferred mean of disinfection for purification systems 
in several countries. It has an advantage over other means of disinfection in that it does not 
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alter the physical or chemical properties. UV light causes disruption of the DNA or RNA 
of the microbial cell which usually leads to lethal changes in the biochemical processes. 
Clearly, only the water passing through the UV unit is subjected to the disinfected action of 
the UV light and those organisms present within the shellfish will not be affected with this 
form of disinfection, unlike chlorination (WHO, 2010). However, the efficacy of UV 
radiation in inactivating bacteria in seawater can be influenced by particles suspended in 
the water. Therefore, it is recommended that a filter is installed with depuration systems, 
particularly for re-circulating systems so that any sand, mud and faeces released by the 
shellfish can be removed from the seawater before it is pumped through a UV sterilizer 
(Bozianis, 2014). 
 
1.5.3. Temperature 
Temperature is an important parameter to consider in the purification process 
according to the type of shellfish (FAO, 2008; Oliveira et al., 2011a). The metabolism of 
shellfish can be directly influenced by the temperature of their environment. Therefore 
water temperatures are required to be kept above a minimum level during depuration and 
these should be specified as part of the approval conditions (WHO, 2010). Lowering the 
temperature may help in keeping bivalves alive longer and maintain lower bacterial 
concentrations, however, this would also extend the period of time required for effective 
depuration, because removal contaminate in shellfish become less active (Oliveira et al., 
2011a; Shumway and Rodrick, 2009). However, if the temperature becomes too high, then 
the dissolved oxygen level in the system may fall again, leading to a cessation of activity 
and potentially also shellfish mortalities (Shumway and Rodrick, 2009). This is likely to 
cause a significant increase in the turbidity of the water which in turn will reduce the 
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efficiency of the UV disinfection system (WHO, 2010). The shellfish themselves are also 
likely to be weakened by the process of spawning and, consequently, their depuration 
efficiency may be affected. Also, water volume and shellfish loading rates will affect the 
pH and the dissolved oxygen levels in the system. The number of bivalve layers in 
depuration recipients can promote increases in the microbial load as result of 
recontamination, obstruction of water flow and restrictions of shell opening (Richards, 
1988). 
 
1.5.4. Salinity 
It is also necessary to provide seawater of the correct salinity range for the shellfish 
being depurated, and to take into account the salinity of the harvesting areas, as 
requirements vary according to species (WHO, 2010). The salinity of the seawater used for 
depuration of shellfish is of critical importance. Specifically, the salinity of the depuration 
processing water in which the shellfish are placed in, can affect the pumping rate and other 
physiological processes. Since the salinities of the depuration processing water may differ 
from the shellfish harvesting area, shellfish should be acclimated to their new seawater 
environment. The period of acclimation is variable but should be long enough to allow for 
adequate pumping activity to be restored. For reasons that still remain unclear, higher 
salinities seem to enhance the depuration process while lower salinities inhibit the process. 
It is recommended that the salinity of the depuration water does not vary more than 20% of 
that of the water where shellfish were harvested (Shumway and Rodrick, 2009). 
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1.5.5. Dissolved oxygen 
Shellfish require oxygen to maintain normal physiological activities (Shumway and 
Rodrick, 2009; WHO, 2010). To facilitate normal shellfish activity, sufficient oxygen must 
be available in the water. Minimum dissolved oxygen levels of 50% saturation are 
recommended for purification systems, however, a well designed and operated system will 
maintain levels that are much higher than this (Shumway and Rodrick, 2009). Various 
factors influence the dissolved oxygen levels of the seawater in the depuration tank. These 
factors include: (1) the surface area of the seawater exposed to air, (2) the flow rate of 
seawater during depuration, (3) the number of shellfish to be depurated, (4) the 
physiological activity of the shellfish during depuration, (5) aeration, (6) the salinity and 
(7) temperature of seawater shellfish require oxygen to maintain used for depuration 
(Shumway and Rodrick, 2009; WHO, 2010). All these factors must therefore be carefully 
controlled during the purification process. The method of aeration must not disturb the 
normal activity of the shellfish, or the settlement of shellfish faecal material. In addition, 
the presence of small gas bubbles in the water may inhibit respiration of the shellfish by 
blocking gas exchange in the gill tissue (WHO, 2010)  
 
1.5.6. Stocking 
Shellfish must be loaded in the trays at a density that allows them the space to be 
able to function normally. They should be able to open as they would in the natural marine 
environment and carry out their normal filter-feeding activity. The density of shellfish will 
vary according to the species being depurated. The level of water above the shellfish 
should be sufficient to ensure that the shellfish remain immersed throughout of the 
depuration. The trays of shellfish are normally orientated so as to allow highly oxygenated 
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water to flow through them to the shellfish (providing oxygen and dispersing metabolic by-
products) (WHO, 2010).  
 
1.5.7. Shellfish to water ratio 
The loading of bivalve shellfish for a given volume of water needs to be controlled, 
for maintain dissolved oxygen levels, ensure optimum shellfish activity and ensure that the 
build-up of metabolic by-products does not reach inhibitory levels. The capacity maximum 
the shellfish is specified in the conditions of each type of system. This will be dependent 
upon the type of system and the individual species concerned (WHO, 2010). 
 
1.5.8. Water flow 
It is essential to provide a sufficient and uniform flow of water throughout the system 
to maintain adequate levels of oxygen in the water and prevent the build-up of metabolic 
by-products which may inhibit normal shellfish activity. The flow of water in must not be 
so great as to prevent the settlement of faecal material or cause the disturbance of such 
material that has already reached the bottom of the tank (WHO, 2010). 
 
1.5.9. Turbidity 
Excessive levels of suspended particulate matter may influence the efficacy of 
depuration. Control of turbidity is important for two reasons. The turbidity affects the 
filtration rate of shellfish and reduces the penetration of UV light through the water, 
thereby reducing their ability to effectively purge themselves during depuration (Jackson 
and Ogburn, 1999). Secondly, if the turbidity is excessive, the gills of the shellfish may 
become clogged, again preventing effective depuration. 
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If the shellfish is disturbed directly by the effects of cascades, aeration or operator 
handling during the purification cycle, the purification should start again. 
 
1.5.10. Limitations of depuration  
This method was established for reducing fecal contamination in shellfish, such as 
Salmonella and E. coli, but is generally not effective against Vibrio spp. (FAO, 2008; 
Otwell et al., 1991). However, low temperature depuration was found to be effective in 
reducing V. parahaemolyticus in oysters by 2 – 3 log MPN/g (Phuvasate et al., 2012); 
although this process took several days. Additionally, the chemical treatments commonly 
used for seawater disinfection result in chemical hazards in seafood. Depuration has been 
shown to be ineffective in reducing a number of Vibrio species in bivalves and there are 
concerns that, if the salinity is in the right range (e.g. between 10 and 30 ppt) and the 
temperature is high enough (e.g. above 20 °C) an increase in the concentration of Vibrio 
spp. may occur during a depuration cycle (FAO, 2008). Chae et al. (2009) reported that 
during the depuration at 15ºC the concentration of V. parahaemolyticus and V. vulnificus in 
Gulf oysters (Crassostrea virginica) was reduced by 2.1 and 2.9 log MPN/g, respectively, 
after 48 h. More recently, other authors investigated depuration with refrigerated seawater 
at 5 ºC for reducing V. parahaemolyticus in the Pacific oysters and reported that the 
process reduced V. parahaemolyticus populations in Pacific oysters by >3.0 log MPN/g 
after 96 and 144 h (Su et al., 2010). 
Studies on the removal of bacteria during depuration using bivalves artificially 
seeded with bacterial cultures tend to show a greater degree of removal than do studies 
using naturally contaminated shellfish (Croci et al., 2002; Jones et al., 1991; Richards, 
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1988). The use of such seeding in the investigation of depuration criteria or the validation 
of the effectiveness of commercial systems is thus questionable. 
Research undertaken in northern Europe with Pacific oysters (C gigas) has shown 
that viruses are removed much more slowly during depuration than is E. coli (indicator of 
an efficient depuration). Even in properly designed and operated systems, approximately 
one-third of the starting concentration of viruses will remain after 2 days at 8 °C. At higher 
temperatures (e.g. from 18 to 21 °C) viruses are removed from the shellfish more quickly, 
however while most virus present will be removed after 5 – 7 days at such temperatures, 
some residual viral contamination may remain even when only moderately contaminated 
shellfish are depurated. Given that the infectious dose of these viral pathogens is thought to 
be low, this means that depuration cannot be regarded as a primary mitigation factor for 
them (FAO, 2008) 
However, such reductions will obviously reduce the risk of illness to some extent and 
therefore it is necessary to optimize the design and operation of systems for the removal of 
pathogens and not to target these simply at the removal of bacterial indicators such as E. 
coli. Data on the depuration of mussels (Mytilus spp.) artificially seeded with Hepatitis A 
virus indicates that the depuration period needed for removal is also prolonged (FAO, 
2008). 
For reduce the risk of transmission of infections caused by microbial pathogens it is 
essential to develop alternative approaches. One of the most promising is the association of 
phages to the depuration process (Rong et al., 2014). This association will contribute to the 
improvement of the decontamination efficiency, likely reducing the time required for the 
depuration, and consequently, the production costs, with additional benefits in bivalve 
safety and quality. 
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1.6. Bivalve harvesting and production in Portugal 
The exploitation of bivalves is an important activity in Portugal, with significant 
impact in the national economy. Seafood is an excellent natural resource which is common 
in the Portuguese diet and is in high demand by tourists. The production of bivalves is 
practiced from north to south of Portugal with significant impact in the national economy. 
It is worth of notice that Tagus estuary harbors the largest natural oyster bed of Europe 
(IPIMAR, 2008). In 2013, shellfish accounted for 50% of total production with carpet shell 
remaining as the most representative species, followed by mussels (1.640 tons) and  
cockles (INE, 2015).The main harvested bivalves were cockles, clams, razor, shells, 
mussels and oysters (Table 1.4).  
 
Table 1.4 List of species of bivalve molluscs according to their interest to fisheries in Portugal 
(data from 2009) (adapted from: Oliveira et al., 2013). 
Scientific English name 
Cerastoderma edule Common edible cockle 
Cerastoderma glaucum Olive green cockle 
Crassostrea angulate Portuguese oyster 
Crassostrea gigas Pacific cupped oyster, Japanese oyster 
Ensis ensis Pod razor shell 
Ensis silique Sword razor shell 
Mytilus edulis Blue mussel 
Mytilus galloprovincialis Mediterranean mussel 
Ostrea edulis European flat oyster 
Pharus legume Bean solen 
Ruditapes decussatus Grooved carpet shell 
Rudipates philippinarum Japanese carpet shell 
Solen marginatus European razor clam 
Spisula solida Solid surf clam 
Benerupis pullastra Pullet carpet shell 
 
In 2013, captured molluscs totalized 18504 tons, with an estimated value of 63065 
thousands of euros. In 2013, cockles represented 11.9% of the national molluscs capture 
accounting for 1925 thousands of euros and carpet shell represented 8.9% corresponding to 
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a profit of 2930 thousand of euros were among the most produced species: dorax clams, 
mussels, oysters and murex, came next in quantity with 1.4% (706 thousands euros), 0.7% 
(93 thousands euros), 0.5% (79 thousands euros) and 0.2% (184 thousands euros) (Figure 
1.4). 
 
A B 
Figure 1.4 Portuguese production in quantity (A) and value (B) during 2013 (adapted from: 
INE, 2015). 
 
The control of salubrity of bivalve production areas (BPA) in Portugal is made by 
IPMA (Instituto Português do Mar e da Atmosfera). This Institute is responsible for the 
classification of these areas, determining if shellfish can be directly consumed or must 
suffer treatment(s) before commercialization (Lees, 2000) safeguarding public health. 
Portuguese production areas are defined in 17 estuarine zones and 9 coastal areas 
(IPIMAR, 2008). The areas that register the higher production of bivalves are the center of 
Portugal and the Algarve (southern Portugal) (Figure 1.5). 
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Figure 1.5 Distribution of bivalve beds (gray areas) and the bivalve production zones (L1 – L9) in 
Portugal (adapted from: Oliveira et al., 2014). 
 
Ria de Aveiro is a coastal lagoon located in the western Atlantic margin of Portugal 
where commercialization of bivalves play an important socio-economic role (Pereira et al., 
2014), especially the harvesting of cockle (Cerastoderma edule), which exceeds 1000 tons 
per year. This coastal lagoon currently has official bivalve capture/production areas 
classified either as B (Canal de Mira, Canal de S. Jacinto, Canal Principal and  Esteiro dos 
Frades, Canal de Ovar, Cale da Moacha and Cale do Ouro) or C (Canal de Ílhavo, Canal do 
Espinheiro and Canal do Parrachil and Testada) (Figure 1.6). 
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Figure1.6 Distribution of bivalve harvesting and production in Ria de Aveiro (adapted from: 
Pereira et al., 2014). 
 
1.7. Phage therapy 
Phage therapy consists in the utilization of bacteriophages, or phages, to inactivate 
pathogenic bacteria. Phages were discovered by the early 1920s and their infectious cycles 
were understood by that time, however, the literature of the past half-century regarding the 
possible therapeutic role of phages against infectious diseases is almost none. The poor 
understanding of mechanisms of bacterial pathogenesis and the nature of phage-host 
interactions, led to a succession of badly designed and executed experiments. This method 
of treatment was used to treat and prevent bacterial infection diseases in the former Soviet 
Union and Eastern Europe, however, was abandoned by the West in the 1940 with the 
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appearance of the antibiotics. The emergence of pathogenic bacteria resistant to antibiotics, 
including multiresistant bacteria, has recently motivated the western scientific community 
to reevaluate phage therapy as a valid option for the treatment of bacterial infections. In the 
time when bacterial resistance to antibiotics is increasing, the use of phages has different 
advantages, along with relatively few disadvantages. The great advances in scientific 
knowledge about the biology of these agents, can provide a better understanding of the true 
potential of phage therapy. Currently, the potential use of phage therapy in agriculture, 
veterinary biocontrol, food safety and in clinical treatment of human infections is also 
being studied (Balogh et al., 2010; Deresinski, 2009; Gill and Hyman, 2010; Kutter et al., 
2010; Mahony et al., 2011; Mole and Maskell, 2001). Although today there are some 
approved applications of phage therapy in the environmental area, namely in food, 
agriculture and veterinary, to prevent and control bacterial infections, no application is 
approved for aquaculture and depuration of bivalves. However, there are already several 
laboratorial studies indicating that phage therapy is a promising alternative to control and 
prevent bacterial diseases and to prevent the spread of multiresistant bacteria in 
aquaculture (Almeida et al., 2009; Nakai and Park, 2002; Rong et al., 2014; Silva et al., 
2016, 2014a). Relatively to the depuration of bivalves there is only one study (Rong et al., 
2014). 
In 2006, a major milestone in Western world phage history was achieved with the 
approval of the first phage-based product (ListShieldTM) (www.ebifoodsafety.com) to 
control L. monocytogenes in meat and received the highly desirable GRAS (generally 
recognized as safe) status for its use in all food products (Endersen et al., 2014; Hagens 
and Loessner, 2010). Phage preparations active against E. coli and Salmonella are also 
offered (www.omnilytics.com); some have approval for being sprayed, showered, or 
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nebulized on cattle and chickens respectively, prior to slaughter of the animals (Johnson et 
al., 2008; Sulakvelidze and Barrow, 2005). Moreover, phage preparations active against 
tomato and pepper pathovars of Pseudomonas putida (www.omnilytics.com), developed 
for treatment of plants against bacterial spot diseases, have been approved for use by the 
US Environmental Protection Agency (EPA) (Balogh et al., 2010). These recent 
developments highlight the fact that, besides the use of phage for direct addition to food, 
much effort has also gone into phage-based control of pathogens that can colonize plants or 
animals used in food production. It can be expected that many more phage products will 
appear on the market in the near to mid-term future. 
 
1.7.1. Bacteriophages 
Phages are viruses that infect only prokaryotes (bacteria and archaea) (Ceyssens and 
Lavigne., 2010; Skurnik and Strauch, 2006), resulting usually in propagative lyses (lytic 
cycle) or lysogenization (lysogenic cycle) of the infected cell (Azizian et al., 2013; Borie et 
al., 2014; Teng-hern et al., 2014). Lytic phages may be candidates for phage therapy, 
because they replicate fast within their hosts and lyse them (Azizian et al., 2013). They can 
be defined as a capsid-encoding organism that is composed by proteins and nucleic acids, 
self-assembles in a nucleocapsid that uses a ribosome-encoding prokaryotic organism for 
the completion of its life cycle (Raoult and Forterre, 2008). They were independently 
discovered and described in 1915 by William Twort, and in 1917 by Felix d’Herelle that 
realized that they had the potential to kill bacteria (Sulakvelidze et al., 2001). They are the 
most abundant organisms in the biosphere and they are a ubiquitous feature of prokaryotic 
existence (total number estimated to be 1030-1032) (Bhardwaj et al., 2015; Clokie et al., 
2011; Fuhrman, 1999). The presence of the phages in the biosphere is that phages co-
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evolve with their host bacteria and provide the earth’s ecological equilibrium in several 
environmental or ecological niches (Vos and Pirnay, 2015). The most of the phages are 
tailed phages, which accounts for 96% of all phages present on earth, belonging to the 
order Caudovirales (families Myoviridae, Siphoviridae and Podoviridae) (Hanlon, 2007). 
However, RNA phages are also present in the marine environment (Alcantara and 
Almeida, 1995; Cole et al., 2003; Doré et al., 2000; Grabow, 2001; Griffin et al., 2000) 
 
1.7.2. Bacteriophages morphology 
The phages present a variety of different morphological types, but the majority 
displays a capsid, collar and tail (Figure 1.7) (Hanlon, 2007). Phages contain a core nucleic 
acid encapsulated with a protein or lipoprotein capsid which is connected with a tail that 
interacts with various bacterial surface receptors via the tip of the tail fibers. The capsid is 
a protein shell often in the shape of an icosahedron and comprises the nucleic acid. The 
capsid has three important functions during the phage life cycle: (1) protect the phage 
genome during its extracellular phase, (2) enable the adsorption of the phage, fixing the 
virus to the host bacterium (in Caudovirales), and (3) the subsequent delivery of the phage 
genome into the host cytoplasm (Goodridge and Abedon, 2003). Phage genomes can be 
double-stranded DNA, single stranded DNA, or single-stranded RNA and can vary 
between 17 kb and 500 kb. The tail may or may not be a contractile structure to which six 
fibres are usually connected, containing receptors on their ends that recognize binding sites 
on the surface of the bacterial cell. However, not all phages have tails and tail fibers and in 
this situation other attachment mechanisms are present (Goodridge and Abedon, 2003; 
Hanlon, 2007). 
35 
 
 
Figure 1.7 Schematic representation of a typical bacteriophage (adapted from: Hanlon, 2007). 
 
1.7.3. Taxonomy of bacteriophages 
The International Committee for Taxonomy of Viruses (ICTV) is presently responsible 
for the classification of the viruses. The taxonomy of these viruses is based on 
morphological (size and shape) and molecular characteristics (type of nucleic acid) (Table 
1.5, Figure 1.8). Phages, of which there are currently 13 families and 30 genera, belong to 
the Caudovirales order, based on the phage tail structure, are divided into three families: 
(1) Myoviridae, in which viruses have a contractile tail constituted by hem, a central tube 
and  a big capsid head (~150 nm), (2) Siphoviridae, in which viruses have long not 
contractible tails, and  a relatively small capsid head (~50-60nm) (3) Podoviridae, in which 
viruses have no contractile tail and have short tails and a small capsid head (~50-60 nm) 
(Ackermann, 2007, 2003; Drulis-Kawa et al., 2012). The other non-tailed phages 
(represent less than 4%), are classified into ten families, and are cubic, filamentous, or 
pleomorphic and contain double-stranded or single-stranded DNA or RNA as the genome. 
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Table 1.5 Basic properties of phage families (adapted from: Ackermann, 2003; Hanlon, 2007). 
Shape Nucleic acid Family name Characteristics 
Tailed 
dsDNA, Linear Myoviridae Contractile tail 
dsDNA, linear Siphoviridae Long, non-contractile tail 
dsDNA, linear Podoviridae Short, non-contractile tail 
Polyhedral 
ssDNA, circular Microviridae Icosahedral capsid 
        dsDNA, circular, 
superhelical 
Corticoviridae Icosahedral capsid with lipid layer  
         dsDNA, linear Tectiviridae Icosahedral capsid with inner lipoprotein vesicle 
ssRNA, linear Leviviridae Quasi-icosahedral capsid 
        dsDNA, linear, segmented Cystoviridae Enveloped, icosahedral capsid, lipids 
Filamentous 
ssDNA, circular Inoviridae Rod-shaped with helical symmetry 
         dsDNA, linear Lipothrixviridae Enveloped filaments, lipids 
         dsDNA, linear Rudiviridae Helical rods 
Pleomorphic 
ssDNA, circular, superhelical  Plasmaviridae Pleomorphic, envelope, lipids, no capsid 
        dsDNA, circular,superhelical Fuselloviridae Envelope, lipids, no capsid 
 
 
Figure 1.8 Schematic representation of the morphology of bacteriophages (adapted from: 
Ackermann, 2003). 
 
1.7.4. The phage life cycle 
The life cycles of phages, typically, can be classified broadly into categories, lytic 
(virulent) and lysogenic (temperate phages) cycles (Figure 1.7) (Hanlon, 2007; Weinbauer, 
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2004). There is a third way by which phages can also interact with their hosts, the 
pseudolysogenic cycle (Figure 1.9) (Weinbauer, 2004). 
In the lytic cycle, the phage injects its genome into the host cell (Hogg, 2013). To 
multiply itself, the phage needs to cause lysis of the host cell to release the newly formed 
phages (Skurnik and Strauch, 2006). Phages adsorb to specific receptor sites on the surface 
of the host cell, which is followed by subsequent irreversible attachment. Ability to 
recognize and attach to receptor molecules on the cell surface largely dictates the host range 
of a bacteriophage. The penetration of tail through cell walls degraded enzymatically drives 
insertion of phage DNA into the cytoplasm of the host. Once inside the cell, the bases of the 
phage DNA are often modified to protect against the attack by restriction enzymes and 
cellular nucleases. The viral genome is transcribed by RNA polymerases of the host cell, 
producing premature mRNA. The premature mRNA function is to take over the metabolic 
machinery of the bacterium and redirect the metabolic processes to the manufacture of new 
viral components (Hanlon, 2007). After the replication and assembly of new phage particles 
within the host cell, the new phages are released to the environment (Hanlon, 2007). Almost 
all of the dsDNA phages develop enzymes that attack the bacterial peptidoglycan, like 
lysozymes that act at the sugar links, endopeptidases that break peptide bonds or amidases 
that act on amide links (Fischetti, 2005). These lytic enzymes (usually called muralytic 
enzymes or endolysins), coded by the phage genome, are produced within the cytoplasm but 
require another enzyme to allow them to cross the cytoplasmic membrane to reach its 
substrate. This enzyme is a holin that ruptures the membrane, allowing the lysin to degrade 
the peptidoglycan (Fischetti, 2005; Young et al., 2000). The holin controls the timing of the 
cell lysis and the release of the phage progeny. The filamentous phage can escape the host 
cell by extrusion through the cell wall without causing the destruction of the host, these 
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phages did not present relevance for phage therapy (Hanlon, 2007). The period of time 
between the attachment of a phage particle to the cell surface and the release of the newly 
synthesized phages is called the latent period, sometimes also known as the burst time 
(Hogg, 2013). 
Temperate phages are viruses that do not enter automatically on a lytic cycle, the 
phage genome will integrate the genome of the host cell. A copy of the phage genome is 
stably maintained in a repressed state within the host genome and replicates in concert with 
the host chromosome (Hogg, 2013; Skurnik and Strauch, 2006). The temperate phages 
induce a state of lysogeny in the bacterial host (Hanlon, 2007). Cells can undergo multiple 
rounds of division but, occasionally, one will spontaneously lyse and release progeny phage. 
Alternatively, a population of lysogenic cells can be induced to lyses by submitting them to 
stress and treatment with mutagens or by exposure to ultraviolet light. The prophage directs 
the synthesis of a repressor protein which blocks the transcription of its own genes and also 
those of closely related bacteriophages. The presence of a prophage may therefore confer a 
certain type of bacterial cell immunity to other infections by phages. Lysogenic bacteria may 
have other advantages, in terms of acquisition of genes that confer increased virulence or 
pathogenicity. When one prophage escapes regulation by the repressor, its DNA is cut free 
inducing a lytic cycle. But, excision of the prophage DNA is often imprecise and bacterial 
genes adjacent to the prophage DNA may be incorporated into infectious phage DNA and 
then transferred into host cells. Temperate phages are generally avoided for direct use as 
therapeutics because they may mediate transduction of genetic material from one bacterial 
cell to another. Indeed, temperate phages may transmit genes that increase the virulence of 
the host in a process known as lysogenic conversion. As a result of their replication cycle, 
they do not kill all of the bacteria that they infect. Moreover, a bacterial cell harboring a 
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prophage within its genome becomes immune to infection by the same or closely related 
phages, a process known as superinfection immunity (Deresinski, 2009; Gill and Hyman, 
2010; Wagner and Waldor, 2002). In contrast, virulent phages have the ability to replicate 
exponentially on a bacterial culture and can rapidly eliminate bacteria regardless of their 
antibiotic resistance profiles. This makes virulent phages very appealing candidates for use 
as biotherapeutic agents. 
The pseudolysogen cycle (i.e., false lysogen) is described as a phenomenon where 
there is a constant production of phage in the presence of high host cell abundance 
(Ackermann and DuBow, 1987). The phage lysis results not in total host death and the 
abundance of phage coexists with exponential host growth. This might be the result of a 
mixture of resistant and sensitive host cells and/or a mixture of virulent and temperate 
phages Thus, in pseudolysogeny infection, the bacteriophage can either proceed with lytic 
infection or enter a dormant intracellular phase but in this case, the phage genome does not 
integrate into host cellular replicons (Wommack and Colwell, 2000). Pseudolysogeny is an 
environmental condition in which the bacterial cell coexists in an unstable relationship with 
infective viruses (Ripp and Miller, 1998, 1997). Under these conditions, host cells do not 
provide enough energy in order to phage entering into a true lysogenic or lytic condition. 
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Figure 1.9 Schematic representation of the phage life cycle (adapted from: Weinbauer, 2004). 
 
1.8. Phage therapy: a new technology in bivalve depuration 
The use of phages as antibacterial agents, may offer an alternative treatment for 
bacterial infections. The use of phages as therapeutic agents in human medicine, veterinary 
science, agriculture and to control food-borne diseases is a great potential new tool (Loc-
Carrillo and Abedon, 2011; Lu and Koeris, 2011; Maura and Debarbieux, 2011).  
However, for our knowledge, there is only one report on the combination of phage therapy 
and bivalve depuration. In this study, Rong et al. (2014) concluded that the application of 
bacteriophage (VPp1) could reduce the population of V. parahaemolyticus in infected 
oysters during depuration without water recirculation. 
Their properties and behavior in vitro strongly support their use, including large-
scale commercialization, however, still further testing in vivo is needed to complement the 
large information generated by in vitro studies. Among these factors is included the 
detailed understanding of the kinetic bacteria /phage. The selection of appropriate 
bacteriophages and the most adequate multiplicity of infection to be used in phage therapy 
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is a critical stage to achieve a successful phage-mediated control of pathogenic bacteria. 
Criteria such as the adsorption rate, latent period, burst size, lysogenic induction capacity, 
survival in the environment and emergency of phage-resistant mutants are determinant in 
the election of suitable phages to use in phage treatment. Another important aspect to 
consider is the narrow host range of phages. In order to apply phage therapy, use of 
bacteriophages with a broader spectrum of activity should be a priority in the investigation 
of these agents. Despite this, this apparent weakness of phage can be remedied through the 
use of viral mixtures, thus extending their range of action. Quality assurance in the massive 
use of this tool is, in their therapeutic role as well as their safety, is a very important aspect 
to consider. This issue can be a major obstacle for its development, due to the time and 
resources required to be invested in, among other issues, sequencing the entire genome and 
study of pharmacokinetic and pharmacodynamics properties (Loc-Carrillo and Abedon, 
2011).  
 
1.8.1. Variation of bacterial communities in the harvesting waters 
In order to apply a successful phage therapy during depuration of bivalves it is 
essential to know the dynamics of the natural microbial community in the harvesting 
waters and in bivalves, with detail on the most important pathogenic bacteria of bivalves 
associated illness. The phage specificity can be a disadvantage when is not known the 
bacteria that cause the infection. However, this difficulty is overcomed when phage 
therapy is applied to cases when the main pathogenic bacteria are well known (Almeida et 
al., 2009). The success of phage therapy to inactivate shellfish pathogenic bacteria during 
the depuration process depends also of the comprehensive knowledge of the seasonal and 
spatial variation of the overall bacterial community, including the main pathogenic bacteria 
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of bivalves associated illness and the indicators of microbiological water quality, in the 
water of the harvesting areas and in bivalves. These studies may help define critical 
periods when phage therapy/depuration should be applied to reinforce the depuration 
process. Several studies observed that most outbreaks of Salmonella infection occurred 
during hot periods (summer and early autumn) (Checkley et al., 2000; Zhang et al., 2012), 
indicating that the summer season is a critical time period for the consumption of bivalve 
molluscs. Other studies also observed that the incidence of V. parahaemolyticus and V. 
vulnificus (Davis and Sizemore, 1982) and of Aeromonas (Maalej et al., 2004) increased in 
the summer months. 
 
1.8.2. Selection of phages 
The selection of appropriate phages becomes a critical factor to the success of the 
phage therapy as a successful phage-mediated control of pathogenic bacteria. Beside the 
efficiency on bacterial inactivation, among the main criteria required to select viruses for 
phage therapy are 1) host range, 2) adsorption rate, 3) survival in the environment; 4) the 
burst size and latent period; 5) no potential for lysogenic conversion and/or generalized 
transduction and, of course, 6) efficiency of bacterial inactivation must be evaluated and 7) 
safety are determinant in the election of suitable phages to use in phage treatment (Almeida 
et al., 2009; Mateus et al., 2014; Nakai, 2010;Pereira et al., 2011a; Skurnik and Strauch, 
2006). 
Therapeutic phages should have a very broad host range, which means that phages 
must present high virulence on a large number of bacterial strains (Koskella and Meaden, 
2013; Mirzaei and Nilsson, 2015). The selected phages with a wide host range limits the 
number of phages in the library, and reduces the cost for clinical trials (Mirzaei and 
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Nilsson, 2015). Mirzaei and Nilsson (2015), observed that spot test cannot be used for 
identification and selection of phages to a phage library and should be replaced by EOP 
assays. These authors observed that high EOP was not correlated to the results from the 
spot tests (Mirzaei and Nilsson, 2015). Lysis is a plausible mechanism which happens 
when an overload of phages simultaneously infects a bacterium leading to lysis either from 
the action of lysins or from rapid depletion of the cells resources (Abedon, 2011). 
An important factor in production is in the bacteriophage infective process: 
adsorption to the host cell. Studies on T-even and T-odd phages have revealed that a 
number of environmental factors, such as, ion concentrations, organic cofactors (i.e. L-
tryptophan), pH and temperature, can have a significant impact on the adsorption of the 
virus to the host cell (Storms et al., 2010). The increased of the adsorption efficiency had 
an effect similar to increasing the initial multiplicity of infection; the number of phages 
produced during amplification decreased (Storms et al., 2010). 
The success of phage therapy to control pathogenic bacteria also depends on viral 
survival and viability in the seawater, maintaining their lytic attributes. Although there are 
some data available about the study of the mechanisms and rates of mortality or loss of 
infectivity of phages in marine waters, but little is known about their time of survival in the 
marine environment. Suttle and coworkers have observed several processes implicated in 
the loss of infectivity of viruses in seawater. They used various indigenous marine phages 
(Suttle and Chen, 1992), cyanophage (Suttle and Chan, 1994), and a virus of Micromonas 
pusilla, a cosmopolitan marine phytoplankter (Cottrell and Suttle, 1995) and concluded 
that sunlight was the dominant factor controlling decay of viral infectivity in seawater. De 
Paepe and Taddei (2006) by comparing life history traits of 16 phages infecting E. coli, 
showed that their mortality rate is constant with time and negatively correlated to their 
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multiplication rate in the bacterial host. They showed that the capsid thickness and the 
density of the packaged genome account for 82% of the mortality rate (De Paepe and 
Taddei, 2006). In other studies, the authors observed that the phages of Aeromonas 
salmonicida (Pereira et al., 2011a) and V. parahaemolyticus (Mateus et al., 2014) survived 
several months in seawater (3 to 9 months). 
The phage burst size (number of phages produce by each host cell) and the latent 
period (time elapsed from virus entry into the cell until the first progeny are released) are 
also important factors to consider when phages are selected. Selecting phages with high 
burst size (i.e. producing a large number of progenys phage), is very important. Phages 
cannot be administered in high doses per diffuse very poorly. A high burst size increases 
the probability that phages reach target bacteria, which is crucial for achieving an efficient 
infection. If phages can eliminate infecting bacteria faster than they can replicate, a high 
burst size also results in a lower risk of selection for phage resistant bacteria (Mirzaei and 
Nilsson, 2015). The phages that have a short latency period during isolation of new phages 
are more prevalent than other phages in the sample. This may be desirable for the phage 
therapy but a phage with long latency period and higher burst size can be never found, if a 
quick phage is present in sufficiently high titre in the sample from the beginning, even if 
this rapid phage has only a fraction of the slower phage’s burst size (Mirzaei and Nilsson, 
2015). The phages with high burst sizes and short latent periods are more effective to  
control bacteria; however, great burst sizes are associated with a long latent period 
(Abedon, 2011) which makes the selection for phage therapy difficult. Mateus et al. (2014) 
observed that the use of phages with high burst sizes and short lytic cycles clearly 
improves the efficiency of phage therapy. In this study, the authors used three phages of 
the V. parahaemolyticus (VP-1, VP-2 and VP-3) and observed that the VP-3 phage 
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presents the highest burst size (more than 3 times of those of VP-1 and VP-2 phages), the 
shortest lytic cycle (less than a half of those of VP-1 and VP-2 phages) and was more 
efficient to inactivate its host than VP-1 and VP-2 phages (more 2 log of inactivation, with 
the maximum of inactivation occurring 4–6 h before than those of VP-1 and VP-2 phages) 
(Mateus et al., 2014). 
To select phages with therapeutic potential it is essential to assure that there is none 
potential for lysogenic conversion in order to avoid the expression of genes that encode 
toxins and to maintain their lytic characteristics, inactivating the pathogenic bacteria 
efficiently. The potential of lysogenic conversion can be evaluated through the detection of 
genes encoding integrase enzymes. The selection of phages must also have in 
consideration a potential ability to perform generalized transduction, i.e. the transmission 
of genes between bacteria (e.g. of virulent genes or other toxic factors on the 
bacteriophage) (Skurnik and Strauch, 2006). The sequencing of the phage genome for use 
with therapeutic agents should be made prior to further experiments (Holguín et al., 2015). 
The sequencing and annotation of the genome is important for the assessing of presence of 
potential toxins and genes associated with the lysogenic cycle, which is one concern when  
application of phage therapy is discussed (Skurnik and Strauch, 2006). Temperate phages 
should be avoided as therapeutic agents due to a variety of disadvantageous traits that 
could compromise the safety of the treatment. The ability to induce lysogeny rather than be 
obligatorily lytic potentially enhances the success of the bacterial host, making them 
resistant to related phages. Furthermore, they have the potential to introduce genes to the 
bacterial host in the process of lysogenic conversion (Abedon et al., 2011). 
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In the preparations of phage suspensions it is also necessary to remove the bacterial 
debris (such as lipopolysaccharides and endotoxins), since this components can be fatal for 
the treated organism (Carlton, 1999; Efrony et al., 2007; Inal, 2003).  
 
1.8.3. Phage-resistant mutants 
A major concern regarding the use of phages to control infections is the emergence 
of phage-resistant mutants. The development of phage-resistant bacteria can arise due to 
alteration or loss of the bacterial cell surface receptor, blocking the receptor by the 
bacterial extracellular matrix, inhibition of phage DNA penetration, production of modified 
restriction endonucleases degrading phage DNA, or inhibition of phage intracellular 
development (Labrie et al., 2010). The mutations affecting phage receptors represent the 
most frequent cause of phage resistance (Heller, 1992; Labrie et al., 2010). The receptors 
of the phages receptors are diverse bacterial surface-exposed molecules including many 
outer membrane proteins, sugar residues in the O antigen or lipopolysaccharide (LPS) core, 
teichoic acids, polysaccharides of the capsule or slime layer, or components of flagella and 
pili (Heller, 1992). Many phage receptors are essential virulence factors in pathogenic 
bacteria, some of which were identified through the selection of phage-resistant mutations. 
The receptors include capsular polysaccharides (Pickard et al., 2010; Smith et al., 1987; 
Smith and Huggins, 1982), adhesion and invasion factors(Begum et al., 2010; Pruzzo et al., 
1983; Ricci and Piddock, 2010), a protein involved in intracellular growth (Spears et al., 
2008), and, very commonly, different components of LPS (Petty et al., 2007, 2006; Zhang 
and Skurnik, 1994). If a phage receptor lies in a surface structure important for virulence, 
the phage-resistant mutants resulting from a loss or alteration of the receptor will be a 
virulent or attenuated. Such mutant bacterial clones will then be eliminated from the host 
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by the immune system and therefore should not present a problem if they arise during 
phage treatment (Levin and Bull, 2004; Ricci and Piddock, 2010; Smith et al., 1987; Smith 
and Huggins, 1982). Another way to overcome the problem of phage resistance is to use 
phage cocktails during treatment. The success of phage cocktails in the case of bacterial 
resistance requires that the selected phages do not possess overlapping cross resistance that 
is, bacterial mutants which are resistant to one phage are still sensitive to the other, and 
vice versa. Therefore, a cocktail consisting only of phages which use bacterial LPS as their 
receptors, for example, could be theoretically less successful than a cocktail made up of 
phages which utilized independent receptors. The ability of the phages in the cocktail to 
penetrate to bacteria sufficiently to achieve adsorption by multiple phages is also required. 
The possibility that phages could interfere with each other upon coinfection is a concern 
(Abedon and Thomas-Abedon, 2010). Pereira et al. (2016a) evaluated the efficacy of the 
E-2 and E-4 and a mixture of both phages (E-2/E-4) to control Enterobacter cloacae, and 
the results showed that the application of the phage cocktail limits the development of 
resistance by the bacteria. However, in several studies was observed that the colonies of 
resistant bacteria were smaller than that of the non-resistant ones and the former displayed 
slower growth (Pereira et al., 2016a; Silva et al., 2016). Colonies formed by resistant 
bacteria were visible only after 5 - 6 days of incubation but the non-resistant bacterial 
colonies were visible after 24 h of incubation. These results indicate that phage-resistant 
bacteria tend to be less fit and, consequently, it is expected that they will be eliminated 
from the environment faster than their wild-type relatives. Similar results were already 
registered for other bacterial hosts (Mateus et al., 2014; Silva et al., 2016). 
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1.8.4. Multiplicity of infection 
The most adequate multiplicity of infection (MOI) to be used in phage therapy is yet 
a controversial aspect. It has been stated that, contrarily to the case of chemicals and other 
substances, precise initial doses may not be essential in treatment, because of the self-
perpetuating nature of phages, revealed by an increasing of phage titers along with bacteria 
in infected fish or in contaminated waters (Mateus et al., 2014; Nakai, 2010; Silva et al., 
2014b). Rong et al. (2014) concluded that the application of phage (VPp1) could reduce 
the population of V. parahaemolyticus in infected oysters (105 CFU/mL) during 
depuration, with decreases, after 36 h of depuration, of 1.24, 1.99, 1.74 and 2.35 log 
CFU/g, respectively, in the negative control (oysters infected V. parahaemolyticus and not 
treated with phage) and in oysters treated with phage VPp1 at MOI 10, 1 and 0.1. Martínez 
and Hipólito-Morales (2013) reported that the phage Vpms1 was effective in eliminating 
the adverse effects of V. parahaemolyticus in brine shrimp with a MOI of 45, 4.2, 2.25 and 
0.45. These authors demonstrated that the reduction in the dosage of phages does not 
induce a significant reduction in the efficacy of Vpms1, not being detected significant 
differences between the doses of Vpms1. The MOI has been referred as an important factor 
influencing phage therapy efficiency, differing among various animals used in in vivo 
experiments namely due to the complex physicochemical environment and host defenses 
(Oliveira et al., 2010; Rong et al., 2014) but differing also from results obtained in in vitro 
assays (Kim et al., 2015; Tsonos et al., 2014). Tsonos et al. (2014) obtained similar results, 
as the efficiency of the phage cocktail used in treating CH2- infected chickens in vivo was 
negligible, even though, in vitro, the phages in the cocktail were able to efficiently lyse the 
APEC strain CH2. However, (Park and Nakai, 2003) obtained similar results in vitro and 
in vivo, and reported that the efficiency of the phage cocktail (PPpW-3 and PPpw-4) was 
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higher than that of the PPpW-3 and PPpW-4 phages when used individually in treating 
Pseudomonas plecoglossicida in both assays. Further studies are needed in order to 
understand the effect of low and high MOI in vitro and in vivo. 
 
1.9. Major advantages of phage therapy 
Phage therapy presents many advantages as biocontrol agents, including:  
(1) High specificity to target their host, determined by bacterial cell wall receptors, 
leaving untouched the remaining microbiota, a property that favors phages over other 
antimicrobials that can cause microbiota collateral damage. Owing to their host 
specificity, which can range from an ability to infect only a few strains of a bacterial 
species to, more rarely, a capacity to infect more than one relatively closely related 
bacterial genus (Gill and Hyman, 2010) phages only minimally impact health-
protecting normal flora bacteria (Gupta and Prasad, 2011; Skurnik et al., 2007). 
(2) Self-replication and self-limiting, meaning that low or single dosages will multiply as 
long as there is still a host threshold present, multiplying their overall antimicrobial 
impact.  
(3) As bacteria develop phage defense mechanisms for their survival, phages 
continuously adapt to these altered host systems.  
(4) Low inherent toxicity, since they consist mostly of nucleic acids and proteins. 
However, phages can interact with immune systems, at least potentially resulting in 
harmful immune responses, though there is little evidence that this actually is a 
concern during phage treatment (Alisky et al., 1998; Carlton, 1999; Kutateladze and 
Adamia, 2010). Nonetheless, it can be imperative for certain phage therapy protocols 
to use highly purified phage preparations (Skurnik and Strauch, 2006) to prevent 
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anaphylactic responses to bacterial components, such as the endotoxins that can be 
found in crude phage lysates (Skurnik et al., 2007). Phages similarly can release 
bacterial components while killing bacteria in situ, a property associated with lysis 
that also can result from the application of cell-wall disrupting antibiotics. 
(5) Limited impact of resistance development, bacteria will certainly develop resistance 
to phages, but the phages have a higher mutation and replication rate, as they can get 
round the adaptation of the bacteria and development of resistance is therefore 
limited. Moreover, it is comparably easier to find new phages because phages co-
evolve with their host bacteria, outnumbering bacteria in the environment by tenfold, 
make possible the rapid isolation of new lytic phages from the environment for 
phage-resistant bacterial mutants. So, even if the bacteria acquire phage resistance, 
new mutant phage that acts lytically against these bacteria can be used against the 
targeted bacteria (Matsuzaki et al., 2003). Smith and Huggins (1983) demonstrated 
that infections produced by phage-resistant mutants of an enteropathogenic strain of 
E. coli and their parents could be successfully controlled with mutant phage derived 
from phage that had been active against the parent bacteria (Durán et al., 2002; 
Lucena et al., 2004). Another possibility to reduce the appearance of resistant strains 
during treatment with the phage preparation is to make a mixture of different phage 
strains (Biswas et al., 2002; Watanabe et al., 2007). Moreover, phage resistant 
bacteria are still not necessarily pathogenic because selection for resistance could 
select against virulence (Levin and Bull, 2004; Nakai, 2010; Sandeep, 2006). The 
relatively narrow host range exhibited by most phages (Hyman and Abedon, 2010) 
limits the number of bacterial types with which selection for specific phage-
resistance mechanisms can occur. In addition, some mutations to resistance 
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negatively impact bacterial fitness or virulence due to loss of pathogenicity-related 
phage receptors (Capparelli et al., 2010; Skurnik et al., 2007). 
(6) Phages are relatively cheap and easy to isolate and propagate but may become time 
consuming when considering the development of a highly virulent, broad-spectrum, 
and non-transducing phage.  
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2.1. Abstract 
 
The recurrent emergence of infections outbreaks associated with shellfish 
consumption is an important health problem, which results in substantial economic losses 
to the seafood industry. Even after depuration, shellfish is still involved in outbreaks 
caused by pathogenic bacteria, which increases the demand for new efficient strategies to 
control the shellfish infection transmission. Phage therapy during the shellfish depuration 
is a promising approach, but its success depends on a detailed understanding of the 
dynamics of bacterial communities in the harvesting waters. This study intends to evaluate 
the seasonal dynamics of the overall bacterial communities, disease-causing bacterial 
populations and bacterial sanitary quality indicators in two authorized harvesting-zones at 
Ria de Aveiro. During the hot season, the total bacterial community presented high 
complexity and new prevalent populations of the main shellfish pathogenic bacteria 
emerged. These results indicate that the spring/ summer season is a critical period during 
which phage therapy should be applied. 
 
Keywords: shellfish harvesting waters, phage therapy, pathogenic bacteria, seasonal 
variation 
 
2.2. Introduction 
Bivalve shellfish is a nutritive food source whose consumption and commercial value 
have risen dramatically worldwide. Bivalves, such as mussels, clams and oysters, as filter 
feeding organisms, can concentrate contaminants from the surrounding water, including 
microorganisms that can cause several infectious diseases to humans (Brands et al., 2005; 
Butt et al., 2004; FAO, 2004; Huss et al., 2000; Muniain-Mujika et al., 2003; Robertson, 
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2007). Moreover, shellfish like oysters and sometimes clams or cockles, is often consumed 
raw or just lightly cooked (Bosch et al., 2009). This cooking habit, together with the fact 
that the whole animal, including viscera, is consumed, represents a major public health 
concern since shellfish act like passive carriers of human pathogenic microorganisms 
(Bosch et al., 2009; Lees, 2000; Murchie et al., 2005; Romalde et al., 2002). 
Pathogenic bacteria associated with seafood such as bivalves can be categorized into 
three general groups: indigenous, non-indigenous and processing contamination 
(Feldhusen, 1999; Iwamoto et al., 2010; Reilly and Kaferstein, 1997). Vibrio cholerae, 
Vibrio parahaemolyticus, Vibrio vulnificus, Clostridium botulinum and A. hydrophila are 
indigenous bacteria of marine or estuarine environments. Non-indigenous enteric bacteria 
such as Salmonella spp., pathogenic Escherichia coli, Shigella spp., Campylobacter spp., 
and Yersinia enterocolitica result from faecal contamination. Some bacteria, such as 
Bacillus cereus, Listeria monocytogenes, Staphylococcus aureus and Clostridium 
perfringens, are introduced during processing (Feldhusen, 2000). 
The microbiological control of shellfish products, as well as the classification of 
growing areas according to the sanitary quality, assumes particular importance (Despacho 
nº 14515, 2010). Adequate safeguards can be valuable in minimizing the probability of 
shellfish microbial contamination, from harvesting to consumption, and in the protection of 
public health. In Europe, the Directives 2006/ 113/CE (Directive 2006/113/CE, 2006) and 
2004/41/CE (Directive 2004/41/CE, 2004) are guidelines to control the levels of 
microbiological indicators of shellfish. The classifications of bivalves harvesting areas in 
Europe are based on the E. coli concentration measured in 100 g of flesh bivalve and intra-
valvular liquid (FIL). The harvesting zones are group in four classes, from A through D. 
The sequence corresponds to healthy, non-healthy, highly non-healthy and forbidden 
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harvesting when the most probable number (MPN) of E. coli per 100 g of FIL is ≤ 230, ≤ 
4600, ≤ 46.000 and > 46.000, respectively. This classification defines whether shellfish can 
be sent directly for consumption or needs prior treatment before its commercialization 
(Lees, 2000). All shellfish sent for direct human consumption without any additional 
processing must comply with the standard of less than 230 E. coli in 100 g of FIL in more 
than 90% of samples. Harvesting from polluted (category B and C) areas is allowed but 
shellfish must undergo treatment, before being commercialized. In this case, shellfish can 
be placed on the market for human consumption following controlled self-purification in 
tanks of clean seawater (commercial depuration), prolonged relaying in clean seawater or 
commercial heat treatment or processing by any other acceptable method (Jones et al., 
1991; Lees, 2000; Murchie et al., 2005). Where E. coli concentrations exceed 46.000 per 
100 g of FIL (category D) harvesting is forbidden.  
Depuration is a useful method to eliminate microorganisms from bivalves when 
conducted under conditions that maximize the natural filtering activity, which results in 
expulsion of intestinal contents. However, some pathogenic microorganisms are resistant 
to this process (FAO, 2008; Martínez et al., 2009; Rong et al., 2014). To reduce the risk of 
the development and transmission of infections caused by microbial pathogens, including 
multidrug-resistant bacteria, other technologies associated with depuration, such as phage 
therapy (application of lytic phages to prevent and/or to treat bacterial infections) must be 
developed. The association of the phage therapy with the depuration process would 
contribute to the improvement of the decontamination, reducing the time required, and 
consequently the production costs, increasing the bivalve safety and quality. As specific 
pathogen-killers, bacteriophages are effective agents for controlling bacterial infections, 
without affecting the normal flora (Hawkins et al., 2010; Park and Nakai, 2003). Moreover, 
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this is a relatively inexpensive method (Almeida et al., 2009). The potential of the use of 
bacteriophages to control bacterial diseases has been reported across diverse fields by 
numerous researchers (Almeida et al., 2009; Bueno et al., 2012; Hooton et al., 2011; 
Karunasagar et al., 2007; Lim et al., 2012; Mateus et al., 2014; Nakai and Park, 2002; Park 
and Nakai, 2003; Pereira et al., 2011a; Rong et al., 2014; Silva et al., 2014a; Viazis et al., 
2011; Vinod et al., 2006). However, the inherent phage specificity, which is one of the 
major advantages of phage therapy, requires an extensive knowledge of phage bacterial 
hosts, including their spatial and temporal dynamics. Therefore, in order to apply a 
successful phage therapy during the depuration of bivalves it is essential to conduct a 
detailed study of the dynamics of the whole natural microbial community in the harvesting 
waters, focusing on the most important pathogenic bacteria (Pereira et al., 2011b). 
The concentration of microorganisms within bivalves is higher than in the milieu 
where they growth, but the composition of their microbiota reflects the microbiological 
quality of harvesting waters (FAO, 1994). Numerous water characteristics, such as 
temperature, salinity, pH, concentration of nutrients and pollutants, as well as the season, 
influence the composition of microbial communities associated with bivalves (Richards, 
2001). Consequently, the monitoring of the microbiological quality of the harvesting water 
is a crucial factor that must be taken into account to control outbreaks associated with 
shellfish consumption. 
This work aimed to evaluate the seasonal dynamics of the composition of bacterial 
communities, including the disease-causing bacteria, and the sanitary quality bacterial 
indicators, in the water of two differently classified (statutes B and C) harvesting zones at 
the Ria de Aveiro (Portugal). The obtained results will be used to define critical periods 
when phage therapy/depuration should be applied to reinforce the depuration process. 
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2.3. Material and methods 
2.3.1. Study area and sampling 
Ria de Aveiro is an estuarine system located in the northwestern coast of Portugal 
(8"4'40W, 40'39'N) with an area of 47 km2 (Almeida and Alcantara, 1992) connected to the 
Atlantic by a narrow opening (Figure 2.1), where the culture of bivalves is an activity of 
great socio-economic importance. The most exploited species are: grooved carpet shell 
clam (Venerupis decussatus), pullet carpet shell clam (Venerupis pullastra), cockle 
(Cerastoderma edule), blue mussel (Mytilus edulis) and grooved razor shell clam (Solen 
marginatus), reaching an annual production of about 5000 tons (Sobral et al., 2000). 
Samples were collected in two authorized harvesting zones. One located in Mira channel 
(40º36'30"N, 8º44'52"W), classified as a statute B (230–4600 MPN E. coli per 100 g of 
FIL) and the other in Ílhavo channel (40º37'50"N, 8º41'9"W) classified as a statute C 
(4600–46.000 MPN E. coli per 100 g of FIL) (Despacho n.o 15264, 2013). Ílhavo channel 
(CI) is close to port and industrial facilities and receives the effluent of the sewage 
treatment plant. Mira channel (CM) is a recreational area which has almost no industrial 
activity and it is subjected to some anthropogenic contamination. Sampling was performed 
on six dates in February, April, June, August, October and December 2012. In each 
sampling site, four water samples were collected at 20 cm below surface with sterile glass 
bottles. Samples were kept cold in refrigerated boxes and immediately transported to the 
laboratory, where they were processed within a period of 1–2 h. 
 
2.3.2. Meteorological conditions and water properties 
Precipitation and solar irradiance prior to sampling events were recorded at the 
meteorological station of the University of Aveiro, located on the vicinity of sampling 
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sites. Temperature and salinity were measured in the field, using a WTW LF 196 
Conductivity Meter. Dissolved oxygen was also determined in the field with a WTW OXI 
96 oxygen meter equipped with a WTW BR 190 stirrer. pH was measured in the 
laboratory, at 25 ºC, with a pH probe (Orion, Model 290 A). 
 
Figure 2.1. Ria de Aveiro lagoon (Portugal) with the main channels of the estuarine system, 
channels indicated with arrows. 
 
2.3.3. Quantification of E. coli 
E. coli was enumerated by the filter membrane method (adapted ISO 9308-1 and 
ISO16649-2) using the selective culture medium Triptone Bile X- glucuronide (Merck, 
Germany). Plates were incubated at 37 ± 1 ºC for 24 h and the number of colony forming 
units per one hundred milliliters (CFU/100 mL) was determined. Three independent 
samples were analyzed at each sampling date and for each sample, two replicated analyses 
were conducted. 
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2.3.4. Quantification of the main pathogenic bacterial groups 
Samples were filtered through 0.22 µm polycarbonate filters (GE Osmonics), fixed 
with 4% paraformaldehyde for 30 min and rinsed twice with 1x Phosphate Saline Buffer 
(PBS) and Milli Q water. The filters were dried and stored at room temperature until 
hybridization. The relative abundances of specific groups of bacteria were determined by 
Fluorescent in situ hybridization (FISH), using 16S rRNA target probes (Amann et al., 
1990) labelled with CY3. The probe mix Eub338-II-III (Daims et al., 1999) was used to 
quantify bacteria belonging to the Domain Bacteria. The bacteria belonging to the non-
indigenous Enterobactereaceae family and to the indigenous Vibrio, Aeromonas and 
Salmonella genera were detected with the specific probes ENT183 (Friedrich et al., 2003), 
VIB572a (Huggett et al., 2008), AERO1244 (Böckelmann et al., 2000) and Salm-63 
(Kutter et al., 2006), respectively. Three replicates were made for each probe. Filter 
sections were placed on a parafilm covered glass slide and overlaid with 30 µL 
hybridization solution containing 2.5 ng/mL of probe. The hybridization solution was 
composed by 0.9 M NaCl, 20 mM Tris–HCl (pH 7.4), 0.01% SDS, and the optimum 
concentration of formamide for each probe (Pernthaler et al., 2001). Filters were incubated 
in a hybridization oven at 46 ºC for 90 min. After hybridization, filters were washed for 20 
min at 48 ºC in a washing solution (20 mM Tris– HCl pH 7.4, 5 mM 
ethylenediaminetetraacetic acid, 0.01% SDS, and the appropriate concentration of NaCl) 
(Pernthaler et al., 2001). Rinsed and dried filter pieces were counterstained with 2mg/mL 
of 4, 6-diamidino-2-phenylindole (DAPI) and mounted on glass slides with 
Vectashield:Citifluor (1:4). The DAPI staining provides a measure of the abundance of 
total microorganisms. Samples were examined with a Leica DM microscope equipped with 
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the appropriate filter sets for DAPI and CY3 fluorescence. For each of the three replicates 
of each sample, 10 random optical fields were counted. 
 
2.3.5. Evaluation of the structural diversity of bacterial communities 
2.3.5.1. DNA extraction 
For DNA extraction, four water samples of 300 mL were filtered through 0.22 lm 
pore-size filters (Poretics, USA). Collected cells were resuspended in 2 mL of TE buffer 
(pH 8.0) and centrifuged for 15 min at 13.000 g. After resuspension in 200 µL TE, 1 
mg/mL lysozyme solution was added to induce cell lysis and incubated at 37 ºC for 1 h 
(Pereira et al., 2011b). DNA extraction was performed using the genomic DNA 
purification kit (MBI Fermentas, Lithuania). After extraction, DNA was resuspended in TE 
buffer and stored at - 80ºC until analysis. The yield and quality of DNA were checked after 
electrophoresis in a 0.8% (w/v) agarose gel. 
 
2.3.5.2. Amplification of 16S ribosomal RNA gene sequences 
The extracted DNA was used to amplify 16 rRNA gene fragments, using a nested 
PCR approach. In the first PCR, the universal bacterial primers 27F (5´-AGA GTT TGA 
TCC TGG CTC AG-3´) and 1494R (5´-TAC GGT TAC CTT GTT ACG AC-3´) were 
used to amplify ca. 1450 bp of the 16S rRNA gene (Weisburg et al., 1991). A reaction 
mixture of 25 µL was prepared containing 1 x PCR buffer (MBI Fermentas, Vilnius, 
Lithuania), 0.2 mM deoxynucleoside triphosphates (MBI Fermentas, Vilnius, Lithuania), 
3.75 mM MgCl2 (MBI Fermentas, Vilnius, Lithuania), 4% (vol/vol) bovine serum albumin 
(BSA – Sigma–Aldrich, Co., St. Louis, MO), 0.1 µM primers, 1U Taq polymerase (MBI 
Fermentas, Vilnius, Lithuania) and template DNA (ca. 10 ng). Reaction was performed in 
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a MyCyclerTM termal cycler (Bio-Rad Laboratories, Hercules, CA, USA). Denaturation of 
the template for 5 min at 94 ºC was followed by 32 cycles of 45 s at 94 ºC, 45 s at 56 ºC, 
and 2 min at 72 ºC. The final extension lasted 10 min at 72 ºC. For DGGE analysis, a 410-
bp rRNA gene fragment was amplified with primers F968-GC-clamp (5´-GC-clamp- 
AACGCGAAGAACCTTAC-3´) and R1401 (5´-GCGTGTGTACAAGACCC-3´) 
(Integrated DNA Technologies, BVBA, Munich, Germany) (Nübel et al., 1996) using as 
template 1 µL of the product obtained from the first PCR. Amplification was conducted in 
a MyCyclerTM thermal cycler (Hercules, CA, USA). Additionally, the reaction mixture 
contained 4% acetamide (Sigma–Aldrich, Co., St. Louis, MO), 0.2 mM deoxynucleoside 
triphosphates (MBI Fermentas, Vilnius, Lithuania), 1 x PCR buffer (MBI Fermentas, 
Vilnius, Lithuania), 0.1 µM of each primer, 3.75 mM MgCl2 (MBI Fermentas, Vilnius, 
Lithuania), and 1 U Taq polymerase (MBI Fermentas, Vilnius, Lithuania). After 4 min of 
initial denaturation at 94 ºC, 34 cycles of 1 min at 95 ºC, 1 min at 53 ºC and 1.30 min at 72 
ºC were performed. Finally, an extension step at 72 ºC for 10 min was carried Positive 
(DNA from a known bacterial species) and negative (water only) controls were included in 
every PCR reaction. PCR products were checked after electrophoresis in a 0.8% (w/v) 
agarose gel. 
 
2.3.5.3. Denaturing gradient gel electrophoresis (DGGE) 
DGGE was performed with the DCode System (Universal Mutation Detection 
System, Bio-Rad. PCR amplification products were loaded onto 6.5% acrylamide gels 
using a denaturing gradient ranging from 40% to 58%, where 100% denaturant 
corresponded to 7 M urea (VWR International, LLC, Radnor, PA) and 40% (v/v) 
formamide (Sigma–Aldrich, Co., St. Louis, MO). A marker standard composed by 11 
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bands halting at different denaturant concentrations was included in the extremities of each 
gel (Heuer et al., 2002). The electrophoresis was performed at 58 ºC for 160 min at 160 V 
in 1 x Tris–acetate-EDTA buffer (5 Prime, Hamburg, Deutschland). After electrophoresis, 
the gels were stained and fixed for 20 min with 0.3 g silver nitrate (Sigma–Aldrich, Co., St. 
Louis, MO) in 0.1% (v/v) etanol 96% (Aga S. A., Loures, Lisboa) and 0.005% acetic acid 
(Merck KGaA, Darmstadt, Germany), rinsed, and then submerged in a developing solution 
of 0.003% (v/v) formaldehyde 37% (Sigma–Aldrich, Co., St. Louis, MO) and 0.33% 
sodium hydroxide (9%) (Merck KGaA, Darmstadt, Germany). Finally, 0.75% Na2CO3 was 
added to stop the development, and the gel was scanned using a Molecular FX apparatus 
(Molecular Image FX apparatus, Bio-Rad Hercules). 
 
2.3.5.4. Analysis of DGGE patterns 
The gels were digitalized and analyzed with the software package Gelcompar 4.0 
program (Applied Maths) as previously described by Smalla et al. (2001). After automatic 
band search, the bands detected were carefully checked and artefacts were removed. The 
band positions and their corresponding intensities (surface) from each treatment were 
exported to Excel (Microsoft). The band surface was converted to relative intensity by 
dividing its surface by the sum of all band surfaces in a lane. The effect of each treatment 
was evaluated based on the calculated Bray–Curtis similarities, using analysis of 
similarities (ANOSIM) to assess the significance of separation between microbial 
communities from different treatments (Ramette, 2007). The R value in ANOSIM ranges 
from 0 to 1, where R > 0.75 indicates significant differences, R > 0.5 moderate separation, 
R = 0.25 to 0.5 indicates broadly overlapping but separable and R < 0.25 high similarity 
(Clarke and Gorley, 2001; Sheader and Van Dover, 2007). 
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2.3.6. Data analysis 
The statistical analysis of data was performed with the IBM SPSS Statistics 22.0 
software. Normal distribution was assessed by the Kolmogorov–Smirnov test and 
homogeneity of variances by the Levene test. The non-parametric test Mann–Whitney U 
was used to compare E. coli concentration and the abundance of possible pathogenic 
bacterial groups at the two studied sites. To test the significance of differences within 
sampling events was used the Friedman’s ANOVA and the post hoc test described by 
Siegel and Castellan, (1988), using the critical difference of 3.74. The relations between 
the different parameters were examined using a Spearman correlation. The values were 
considered significantly different after applying the Bonferroni´s correction to a = 0.05. 
 
2.4. Results 
2.4.1. Meteorological conditions 
The values of solar irradiance and precipitation are shown in Table 2.1. The three-day 
average values of solar irradiance prior to sampling events varied between 6515.4Wm-2, in 
December and 24496.4Wm-2 in June. Precipitation (cumulative 21 days before sampling 
date) oscillated from 0.0 mm in February and 103.8 mm in December. 
 
2.4.2. Water properties 
The values of salinity, temperature, oxygen concentration and pH in the water samples 
collected at the two studied sites are shown in Table 2.1. In the Mira channel, salinity 
varied between 13.9, in December and, 28.6 in June and August. Temperature oscillated 
from 14.6 ºC in October to 22.8 ºC in August and the dissolved oxygen ranged between 6.2 
mg/L in October and 10.8 mg/L in April. pH varied between 7.8 in August and 8.1 in 
66 
 
December. In the Ílhavo channel, salinity varied between 17.1 in December and 28.4 in 
August. Temperature oscillated from 15.2 ºC in December and 23.0 ºC in August and the 
dissolved oxygen ranged between 5.8 mg/L in October and 10.1 mg/L in February and 
April. pH varied between 7.8 in June and August and 8.4 in December. 
 
Table 2.1 Water properties in the Mira and Ílhavo channels during the study period. 
Sampling 
dates 
Precipitation 
(mm) 
 
Solar 
irradiance 
(W m-2) 
Mira Channel Ílhavo Channel 
Salinity 
Temperature 
(ºC ) 
pH 
Dissolved 
oxygen 
(mg/L) 
Salinity 
Temperature 
(ºC) 
pH 
Dissolved 
oxygen 
(mg L) 
February 0.0 11820.0 26.4 15.0 7.9 9.7 26.1 15.5 8.0 10.1 
April 62.6 22584.2 26.0 16.2 8.0 10.8 26.9 15.9 7.9 10.1 
June 28.4 24496.4 28.6 20.5 7.9 7.5 28.2 20.8 7.8 6.2 
August 18.4 16061.2 28.6 22.8 7.8 7.1 28.4 23.0 7.8 6.4 
October 75.2 8617.6 26.5 14.6 7.9 6.2 27.8 15.7 7.9 5.8 
December 103.8 6515.4 13.9 14.9 8.1 9.3 17.1 15.2 8.4 9.6 
 
 
2.4.3. E. coli concentration 
The variation of E. coli concentration (Figure 2.2) was distinct in the two sampling 
sites (Mann–Whitney U test, p < 0.05). In the Ílhavo channel, the concentration of E. coli 
was higher than in the Mira channel and varied between 21 CFU/mL (April 2012) and 208 
CFU/mL (December 2012). A clear increase in the abundance of E. coli was noticed over 
the study period (June, August, October and December), reaching the highest values on 
June and December. The seasonal differences were statistical significant between April 
and, June, August and December (Friedman´ s test, p < 0.05). In the Mira channel, the 
highest value of E. coli was obtained in December 2012 (24.5 CFU/100 mL) and the 
lowest in April 2012 (5.75 CFU/100 mL). The differences between these two sampling 
moments were statistically significant (Friedman’s test, p < 0.05). 
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Figure 2.2 Seasonal variation of E. coli in Mira and Ílhavo channels 
 
2.4.4. Abundance of total bacterial cells 
Microbial abundance (DAPI counts) was significantly higher (Mann–Whitney U test, 
p < 0.05) in the Ílhavo Channel (1.9 – 4.2 x 109 cells/L) compared to the Mira channel (1.6 
–3.6 x 109 cells/L) (Figure 2.3). The relative abundance of the Bacteria domain (Eub338-
II-III), ranged from 81.7% to 96.1% and was similar (Mann–Whitney U test, p > 0.05) in 
the Mira and Ílhavo channels (data not shown). 
 
 
Figure 2.3 Total microbial abundance (DAPI counts) in Mira and Ílhavo channels. 
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2.4.5. Evaluation of the seasonal dynamics of bacterial community structure 
Bacterial community structure in the water of Mira and Ílhavo channels was 
examined by comparing DGGE profiles of 16S-rDNA fragments corresponding to the 
different sampling moments (Figures 2.4 and 2.5). Reproducibility of PCR amplification 
and DGGE was confirmed by similar results obtained for the four samples analyzed at each 
date (Figures 2.4B and 2.5B). DGGE profiles of the Mira between the structural diversity 
of bacterial in water samples collected in the different months. The communities in the 
water samples collected in June and August 2012 showed the highest value of similarity 
(>75%) and the lowest similarity corresponded to the February samples (<50%). In 
October and December, the bacterial communities present in the water samples showed 
similarity index (~ 60%). Statistical analysis confirmed that the bacterial community in the 
Mira channel differed significantly among the different sampling moments (ANOSIM R = 
1). 
 
Figure 2.4 Seasonal DGGE profile of 16S rDNA of bacterial communities of the Mira channel (A) 
and dendrogram generated from the pattern of bands obtained by DGGE (B). 
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In the Ílhavo channel, the Bray–Curtis similarity index for bacterial population 
ranged from ~ 45% to ~80%, varying between sampling moments (Figure 2.5B). Statistical 
analysis confirmed that the bacterial community in the Ílhavo channel differed 
significantly between different periods (ANOSIM R = 1). Cluster analysis of the band 
patterns obtained from DGGE analysis (Figure 2.5B) of the water samples of the Ílhavo 
channel, showed the lowest similarity index between December (~ 45%) and the remaining 
samples (Figure 2.5B). The communities in the water samples collected in August showed 
the highest value of similarity (80%) with water samples collected in October 2012. In 
June, April and February, the bacterial communities present in the water samples showed 
similarity index (>60%).  
 
Figure 2.5 Seasonal DGGE profile of 16S rDNA of bacterial communities of the Ílhavo channel 
(A) and dendrogram generated from the pattern of bands obtained by DGGE (B). 
 
DGGE profiles of 16S rDNA fragments of two sites (Figure 2.6) indicate that 
communities in the Mira and Ílhavo channel were statistically distinct in all sampling 
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moments (ANOSIM R = 0.408). A clear grouping by sampling site occurs for each 
sampling date (Figure 2.6B). 
 
 
Figure 2.6 Comparison of DGGE patterns of 16S rDNA fragments amplified from water DNA of 
the Mira and Ílhavo channels at six sampling dates. (A) Multidimensional scaling (MDS) 
ordination and (B) Cluster analysis. 
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2.4.6. Abundance of potential pathogenic bacterial groups 
In both sites and over the different sampling dates, Enterobactereaceae family was 
the most abundant bacterial group (Figure 2.7). The abundance of this family ranged from 
0.29 to 1.1 x 109 cells/L and was different in the two sites (Mann–Whitney U test, p < 
0.05). A clear and significant seasonal pattern of variation was observed in both channels, 
with highest and lowest values in the summer and winter, respectively (Friedman´ s test, p 
< 0.05). 
Vibrio was the second most abundant group, varying between 1.2 and 5.0 x 108 
cells/L. This group of bacteria showed a pattern of spatial variation that was different other 
groups, with higher relative values in the Mira channel. However, this difference was not 
statistically significant (Mann–Whitney U test, p > 0.05). 
In the Mira channel, the least abundant group was Aeromonas, with exception of 
October samples (Figure 2.7A). Aeromonas showed a seasonal profile of variation 
(Friedman´ s test, p < 0.05), ranging from 4.0 x 107 cells/L to 1.8 x 108 cells/L in the Mira 
channel and from 1.2 to 2.4 x 108 cells/L in the Ílhavo channel. The abundance of 
Aeromonas was similar (Mann–Whitney U test, p > 0.05) in the two sites. In the Ílhavo 
channel, Salmonella corresponded to the least abundant group in February, April, October 
and December, whereas in June and August, Aeromonas was the least abundant pathogen 
(Figure 2.7B). The seasonal differences were statistically significant between hot and cold 
seasons (Friedman´ s test, p < 0.05). The relative abundance of Salmonella was similar 
(Mann–Whitney U test, p > 0.05) in the two sites, varying between 5.3 x 107 cells/L and 
4.6 x 108 cells/L and showing a seasonal profile of variation with the highest values in 
summer and the lowest in winter. 
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A 
B 
 
Figure 2.7 Abundance of Enterobactereaceae family, Salmonella, Vibrio and Aeromonas 
quantified by FISH in Mira (A) and Ílhavo (B) channels. 
 
2.4.7. Correlations between bacteria and abiotic factors and between the different groups 
of bacteria 
The values of the Spearman´ s rho correlation among the abundance of bacterial 
groups and abiotic factors at the two studied sites are shown in Table 2.2.  
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Table 2.2 Spearman’s rho correlation between the abundance of bacterial groups and water 
proprieties at the Mira and Ílhavo channels. 
 
The abundance of total bacteria (DAPI counts) in the harvesting waters of both sites 
was correlated with temperature. At the Ílhavo channel, DAPI counts also correlated with 
salinity. The abundance of Enterobactereaceae was not correlated with any of the studied 
abiotic variables at the Mira channel, whereas at the Ílhavo channel correlated positively 
with salinity and negatively with precipitation. The abundance of Aeromonas also failed to 
show significant correlations at the Mira channel, whereas at the Ílhavo channel, there 
were positive correlations with salinity and temperature. At the Mira channel, the 
abundance of Vibrio was correlated with salinity and precipitation, whereas at the Ílhavo 
channel, was only correlated with precipitation. The abundance of Salmonella showed a 
strong correlation with temperature at both sites, and also with salinity at the Ílhavo 
channel. The abundance of E. coli was not correlated with any of the studied abiotic 
variables. 
Spearman 
Correlation 
(rs) 
DAPI Enterobactereaceae Aeromonas Vibrio Salmonella E. coli 
Mira Channel 
 
Irradiation. 
 
0.771 (n.s) 
N=6 
-0.200 (n.s) 
 N=6 
0.200 (n.s) 
N=6 
0.257 
(n.s) N=6 
0.771 (n.s) 
N=6 
-0.257 (n.s) 
N=6 
Precipitation. 
-0.455(n.s) 
N=6 
-0.698 (n.s)  
N=6 
-0.334 (n.s) 
N=6 
-0.820 (*) 
N=6 
-0.455 (n.s) 
N=6 
-0.213 (n.s) 
N=6 
Temperature. 
1.000 (**) 
N=6 
0.371 (n.s) 
 N=6 
0.543 (n.s) 
N=6 
0.486 
(n.s) N=6 
1.000 (**) 
N=6 
0.029 (n.s) 
N=6 
Salinity 
0.580 (n.s) 
N=6 
0.290 (n.s) N=6 
0.580 (n.s) 
N=6 
0.928 (**) 
N=6 
0.580 (n.s) 
N=6 
0.116 (n.s) 
N=6 
Ílhavo Channel 
Irradiation 
 
0.771 (n.s) 
N=6 
0.257 (n.s)  
N=6 
0.657 (n.s) 
N=6 
0.314 
(n.s) N=6 
0.600 (n.s) 
N=6 
-0.771(n.s) 
N=6 
Precipitation 
-0.395 (n.s) 
N=6 
-0.820 (*) 
 N=6 
-0.213 (n.s) 
N=6 
-0.941 
(**) N=6 
-0.516 (n.s) 
N=6 
-0.213 (n.s) 
N=6 
Temperature 
1.000 (**) 
N=6 
0.657 (n.s) N=6 
0.943 (**) 
N=6 
0.600 
(n.s) N=6 
0.943 (**) 
N=6 
-0.600 (n.s) 
N=6 
Salinity 
0.943 (**) 
N=6 
0.829 (*)  
N=6 
0.886 (*)  
N=6 
0.714 
(n.s) N=6 
1.000 (**) 
N=6 
-0.486 (n.s) 
N=6 
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The values of the Spearman´ s rho correlation coefficient among the different bacterial 
groups at the two studied sites are shown in Table 2.3. At the Mira channel, the abundance 
of E. coli was correlated with the abundance of Enterobactereaceae and Aeromonas, 
whereas at the Ílhavo channel, it was not correlated with the abundance of other bacterial 
groups. The abundance of Salmonella was correlated with of the abundance of Vibrio and 
Aeromonas at the Mira channel, whereas at the Ílhavo channel was correlated with all of 
the other groups. The abundance of Vibrio was correlated with Enterobactereaceae and 
Aeromonas abundances at the Mira and Ílhavo channel. At the Ílhavo channel, the 
abundance of Enterobactereaceae was correlated with the Aeromonas abundance. 
 
Table 2.3 Spearman´ s rho correlation between the concentration of E. coli and the abundance of 
Enterobactereaceae, Vibrio, Aeromonas and Salmonella, in Mira and Ílhavo channels. 
 
 
 
 
 
 
2.5. Discussion 
Depuration is a process by which shellfish release the intestinal content, including 
microorganisms. Its efficiency to remove bacteria depends on the bacterial group. For 
instance, presently practiced depuration is effective in the elimination of various faecal 
bacteria from shellfish but is not reliable in removing naturally occurring marine bacteria 
such as V. parahaemolyticus and V. vulnificus (FAO, 2008). Therefore, the association of 
Spearman 
Correlation (rs) 
Enterobactereaceae Vibrio Aeromonas Salmonella 
Mira Channel 
Vibrio 0.605 (**) N=18    
Aeromonas 0.453 (n.s) N=18 0.766 (**) N=18   
Salmonella 0.337(n.s) N=18 0.638 (**) N=18 0.596 (**)N=18  
E.coli  0.593 (**) N=18 0.405 (n.s) N=18 0.697 (**) N=18 0.177 (n.s) N=18 
Ílhavo Channel 
Vibrio 0.865 (**) N=18    
Aeromonas 0.662 (**) N=18 0.627 (**) N=18   
Salmonella 0.741 (**) N=18 0.709 (**) N=18 0.877 (**) N=18  
E. coli 0.091  (n.s) N=18 0.051 (n.s) N=18 -0.265 (n.s) N=18 -0.411 (n.s) N=18 
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depuration with phage therapy, which can selectively inactivate the remaining pathogenic 
bacteria in the shellfish, would significantly improve the efficiency of the decontamination 
process. Moreover, the quality of the harvesting water from which shellfish concentrated 
bacteria highly influences the success of depuration. However, the classification of the 
harvesting waters is solely based on the concentration of one indicator of faecal pollution, 
E. coli, which is a non-indigenous indicator.  
The present study showed that total bacterial number and the structure of the 
bacterial communities, which incorporates non and pathogenic bacteria, presented a broad 
temporal variation at both harvesting areas. The DGGE results showed that the similarity 
of the bacterial community structure between the sampling events was significantly 
different. At both areas, the bacterial community structure in the hot months (June and 
August) was more diverse and distinct from that in cold months (December and February). 
This temporal profile highlights the necessity of taking into consideration the dynamic of 
the whole community, including the seasonal variation, when choosing specific phages for 
the inactivation of shellfish pathogenic bacteria. 
Compared to the total bacterial numbers, the variation of the relative abundance of 
particular bacterial groups was more pronounced during the sampling period. Among the 
potentially pathogenic bacteria, the family Enterobactereaceae, which comprises the 
indicator E. coli used to classify the harvesting waters, was the most abundant group, 
indicating that non-indigenous bacteria are prevalent and an important source of 
contamination in these shellfish growing areas. Salmonella, also a non-indigenous 
pathogenic bacterium, showed a seasonal pattern of variation, correlating strongly with 
temperature at both sites. Several studies also observed that most outbreaks of Salmonella 
infection occurred during hot periods (summer and early autumn) (Checkley et al., 2000; 
76 
 
Zhang et al., 2012), indicating that the summer season is a critical time period for the 
consumption of bivalve molluscs. 
The indigenous Vibrio and Aeromonas, including V. parahaemolyticus, V. vulfinicus, 
V. cholerae and A. hydrophila (Colakoglu et al., 2006; Fukuda et al., 1996; Nakai and 
Park, 2002; Nakai et al., 1999), which are frequently associated with gastrointestinal 
outbreaks transmitted by the consumption of shellfish (Butt et al., 2004; FAO, 2004; Huss 
et al., 2000), were also present at high concentrations in the harvesting water. Vibrio and 
Aeromonas also presented a seasonal pattern of variation, with values up to 20 times higher 
in the hot season, when compared to the cold season. This observation reinforces the 
previous observation that the summer season is the critical period for gastrointestinal 
outbreaks associated with the consumption of bivalve molluscs. Other studies also 
observed that the incidence of V. parahaemolyticus and V. vulnificus (Davis and Sizemore, 
1982) and of Aeromonads (Maalej et al., 2004) increased in the summer months. Both non- 
and indigenous bacterial groups, as the total bacterial number, registered the highest values 
in summer. During this season, the volume of effluents from sewage treatment plants 
increases due to the tourism pressure (Silva, 2013). The central region of Portugal is visited 
by a high number of tourists during this period (between July and September), with the 
lowest values of activity registered between November and March (Silva, 2013). 
Fluorescence in situ hybridization, a culture-independent approach that uses specific 
probes for bacterial groups, provided a good overview of the real proportion of different 
cultivable and non-cultivable pathogenic bacteria and their dynamics in the harvesting 
waters. This information was crucial to the selection of phages to use in phage therapy 
during depuration, which must include specific phages of Enterobactereaceae, Salmonella, 
Vibrio and Aeromonas groups. 
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In general, the harvesting waters from the Ílhavo channel were more contaminated 
than from the Mira channel. This might be explained by the fact that Ílhavo channel is 
impacted by industrial facilities and receives the effluent of a sewage treatment plant. 
Moreover, this estuarine channel is classified as a C area due to a persisting natural 
occurring and anthropogenic microbial contamination. Contrastingly, the Mira channel has 
almost no influence of industrial activities, being only subjected to some contamination 
introduced by human and therefore classified as a B zone. The bacterial indicator used to 
classify the harvesting waters, E. coli, was present during the entire sampling period in the 
water of both harvesting areas, but, contrarily to Enterobactereaceae, Salmonella, Vibrio 
and Aeromonas, its seasonal variation was clearly stronger at the area located in the Ílhavo 
channel than in the Mira channel. Moreover, the seasonal profile of variation of E. coli was 
different of those observed for the other bacterial groups. In general, the abundance of the 
other bacterial groups studied in this work and the diversity of the bacterial community 
were higher during the hot season. However, for this bacterium, maximum values were 
observed in the cold months, namely in December in the Ílhavo channel. This might be due 
to the runoff from land and by resuspension of bottom sediments during the rainy period. 
In fact, the Enterobactereaceae family also showed lower decreases than those observe for 
Vibrio and Aeromonas groups in December and February. At the Mira channel, the 
abundance of E. coli was correlated with the abundance of Enterobactereaceae and 
Aeromonas, whereas at the Ílhavo channel, was not correlated with others bacterial groups. 
This spatial variability suggests that E. coli is not a good indicator of the presence of the 
other groups of bacteria, including pathogenic bacteria. Although a seasonal variation for 
the abundance of all bacterial groups and the bacterial community structure was observed 
at both harvesting zones, the seasonal profiles of variation were more evident in the 
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harvesting area of Mira channel. In the Ílhavo channel zone, a more land influenced area 
(Silva and Batista, 2008), the abundance and diversity of the bacteria might be influenced 
by other factors besides the seasonal variation. For harvesting areas where both seasonal 
and anthropogenic factors influence the abundance and structure of bacterial communities 
similar to this one, phage therapy during depuration must include phages against both 
indigenous and non-indigenous bacteria during the hot season and, during the cold season 
only against to non-indigenous bacteria. The overall bacterial community and the disease-
causing bacteria, as well as the indicator of microbiological water quality of both shellfish 
harvesting areas showed clear but distinct patterns of variation. The highest concentration 
of the main fish pathogenic bacteria and the bacterial indicators of faecal contamination 
occurred during the summer season. However, the maximum value of non-indigenous 
bacteria was registered during the rainy season, which indicates that the risk of diseases 
outbreak to humans in the shellfish harvesting areas is present during the cold season as 
well. Despite of the permanent risk of outbreak throughout the year, the summer season, 
when the most common pathogenic bacteria responsible for the transmission of shellfish 
infections reach the highest density, is the critical period for shellfish disease transmission. 
It is easier, fast and more affordable to quantify bacterial indicators in harvesting waters 
than in bivalves. However, the guidelines to classify bivalve harvesting areas are based on 
the quantification of the levels of microbiological indicators in shellfish (in 100 g of FIL) 
and not in the harvesting waters. Further studies will be conducted in order to evaluate the 
concentration and seasonal variation of the different bacterial groups within shellfish. This 
knowledge will provide further information that will help in the choice of the more 
appropriate phages to use in phage therapy to apply during the depuration process. 
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2.6. Conclusion 
In order to apply a successful phage therapy to inactivate shellfish pathogenic 
bacteria during the depuration process, is essential to have a comprehensive knowledge of 
the seasonal and spatial variability of the overall bacterial community, including the 
disease- causing bacteria and the indicators of microbiological water quality, in the water 
of the harvesting areas. A higher complexity of the whole community and an increase of 
abundance of the main pathogenic bacteria in the summer, indicate that this season is the 
critical time frame when phage therapy should be applied. In anthropogenic impacted and 
land influenced harvesting waters, phage therapy could be necessary also during the cold 
season. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 
 
 
 
 
 
81 
 
 
Chapter 3. Characterization and in vitro evaluation of new bacteriophages for 
the biocontrol of Escherichia coli 
 
Carla Pereiraa, Catarina Moreirinhaa, Magdalena Lewickab, Paulo Almeidab, Carla 
Clementeb., Jésus L. Romaldec, Maria L. Nunes d, Adelaide Almeidaa* 
 
aDepartment of Biology and CESAM, University of Aveiro, Campus Universitário de Santiago, 3810-193, 
Aveiro, Portugal. 
bSTAB VIDA-Investigação e Serviços em Ciências Biológicas, Madan Parque, 2825-182 Caparica, Portugal. 
cDepartamento de Microbiología e Parasitología, CIBUS-Facultad de Biologia, Universidade de Santiago de 
Compostela, Campus Vida s/n., 15782 Santiago de Compostela, Spain 
dCIIMAR/CIMAR - Centro de Investigação Marinha e Ambiental, Rua dos Bragas, 289, 4050-123 Porto, 
Portugal 
 
 
 
 
 
 
 
 
 
 
The content of this chapter was submitted as: 
Pereira C., Moreirinha C., Lewickab M., Almeida P., Clemente C., Romalde J.L., Nunes M.L., Almeida, A. 
(2016) Characterization and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli. 
Virus Research (Submitted) 
 
 
 
 
82 
 
 
83 
 
 
3.1. Abstract 
In the present study two new phages (phT4A and ECA2) were characterized and 
their efficacy was evaluated separately and in cocktail (phT4A/ECA2) to control 
Escherichia coli. The isolated phages, phT4A and ECA2, belonged to the Myoviridae and 
Podoviridae family, respectively and both are safe (no integrase and toxin codifying genes) 
to be used in bacterial control. In general, the increase of multiplicity of infection (MOI) 
from 1 to 100 promoted a significant increase in the efficiency of phage phT4A and phage 
cocktail phT4A/ECA2. Both phages were effective against E. coli, but phage phT4A 
(reduction of 5.8 log CFU/mL after 8 h treatment) was more effective than phage ECA2 
phage (reduction of 4.7 log CFU/mL after 8 h treatment). The use of a cocktail 
phT4A/ECA2 was significantly more effective (reductions of 6.2 log CFU/mL after 6 h 
treatment) than the use single phage suspensions of phT4A and ECA2 (reductions 5.3 log 
CFU/mL and 4.9 log CFU/mL, respectively, after 6 h treatment). The rate of emergence of 
phage-resistant mutants was lower for phage phT4A when compared with phage ECA2 
and phage cocktail phT4A/ECA2.The results indicate that in addition to the efficacy, the 
potential development of phage-resistant mutants must also be considered in the design of 
phage cocktails. 
 
Keywords: Bacterial-phage inactivation, phage cocktail, multidrug resistance bacteria, 
phenotypic resistance  
 
3.2. Introduction 
Global bivalve production in aquaculture has consistently increased over the years 
from 7.1 million tonnes in 1995 to 14.2 million tonnes in 2010, and the consumer demand 
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is expected to further increase in the future (FAO, 2012). In Portugal, bivalve represent the 
most important seafood group, representing 48% of total aquaculture production 
(INE/DPGA, 2010), and assuming prominent role in sustainable seafood production. 
Bivalve molluscan shellfish feed by filtering large volumes of seawater and 
accumulating food particles from their surrounding environment (Brands et al., 2005; Butt 
et al., 2004; FAO, 2004; Huss et al., 2000; Muniain-Mujika et al., 2003; Robertson, 2007). 
In order to protect public health and to provide safe products of high quality to consumers, 
several regulations have been imposed by the European Commission on shellfish 
production and trade chain in member states (FAO, 2008). These European regulations 
(EC Regulations, 2007, 2004b) establish limits for microorganism indicators (less than 300 
faecal coliforms or less than 230 E. coli per 100 g of flesh and inter-valve liquid - FIL) and 
pathogens (absence of Salmonella spp. in 25 g of flesh shellfish) for a production area of 
bivalves suitable for direct human consumption. Pathogenic strains of E. coli are 
transferred to seafood through sewage pollution of the coastal environment or by 
contamination after harvest (Kanayama et al., 2015; Potasman et al., 2002). E. coli food 
infection causes abdominal cramping, water or bloody diarrhea, fever, nausea and vomiting 
(Kanayama et al., 2015; Macrae et al., 2005; Martins et al., 2004; Potasman et al., 2002; 
Ward et al., 1997). 
Depuration conducted under conditions that maximize the natural filtering activity is 
a useful way of eliminating or reducing the concentration of microorganisms in bivalves by 
clearance of intestinal contents. However, some pathogenic microorganisms are resistant to 
this process (FAO, 2008; Martínez et al., 2009; Rong et al., 2014) . In order to reduce the 
risk of transmission of infections caused by microbial pathogens, including multidrug-
resistant bacteria, it is essential to develop alternative approaches. One of the most 
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promising is the association of phage therapy (application of lytic phages to prevent and/or 
to treat bacterial infections) to the depuration process (Rong et al., 2014). This association 
will contribute to the improvement of the decontamination efficiency, likely reducing the 
time required for the depuration, and consequently, the production costs, with additional 
benefits in bivalve safety and quality. After depuration, bivalves may be intended for 
consumption if they have a level lower than 230 E. coli in 100 g of flesh and intra-valvular 
liquid (FIL), and absence of Salmonella spp. (FAO, 2008).  
Phages, which are viruses that infect bacteria, have been used as therapeutic or 
prophylactic agents to control bacterial infections (Biswas et al., 2002; Bruttin and 
Brussow, 2005; Chhibber et al., 2008; Jun et al., 2014b, 2013; Kumari et al., 2009; Park et 
al., 2000). Phage-based applications have been demonstrated for food safety (Denes and 
Wiedmann, 2014; Endersen et al., 2014). As specific pathogen-killers, bacteriophages are 
effective agents for controlling bacterial infections, without affecting the normal 
microbiota (Hawkins et al., 2010; Park and Nakai, 2003; Pereira et al., 2011a). The 
association of depuration and phage therapy will contribute to the improvement of the 
decontamination efficiency, likely reducing the time required for the depuration, and 
consequently, the production costs, with additional benefits in bivalve safety and quality. 
To the best of our knowledge, there is only report on the combination of phage therapy and 
bivalve depuration. In this study, Rong et al. (2014) concluded that the application of 
bacteriophage (VPp1) could reduce the population of Vibrio parahaemolyticus in infected 
oysters during depuration without water recirculation (Rong et al., 2014). 
The aim of this study was to evaluate the efficiency of two new phages of E. coli 
(phT4A and ECA2), individually or combined in cocktails, to control E. coli in the 
perspective of their potential use for phage-enhanced bivalve depuration. 
86 
 
3.3. Material and methods 
3.3.1. Bacterial strains and growth conditions 
The bacterial strain E. coli (ATCC 13706) was used in this study as phage host. The 
bacterial strains used in host range studies are listed in Table 3.1. E. coli (ATCC 25922), 
Salmonella enterica serovar Typhimurium (ATCC 13311 and ATCC14028), Aeromonas 
hydrophila (ATCC 7966), Vibrio fischeri (ATCC 49387), Vibrio parahaemolyticus (DSM 
27657), Vibrio anguillarum (DSM 215 97), Photobacterium damselae damselae (DSM 
7482), Shigella flexneri (DSM 4782), Listeria innocua (NCTC 11288), Listeria 
monocytogenes (NCTC1194) and Aeromonas salmonicida (CECT 894) were purchased 
from ATCC, DSM, NCTC and CECT collection, respectively. Five Salmonella enterica 
serovar Enteriditis strains were isolated from food samples and gently provided by 
Controlvet Laboratory. The other bacterial strains used in this study were isolated in 
previous works from water samples collected in Ria de Aveiro (Louvado et al., 2012; 
Pereira et al., 2016a). Fresh bacterial cultures were maintained in Tryptic Soy Agar (TSA; 
Liofilchem, Italy) at 4 °C. Before each assay, one isolated colony was aseptically 
transferred to 10 mL of Tryptic Soy Broth (TSB; Liofilchem, Italy) and grown overnight at 
37 ºC. An aliquot of this culture (100 μL) was aseptically transferred to 10 mL of fresh 
TSB and grown overnight at 37 °C to reach an optical density (O.D. 600 nm) of 0.8, 
corresponding to about 109 cells per mL. 
 
3.3.2. Phage isolation and purification 
Two phages were isolated from sewage network of Aveiro (station EEIS9 of 
SIMRIA Multi Sanitation System of Ria de Aveiro) collected in different places at 
different times (December 2014 and March 2015). Sewage water was filtered through 0.45 
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µm pore size polycarbonate membranes (Millipore, Bedford, MA, USA). The filtrate was 
added to double-concentrated TSB medium with 1 mL of fresh culture of the host, E. coli 
(ATCC 13706). The mixtures were incubated at 37 ˚C for 18 h at 80 rpm, and then filtered 
through a 0.2 µm membrane (Millipore Bedford, MA, USA). Chloroform (final volume of 
1%) was added to the supernatants and phage concentration was determined as described 
before. Plates were incubated at 37 ˚C and examined for the presence of lytic plaques after 
12 h. One single plaque was removed from the agar, diluted in TSB, and then chloroform 
(final volume of 1%) was added to eliminate bacteria. The sample was centrifuged and the 
supernatant was used as a phage source for a second isolation procedure. Three successive 
single-plaque isolation cycles were performed to obtain pure phage stocks for both 
bacteria. All lysates were centrifuged at 10.000 g for 10 min at 4 ˚C, to remove intact 
bacteria or bacterial debris. The phage stock was stored at 4 ˚C and 1% chloroform (final 
volume) was added. The phage produced on E. coli was designated as phT4A and ECA2. 
The phage suspension titre was determined by the double-layer agar method using TSA as 
culture medium (Adams, 1959). The plates were incubated at 37 °C for 8 h and the number 
of lysis plaques was counted. The results were expressed as plaque forming units per 
millilitre (PFU/ mL). 
 
3.3.3. Electron microscope examination 
Phage particles of a highly concentrated suspension (109 PFU/mL) were negatively 
stained with 2% uranyl acetate (Electron Microscopy Sciences, Hatfield, UK) and electron 
micrographs were taken using a JEOL 1011 transmission electron microscope (JEDL USA 
Inc, Peabody, MA, USA) operating at 100 kV. Images were acquired with a Gatan CCD-
Erlangshen ES100W. 
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3.3.4. Phage DNA extraction 
Bacteriophage suspensions (109 PFU/mL) of the two phages (phT4A and ECA2) 
were centrifuged 3 times at 13.000 g for 10 min. The phage lysates were ultracentrifuged 
(Beckman, Optima LE-80K) at 100.000 g for 2 h at 10 °C. The extraction of nucleic acid 
from phage particles was performed using the phage DNA isolation kit (Norgen Biotek 
Corp, Canadan), as indicated by the instructions provided by the manufacturer. Nucleic 
acid yield was quantified in the Qubit 2.0 Fluorometer (Invitrogen, Carlsbad, CA, USA). 
The resulting product was electrophoresed through 0.8% agarose gel at 80 V for 40 min. 
 
3.3.5. Whole genome sequencing and bioinformatics analyses 
Phage DNA samples (176 and 200 ng of phage ECA2 and phage T4 DNA samples 
respectively) were firstly fragmented using NEB Next dsDNA Fragmentase (New England 
Biolabs) and digested DNA further processed for libraries construction, using reagents 
from KAPA Library Preparation Kit for Ion Torrent according to manufacturers' protocol. 
470 bp long high quality libraries containing about 370 bp long insert were further used for 
template preparation using Ion PGM Hi-Q Template Kit and sequencing on Ion Torrent 
PGM machine using the chip316 v2 and Ion PGM HiQ Sequencing Kit according to 
manufacturers' protocol. The generated raw sequence data were analysed with CLC 
Genomics Workbench 8.5.1 (CLC Bio-Qiagen, Aarhus, Denmark). After quality trimming, 
the sequence reads were de novo assembled and the consensus sequence of the most 
represented contigs of both genomes, was generated. The annotation for both genomes was 
performed using the phage/plasmid pipeline from the RAST server Version 2.0 (Aziz et al., 
2008). The nucleotide sequences were compared with those of other genes in GenBank 
using BLAST. Open reading frames (ORFs) were identified using the NCBI ORF Finder. 
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The genome sequences of both phages were deposited in GenBank under the accession 
numbers KX130727 (phage phT4A) and KX130726 (phage EC2A).  
 
3.3.6. Phage host range determination and efficiency of plating (EOP) analysis 
Bacterial strains used in the present work are listed in Table 3.1. As a first approach, 
phage host range was determined by spot testing according to (Adams, 1959). The plates 
were incubated at 37 °C and examined for plaques after 8 - 12 h. Bacterial sensitivity to a 
bacteriophage was established by a lysis cleared zone at the spot. According to the clarity 
of the spot, bacteria were differentiated into two categories: clear lysis zone (+), no lysis 
zone (-). The EOP was determined for bacteria with positive spot tests (occurrence of a 
clear lysis zone), using the double-layer agar method (Adams, 1959). For each phage, three 
independent experiments were performed. The EOP was calculated (average PFU on target 
bacteria / average PFU on host bacteria) (Kutter, 2009) along with the standard deviation 
for the three measurements. 
 
3.3.7. Phage adsorption 
Exponential host bacterial cultures of E. coli strain (ATCC 13706) were adjusted to a 
0.8 O.D. at 600 nm (corresponding to a cell density of 109 CFU/mL). Ten microliters of the 
phage suspensions were added to 10 mL of the E. coli strain (ATCC 13706) in order to 
have a MOI of 0.001 (Stuer-Lauridsen et al., 2003) and incubate at 25ºC. Aliquots of 
mixture were collected after 0, 5, 10, 15, 20, 25, 30, 40, 50, 60 and 70 min of incubation 
and chloroform (final volume 1%) was added. The mixture was centrifuged at 12.000 g for 
5min and supernatants were immediately filtered by using 0.2 µm membrane (Millipore 
Bedford, MA, USA). The filtrates containing unadsorbed phages were diluted and titrated. 
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The plates were incubated at 37 °C and examined for plaques after 4-8 h. Adsorption was 
expressed as the percentage decrease of the phage titre in the supernatant, as compared to 
the time zero. Suspensions of phages without any cells were used as no-adsorption 
standard for calculations (Stuer-Lauridsen et al., 2003). Three independent assays were 
done. 
 
3.3.8. One step growth assays 
Exponential host bacterial cultures of E. coli strain (ATCC 13706) were adjusted to a 
0.8 O.D. at 600 nm (corresponding to a cell density of 109 CFU/mL). Ten microliters of the 
phage suspensions were added to 10 mL of the bacterial culture in order to have a MOI of 
0.001 and incubated at 25 ºC (Mateus et al., 2014). The mixture was centrifuged at 12.000 
g (ThermoHeraeus Pico, Hanau, Germany) for 5 min, the pellet was re-suspended in 10 
mL of TSB at 25 ºC and then were diluted and titrated. The plates were incubated at 37 °C 
and examined for plaques after 4 - 8 h (Mateus et al., 2014). Three independent assays 
were done. 
 
3.3.9. Bacterial kill curves 
Bacterial inactivation was determined with the two single phage suspensions (phT4A 
and ECA2) and the phage cocktail (phT4A/ECA2, the two phages were mixed together and 
each phage at the same concentration) using the bacterium E. coli as host, at a MOI of 1 
and 100. For each assay, two control samples were included: the bacterial control (BC) and 
the phage control (PC). The bacterial control was not inoculated with phages and the phage 
controls were inoculated with phages but not with bacteria. Controls and test samples were 
incubated exactly in the same conditions. Aliquots of test samples and of the bacterial and 
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phage controls were collected after 0, 2, 4, 6, 8, 10, 12 and 24 h of incubation. In all 
assays, the phage titre was determined in duplicate through the double agar layer method 
after an incubation period of 4 – 8 h at 37 °C. Bacterial concentration was determined in 
duplicate in TSA after an incubation period of 24 h at 37 °C. Three independent 
experiments were performed for each condition. 
 
3.3.10. Isolation of phage-resistant mutants 
Sensitive E. coli was grown at 37 ºC for 16 h. A soft agar overlay seeded with 300 
µL of fresh bacterial culture was then spotted with 10 µL of each of the two lytic phage 
suspensions. Using high phage titers were formed clear lysis plaque zones, where there 
was complete absence of visible bacterial growth after 6h of incubation. However, after 24 
h of incubation, resistant colonies were observed in these zones. The phage resistant 
colonies were picked up and purified by successive sub-culturing in TSA, in order to 
remove attached phage particles, and were used in further experiments. 
 
3.3.11. Determination of the rate of emergence of bacterial mutants 
In order to determinate the mutation frequencies per cell, ten isolated colonies were 
picked and inoculated into ten tubes with TSB medium, grown at 37 °C for 24 h. Aliquots 
of 0.1 mL from the 100 –10-3 dilutions were inoculated onto the double-layer plates and 
were incubated at 37 °C for five days (because some of the phage-resistant mutants grow 
very slowly). Simultaneously, 0.1 mL aliquots of 10-5, 10-6 and 10-7 dilutions were plated 
on TSA medium without phage, for determination of colony number. The averaged colony 
number of mutants (obtained from the ten isolated colonies) in 1 mL of culture (prepared 
from the culture with phages) was divided by the averaged colony number of the control 
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(prepared from the culture without phages) (Filippov et al., 2011). Three independent 
assays were performed. 
 
3.3.12. Fitness of phage resistant mutants 
 The growth of the bacterial populations was quantified in the presence and in the 
absence of each of the phages and cocktail. Fitness of each bacterial population was 
analysed in two ways: (i) determining bacterial concentration after 6 and 12 h incubation 
and (ii) determining population growth rate using the optical density (OD). 
 Exponential host bacterial cultures of sensitive E. coli strain (ATCC 13706, without 
phage contact) and resistant mutants of phage phT4A, EC2A and cocktail phT4A/EC2A 
were adjusted to a 0.8 O.D. at 600 nm (corresponding to a cell density of 109 CFU/mL). E. 
coli sensitive was added to 4 of the 10 samples to obtain a final concentration of 105 
CFU/mL. Three of the inoculated samples with sensitive E. coli were inoculated with 
phages phT4A, EC2A and cocktail phT4A/EC2A, respectively (sensitive with phage 
phT4A, sensitive with phage EC2A and sensitive with cocktail phT4A/EC2A) to obtain a 
final concentration 107 PFU/mL and the remaining infected sample was not added of 
phages sensitive bacteria without phages). Resistant mutants to phage phT4A were added 
to 2 of 10 samples to obtain a final concentration of 105 CFU/mL. One of these samples 
was inoculated with phage phT4A (resistant with phage phT4A) to obtain a final 
concentration 107 PFU/mL and the remaining infected samples were not added of phages 
(resistant bacteria without phages). The same protocol was followed for the mutants 
resistant to phage ECA2 and to the cocktail phT4A/ECA2. Samples were incubated at 25 
ºC and bacterial concentration was determined by the spread method in duplicate in TSA 
medium after an incubation period of 6 and 12 h post inoculation. The plates were 
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incubated at 37 °C and bacterial concentration (CFU/mL) was calculated after 24 h 
incubation. Three independent experiments were performed for each condition. 
 In parallel with this assay we determined 12 h growth curves using a 
spectrophotometer (Halo DB- 20, Dynamica Scientific) using culture turbidity as a proxy 
for bacterial density. OD600nm was taken at 0, 2, 4, 6, 8, 10 and 12 post inoculation. Three 
independent experiments were performed for each condition. 
 
3.3.13. Prophage detection in the host bacterium after phage addition 
The phage resistant mutants isolated (section 3.3.11) were stress induced with 
mitomycin C (Sigma Chemical, St. Louis, MO, USA). An isolated colony was picked out 
from the lysis plaque, inoculated into tubes with TSB medium and stress-induced with 
mitomycin C (Sigma Chemical, St. Louis, MO, USA) at a final concentration of 1 μg/mL. 
Cells with temperate phages usually result in the release of the phage (after inducing it by 
mitomycin C). A negative control, without mitomycin C was prepared. The samples were 
incubated overnight at 37 °C and centrifuged (10.000 g, 10 min). The supernatant was 
filtered through 0.22 µm (GE Osmonics), and tested against each phage-sensitive host 
strain by applying the spot test. After an overnight incubation at 37 ºC, bacterial lawns 
were checked for clear zone. The presence of a clear zone after stress inducing indicates 
that bacteria have prophages in their genome. Three independent assays were performed.  
 
3.3.14. Detection of host sensitivity to bacteriophages after one cycle of phage contact  
 The isolated phage resistant mutants (section 3.3.10) were used. Ten isolated 
colonies were picked out from the lysis plaque, inoculated in TSB medium and incubated 
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for 24 h. After incubation, the culture was tested against each phage- resistant host strain 
by applying the spot test and was also streak-plated on TSA plates. An isolated colony 
grown in TSA was selected and the procedure was repeated more 4 times. Overall, 5 
streak-plating steps on solid medium were done (Pereira et al., 2016a). A control using 
phage sensitive strain was prepared. Controls and test samples were incubated exactly in 
the same conditions. After to be done 5 streak-plating steps on solid medium was 
determined efficacy of plating and adsorption of phages to resistant bacteria as described in 
Section 3.3.6 and 3.3.7, respectively. Three independent assays were done. 
 
3.3.15. Statistical analysis 
Statistical analysis was performed using GraphPad Prism 6. The geometric mean 
(GM) was calculated as the antilog of the mean of log10 transformed concentrations; the 
standard deviations (SD) of log10 transformed concentrations were also determined, as 
well as the 95% confidence interval for the mean and the range of values. Student’s t-test 
was used to examine differences between the growth of resistant bacteria and sensitive 
bacteria in presence of the phage after 6 and 12h incubation, and the differences between 
the growth of resistant and sensitive bacteria in absence of the phage after 6 and 12h 
incubation. In order to determine whether or not to use a t-test, Levene’s test for 
homogeneity of variances was used, assuming equal or unequal variances in the two 
groups compared, with the hypothesis of equal variance being rejected at p > 0.05. 
Two-way ANOVA with repeated measures was used to analyze the statistical 
differences between growth curves of the sensitive and resistant bacteria in presence and 
absence of the phages during the sampling time. Normal distribution was assessed by the 
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Kolmogorov–Smirnov test and homogeneity of variances by the Levene´s test, and the 
signiﬁcance was assumed when p < 0.05. 
The existence of significant differences on bacterial concentration in killing curves 
assays was analyzed using a two-way ANOVA with repeated measures, with MOIs (1 and 
100), phages (phT4A, EC2A and phT4A/EC2A) and treatment times being used as fixed 
factors. The significance of the differences was evaluated by comparing the results 
obtained in the test (BP phT4A, BP EC2A, BP phT4A/EC2A) and control samples (BC) 
for the different times among treatments of each of the three independent assays, and 
analyzing the results obtained in different treatments (BP phT4A MOI 1, BP EC2A MOI 1, 
BP phT4A/EC2A MOI 1, BP phT4A MOI 100, BP EC2A MOI 100, BP phT4A/EC2A 
MOI 100) and bacterial control (BC MOI 1 and BC MOI 100), along different times. The 
significance of the differences of viral concentration in killing curves assays was analyzed 
using a two-way ANOVA with repeated measures. The significance of differences was 
evaluated by analyzing the results obtained in the test (BP phT4A, BP EC2A, BP 
phT4A/EC2A) and phage control (PC) during the sampling time, and comparing the results 
obtained in the test (BP phT4A MOI 1, BP EC2A MOI 1, BP phT4A/EC2A MOI 1, BP 
phT4A MOI 100, BP EC2A MOI 100, BP phT4A/EC2A MOI 100) and phage control (PC 
phT4A MOI 1, PC EC2A MOI 1, PC phT4A/EC2A MOI 1, PC phT4A MOI 100, PC 
EC2A MOI 100, PC phT4A/EC2A MOI 100) for the different times, among treatments, of 
each of the three independent assays. Normal distribution was assessed by the 
Kolmogorov–Smirnov test and homogeneity of variances by the Levene´s test. Whenever 
signiﬁcance was accepted, at p < 0.05, Tukey's multiple comparison test was used for a 
pairwise comparison of the means. To test the significance of the interactions, F test was 
applied.  
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3.4. Results 
3.4.1. Phage isolation and purification 
The phT4A and ECA2 phages, isolated from Aveiro municipal sewage using E. coli 
as host, formed clear plaques on the host strain with a diameter of 0.5 - 2 mm and 1 - 5 
mm, respectively (Figure 3.1). High titre suspensions (109 PFU/mL) were obtained.  
 
3.4.2. Virion morphology 
Based on the morphological analysis by Transmission Electron Microscopy (TEM) 
(Figure 3.1), the two phages were identified as Caudovirales. Phage ECA2 has an 
icosahedral head with approximately 56 ± 2 nm of width and was identified as member of 
family Podoviridae. Phage phT4A has an elongated icosahedral head with approximately 
80 ± 2 nm width and a contractile tail with a length approximately 107 ± 3 nm, being 
identified as a member of family Myoviridae. 
 
Figure 3.1 Examples of phage plaque morphologies and electron micrographs of phages E. coli. 
(A) Phage phT4A. (B) Phage ECA2. The bars represent 50 nm 
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3.4.3. Genome sequencing 
The phage genomes were sequenced with an Ion Torrent PGM semiconductor 
approach. The sequencing run of phage genomes resulted in 246.183 reads of 358.2 bp 
mean length for phage ECA2, of which 206 413 were specific representing a fold coverage 
of approximately 1.354, and 52.403 reads of 380.5 bp mean read length for phage phT4A, 
of which 40.869 were specific, representing a fold coverage of approximately 59. Phage 
genomes were de novo assembled using CLC Genomics Workbench 8.5.1. 
For phage phT4A 17.070 - fold coverage was obtained, 170.698 bp genome and a 
G+C content of 41.67%. For phage ECA2, 6.192- fold coverage, 38.890bp genome and 
49.96% G+C content. The sequence analysis revealed the presence of 255 potential 
number of Coding Sequences (CDS) in phage phT4A and 47 potential CDS in phage 
ECA2 (Table 3.1S and 3.2S). In general, the genes of phages phT4A and ECA2can be 
roughly classified into three classes of clusters. The early (Class I), the class comprising 
gene clusters dealing with DNA metabolism (Class II) and finally the third group (Class 
III) with structural proteins of virion, helpers for assembly, and responsible for host lysis 
(Table 3.1S and 3.2S). None of the genomes featured any lysogenic related genes and it 
can be safety assumed that the two phages feature a lytic lifestyle. No genes encoding 
toxins, virulence factors or antibiotic resistance genes were identified based on amino acid 
sequence homology searches. Overall, the genome sequence of phage phT4A had the 
highest similarity with three of the Myoviridae phages: 99% with Klebsiella phage Matisse 
(accession number KT001918.1) and Klebsiella phage KP15 (accession number 
GU295964.1) and 98% with Klebsiella phage KP27 (accession number HQ918180.1). 
However, the genome sequence of phage ECA2 feature 98, 97 and 96% similarity with 
other three of the phages  Podoviridae Enterobacter phage E-2 (accession number 
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KP791805.1), Enterobacter phage E-4 (accession number KP791807.1) and Enterobacter 
phage E-3 (accession number KP791806.1) respectively. 
 
3.4.4. Analysis of phage host range and efficiency of plating (EOP) 
Table 3.1 Lytic spectra of two phages E. coli isolates determined on 40 bacterial strains included in 
eight genera. Clear lysis zone (+), no lysis zone (-).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Species 
Infectivity of phage 
phT4A ECA2 
Salmonella Typhimurium ATCC 13311 + + 
Salmonella Typhimurium ATCC 14028 + + 
Salmonella Enteriditis CVA + + 
Salmonella Enteriditis CVB + - 
Salmonella Enteriditis CVC + + 
Salmonella Enteriditis CVD + + 
Salmonella. Enteriditis CVE + + 
Escherichia coli ATCC 25922 - - 
Escherichia coli ATCC 13706  + + 
Escherichia coli BC30 - - 
Escherichia coli AE11 + + 
Escherichia coli AD6 + + 
Escherichia coli AF15 + + 
Escherichia coli AN19 - - 
Escherichia coli AC5 + - 
Escherichia coli AJ23 - + 
Escherichia coli BN65 + + 
Escherichia coli BM62 - - 
Shigella flexneri DSM 4782 - - 
Citrobacter freundii 6F + + 
Citrobacter freundii 10I + + 
Providencia vermicola + + 
Providencia sp. + + 
Proteus vulgaris  + + 
Proteus mirabilis + + 
Klebsiella pneumoniae - - 
Enterobacter cloacae + + 
Listeria innocua NCTC 11288 - - 
Listeria monocytogenes NCTC 1194 - - 
Vibrio parahaemolyticus DSM 27657 - - 
Vibrio anguillarum DSM 21597 - - 
Vibrio fischeri ATCC 49387 - - 
Photobacterium damselae damselae DSM 7482 - - 
Aeromonas hydrophilla ATCC 7966 - - 
Aeromonas salmonicida CECT 894 - - 
Pseudomonas aeruginosa - - 
Pseudomonas fluorescens - - 
Pseudomonas putida - - 
Pseudomonas segetis - - 
Pseudomonas gingeri - - 
Total number of strains lised 20 19 
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Spot test indicated that phage phT4A had the capacity to form completely cleared 
zones on 20 of the 40 strains and the phage ECA2 form cleared zones on 19 of the 40 
strains (Table 3.1). However, EOP results indicate that the two phages formed phage lysis 
plates only in presence of the host. 
 
3.4.5. Phage adsorption 
Phage adsorption assays with phage phT4A showed that approximately 38% of the 
phage particles adsorbed to the host cell after 40 min and 97% adsorbed after 70 min 
(Figure 3.2). For phage ECA2, 46% of particles adsorbed to E.coli within 20 min and 98% 
after 40 min (Figure 3.2). 
 
Figure 3.2 Adsorption of phages phT4A and ECA2 to E. coli. Percentage of unadsorbed phage is 
the ratio of PFU in the supernatant to the initial PFU and was determined by tittering an equivalent 
dilution of the phage in the absence of host cells. Values represent the mean of three experiments; 
error bars represent the standard deviation. 
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3.4.6. Burst size and explosion time 
The one step growth curve for phages phT4A and ECA2 was determined in TSB at 
25 ºC (Figure 3.3). From the triphasic curves obtained, an eclipse period of 30 min, a latent 
period of 50 min and a burst size of 17 ± 2 PFU/host cell were calculated for phage 
phT4A. The phage ECA2 phage is characterized by an eclipse period of 10 min, the latent 
time was at 30 min and each infected bacteria produced 117± 11 PFU/host cell.  
 
Figure 3.3 One-step growth curves of phages phT4A and ECA2 in the presence of E. coli as host. 
Values represent the mean of three experiments; error bars represent the standard deviation. 
 
3.4.7. Killing curves 
ANOVA revealed that the differences between sampling time among treatments 
(F6,12 = 552.1, p < 0.0001) and density of the E. coli (F7,14 = 575,7, p < 0.0001) were highly 
significant. There was also a significant interaction between treatments and density of the 
E.coli (F42,84 = 118.7, p < 0.0001). 
At a MOI of 1, the maximum of bacterium inactivation with phage phT4A phage was 
5.8 log CFU/mL (Figure 3.4A), achieved after 8 h of phage therapy (ANOVA, p < 0.05). 
Increasing the MOI to a value of 100 did not significantly increase the inactivation factor 
(5.8 log CFU/mL) after the same period of time (ANOVA, p > 0.05). ). However, after 4 h 
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of incubation, increasing the MOI from 1 to 100, significantly increases the inactivation 
(ANOVA, p < 0.05) (decreased of 1.5 log CFU/mL to MOI of 1 and of 4.0 log CFU/mL to 
MOI of 100) (Figure 3.4A). After 12 h, the inactivation factor was about 5.5 log CFU/mL 
for both MOI of 1 and 100 (ANOVA, p > 0.05) (Figure 3.4A). 
For the phage ECA2, the maximum inactivation was about 4.9 log CFU/mL for both 
MOI, achieved after 6 h of applying phage therapy (ANOVA, p < 0.05) (Figure 3.4A). 
After 12 h, the rate of inactivation was still considerably high (3.9 log CFU/mL; ANOVA, 
p < 0.05) for both MOI (Figure 3.4A). At a MOI of 1, the inactivation of phages phT4A 
and ECA2 was statistically similar during the treatment (ANOVA, p > 0.05), however, at a 
MOI of 100, the inactivation of two phages was statistically different (ANOVA, p < 0.05). 
At a MOI of 100, the rate of bacterial inactivation with the phage phT4A (maximum 
reduction of 5.8 log CFU/mL after 8 h) was, in general, significantly higher (ANOVA, p < 
0.05) than the one obtained with the phage ECA2 (maximum reduction of 4.9 log CFU/mL 
after 6 h). However, after 4 h of treatment, the bacterial inactivation of phage ECA2 was 
significantly higher (ANOVA, p < 0.05) than the obtained with the phage phT4A for the 
both MOIs (Figure 3.4A) 
At MOI of 1, the maximum inactivation factor with phage cocktail phT4A/ECA2 
was 5.3 log CFU/mL, achieved after 8 h of phage therapy (ANOVA, p < 0.05). Increasing 
MOI to a value of 100 did significantly increase the rate of inactivation (6.2 log CFU/mL) 
after the same period of time (ANOVA, p > 0.05) (Figure 3.4A). However, after 4 h, the 
inactivation factor was considerably higher for the MOI 100 (4.3 log CFU/mL for to MOI 
of 1 and 5.6 log CFU/mL for to MOI of 100; ANOVA, p < 0.05) and significantly higher 
(ANOVA, p < 0.05) than the one obtained with the phage phT4A for both MOI (1.5 log 
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CFU/mL for to MOI of 1 and 4.0 log CFU/mL for to MOI of 100; ANOVA, p < 0.05) and 
phage ECA2 for MOI of 100 (4.8 log CFU/mL; ANOVA, p < 0.05) (Figure 3.4A). 
Bacterial density in the BC increased by 3.5 log CFU/mL (ANOVA, p < 0.05) during 
the first 12 h of incubation. The differences in bacterial concentration between different 
MOI values were not significant (ANOVA, p > 0.05) (Figure 3.4A). 
ANOVA revealed that the differences between sampling time among treatments 
(F6, 12 = 552.15, p < 0.0001) and concentration of the phages (F11, 22= 341.3, p < 0.0001) 
were highly significant. There was also a significant interaction between treatments and 
concentration of the phages (F66, 132 = 113.2, p < 0.0001). 
No decrease on the phage survival was observed during the 12 h of the experiments 
for the phage alone and for the phage in the presence of the host (Figure 3.4B) in different 
treatments. While the phage control (PC) remained constant throughout the experiment 
(ANOVA, p > 0.05), when the phage phT4A was incubated in the presence of the host, a 
significant increase (1.5 log PFU/mL, ANOVA, p < 0.05) was observed for the MOI of 1 
(ANOVA, p < 0.05) (Figure 3.4B). Increasing the MOI to 100 caused a smaller increase in 
phage survival (about 0.5 log PFU/mL). For phage ECA2, the survival factor increased up 
to 1.5 log PFU/mL for MOI of 1 and 0.35 log PFU/mL for MOI of 100. Similar survival 
factors were observed for phage cocktail phT4A/ECA2 (1.4 log PFU/mL for MOI of 1 and 
0.3 log PFU/mL for MOI of 100) (Figure 3.4B). 
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Figure 3.4 Inactivation of E. coli by the two phages alone (phT4A and ECA2) and phage cocktail 
(phT4A/ECA2) at a MOI of 1 and 100 during 12 h. A. Bacterial concentration: BC — bacteria 
control; BP — bacteria plus phage. B. Phage concentration: PC — phage control; BP — bacteria 
plus phage. Values represent the mean of three experiments; error bars represent the standard 
deviation. 
 
3.4.8. Fitness of phage resistant mutants 
In presence of phages differences between the growth of resistant bacteria and the 
growth of sensitive bacteria were observed, with resistant bacteria to phage phT4A (Figure 
3.5A , t = 55.12, p = 0.0003 at 6 h and t = 18.07, p = 0.003 at 12 h), EC2A (Figure 3.5B, t 
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= 14.05, p = 0.005 at 6 h and t = 18.79, p = 0.0028) and cocktail phT4A/EC2A (Figure 
3.5C, t = 14.33, p = 0.0048 at 6 h and t = 50.14, p = 0.0004) with higher concentration at 6 
and 12 h than the sensitive bacteria. In absence of phages no differences were found 
between  the concentration of resistant bacteria to the phage phT4A (Figure 3.5A , t = 
0.3950, p = 0.7310 at 6 h and t = 0.6928, p = 0.5601), the phage EC2A (Figure 3.5B , t = 
1.746, p = 0.2230 at 6 h and t = 0.6928, p = 0.5601 at 12 h) and to the cocktail 
phT4A/ECA2 (Figure 3.5C, t = 2.00, p = 0.1835 at 6 h and t = 2.097, p = 0.1710 at 12 h) 
and the concentration of sensitive bacteria. 
 
Figure 3.5 In vitro bacterial concentration of resistant mutants versus their sensitive bacteria in the 
presence or absence of phages after 6 and 12h. (A) phage phT4A, (B) phage EC2A and (C) cocktail 
phT4A/EC2A. 
 
In parallel with this assay, we determined the growth curves using the sensitive 
bacteria and resistant bacteria for the phage phT4A, EC2A and phT4A/EC2A (Figure 3.6). 
For both phages and cocktail, ANOVA revealed significant differences (ANOVA, p < 
0.05) between growth rate of the sensitive bacteria in presence the phage and, sensitive and 
resistant bacteria in absence of the phage and resistant bacteria with phage, after 8 h of 
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incubation. ANOVA did not reveal any difference in growth rates (ANOVA, p > 0.05) 
between the sensitive and resistant bacteria in the absence of phage and resistant bacteria 
with phage, during the 12 h incubation 
 
 
Figure 3.6 Growth curves of sensitive bacteria and resistant mutants in presence or absence of 
phages during 12h, with optical density readings at 600 nm. (A) phage phT4A, (B) phage EC2A 
and (C) cocktail phT4A/EC2A. 
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3.4.9. Rate of emergence of bacterial mutants resistant to bacteriophages 
E. coli (ATCC 13706) showed different rates of phage-resistant mutants for single 
phage suspensions and for phage cocktails (Table 3.2). Mutants bacterial colonies were 
smaller than those of the control without added phage and were visible only after 6 days of 
incubation. In the control, colonies were visible after 24 h of incubation in similar 
conditions. 
 
Table 3.2 Frequencies of E. coli spontaneous mutations to bacteriophage resistance 
 Control sample 
(CFU mL-1) 
Sample treated 
with phages 
Frequency of 
mutants 
phT4A 1.07  0.64 x109 3.77  0.90 x105 3.52 x10-4 
ECA2 5.70  0.18 x108 1.58  0.46 x106 2.77 x10-3 
phT4A/ECA2 9.72  0.32 x108 1.17  0.51 x106 1.20 x10-3 
 
 
3.4.10. Prophage detection in the host after phage addition 
No phages were detected in the supernatant of cultures of E. coli or in the mixture of 
bacteria and phages after treatment with mitomycin C (1µg/mL). 
 
3.4.11. Host sensitivity to bacteriophages after one cycle of phage contact 
After incubation in the presence of single phages and phage cocktail and five streak-
plating steps on solid medium, host bacterium had the capacity to form completely cleared 
zones (positive spot test). However, EOP results indicated that the two phages and phage 
cocktail did not form phage lysis plates and cannot adsorb and replicate in the presence to 
the resistant strains bacteria after five streak-plating steps on solid medium.  
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3.5. Discussion 
To our knowledge, there is not yet any report regarding the use of phages to control 
E. coli during depuration. In this study, the data provide proof of the principle that the 
application of phages (phT4A and ECA2) could reduce the population of E. coli. 
Elimination of E. coli in bivalves is important for public health because this pathogen can 
easily accumulate in raw bivalves (Kanayama et al., 2015; Potasman et al., 2002). 
Depuration is a process by which shellfish expulse their intestinal contents, however, some 
pathogenic microorganisms are resistant to this process (FAO, 2004; Martínez et al., 2009; 
Rong et al., 2014). 
The selection of appropriate bacteriophages to be used in phage therapy is a critical 
stage to achieve a successful phage-mediated control of pathogenic bacteria. Criteria such 
as the host range, adsorption rate, latent period, burst size, lysogenic induction capacity, 
survival in the environment and safety are determinant in the election of suitable phages to 
be used in phage treatment (Mateus et al., 2014; Pereira et al., 2011a). 
The genome sequence of the two phages isolated in this study was obtained, and no 
genes encoding products such as toxins, antibiotic resistance and integrase enzymes were 
detected by aminoacid sequence comparisons. Consequently, from our current state of 
knowledge, these phages can be considered safe to be used in phage therapy. Based on 
genomic analysis but also on the lack of lysogenic strains following the resistance 
development experiment, EC2A and phT4A phages can be considered as lytic 
bacteriophages which is a prerequisite for phage therapy. One of the major advantages of 
phage treatment is the phage specificity, since the non-target bacterial populations should 
remain relatively undisturbed (Koskella and Meaden, 2013). The two phages infected only 
their hosts, spot test indicated that phage phT4A had the capacity to form completely 
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cleared zones on 20 of the 40 strains, and the EC2A phage form cleared zones on 19 of the 
40 strains. However, efficiency of plating (EOP) results indicated that the two phages did 
not form lysis plaques in none of the strains. Mirzaei and Nilsson (2015), obtained similar 
results, stating that spot test cannot be used for identification and selection of phages to a 
phage library and should be replaced by EOP assays. Lysis is a plausible mechanism which 
happens when an overload of phages simultaneously infects a bacterium leading to lysis 
either from the action of lysins or from rapid depletion of the cells resources (Abedon, 
2011). In addition, as observed by Mirzaei and Nilsson (2015), high EOP was not 
correlated to the results from the spot tests. Further studies are needed to understand the 
different results obtained by both approaches. 
Although, the genome sequence of phage phT4A has a similarity between 98-99% 
with three phages of the Klebsiella pneumonie (phage Matisse, phage KP15 and phage 
KP27), the phage phT4A not infect the strain of the K. pneumonie (negative spot test) used 
in this study. However, the genome sequence of the phage ECA2 has a similarity 96 - 98% 
with three phages of the Enterobacter cloacae (phage E-2, phage E-3 and phage E-4) and 
had the capacity to form completely cleared zones of the E. cloacae, but presented 
different host ranges. The host range is determined by the tail fibers on the phage and the 
cell receptors on the host cell (Beckendorf et al., 1973). Alterations of either of these 
structures alter the host range. Phages that differed in host range showed completely 
unrelated variable regions, while phages overlapping host ranges shared highly related 
variable regions (Brussow and Desiere, 2001). 
Phage ECA2 presented the highest burst size (117±11 PFU/host cell), around 7 times 
higher than that of phage phT4A (17 ± 2 PFU/host cell) and the shortest latent period, 30 
min (50 min for the phage phT4A). Similar higher burst size and small latent period were 
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also found in other bacteriophages such as E. coli O157:H7 phage CEV1 (150 PFU/cell, 26 
min) (Raya et al., 2006). Other study shows for E. coli phage PPO1, as for the phage 
phT4A, a small burst size of 14 particles per cell with a latent period of 26 min (Fischer et 
al., 2004). The relatively short latent period and large burst size of phage ECA2 relatively 
to phage phT4A make the former more suitable to be used for the control of E. coli during 
bivalve depuration. 
Before application of phages to inactivate pathogenic bacteria, like E. coli, during 
bivalves depuration, it is important to characterize in vitro the dynamics of phage-host 
replication. The kinetic theory of phage therapy predicts that the MOI could be critical to 
the bacterial inactivation efficiency. It has been shown, both in vitro and in vivo, that the 
reduction of pathogenic bacteria increases in parallel with MOI or that bacterial reduction 
occurs sooner at higher MOI values (ChiHsin et al., 2000; Pasharawipas et al., 2011; 
Prasad et al., 2011). However, Nakai (2010) related that the precise initial doses of phage 
may not be essential because of the self-perpetuating nature of phages, revealed by an 
increasing of phage titers along with bacteria (Nakai, 2010). In the present study, the 
increase in MOI from 1 to 100 promoted a significant increase in the efficiency of phage 
phT4A phage and of phage cocktail phT4A/ECA2. For the phage ECA2, the efficiency 
was similar for both MOI. However, the number of phages after 4 h of treatment in the 
presence of the host at MOI of 1 increased more (by 1.5 log PFU/mL) than at MOI 100 (by 
0.5 log PFU/mL). This confirms the hypothesis that due to the self-perpetuating nature of 
phages precise initial doses of phage may not be essential. 
Both single phage suspensions and phage cocktails of the phages isolated in this 
study can be used to inactivate E. coli. The phage cocktail was, however, more efficient 
than the single phage suspensions. Moreover, bacterial inactivation with the phage cocktail 
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occurred sooner than with phage phT4A suspension. These results are in accordance with 
other studies (Mateus et al., 2014; O’Flynn et al., 2006; Wagner and Waldor, 2002) that 
achieved a faster and higher inactivation by using phage cocktails, than that obtained with 
single-phage suspensions.  
The emergency of phage-resistant mutants is currently a major concern related with 
the use of phages to control infections and it generally accepted that the selection of 
resistant strains can be prevented by the combined use of cocktails of two or more phages 
(Hooton et al., 2011; Sandeep, 2006; Scott et al., 2007). In this study, the use of phage 
cocktails, as well as the use of single-phage suspensions, did not prevent the occurrence of 
phage-resistant mutants. The rate of proportion of phage-resistant bacteria (determined 
using only resistant mutants selected from the surviving bacteria after treatment) to phage 
cocktail phT4A/ECA2 was, however, slightly lower than that observed when phage ECA2 
was tested, but around 3 times higher than that of phage phT4A. Similar results have been 
observed for other phages (Filippov et al., 2011; Silva et al., 2014a). 
Bacterial resistance to phages can evolve via a number of different mechanisms, 
which vary in their specificity. Many of these resistance mechanisms impose a significant 
fitness cost (Bohannan et al., 1999; Brockhurst et al., 2005), but these costs can vary across 
environments and the degree of competition for resources (Lennon et al., 2007; Quance 
and Travisano, 2009). Given the potential use of phages as biocontrol against pathogenic 
bacteria, a clear understanding of costs associated with evolved resistance could lead to 
more effective management strategies (Flynn et al., 2004; Heringa et al., 2010; Levin and 
Bull, 2004). In the experiments of cost of resistance no differences were observed between 
the concentration of sensitive bacteria and resistant mutants when grown in the absence of 
phages. Similar results have been observed by Meaden et al. (2015). Under standard 
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laboratory conditions, Meaden et al. (2015) found no differences in density or maximum 
growth rates of sensitive versus resistant mutants when grown, in the absence of phages, 
however, when grown in plant the resistant mutants exhibited reduced densities relative to 
the sensitive population. These authors demonstrate that phage-mutants that have evolved 
resistance via a single mutational step pay a substantial cost for this resistance when grown 
on their in vivo, but do not realize any measurable growth rate costs in vitro. In future 
studies, it is necessary to study the cost of resistance in bivalves since that resistance to 
phage can significantly alter bacterial growth, and therefore that phage-mediated selection 
in nature is likely to be an important component of bacterial pathogenicity. 
After five streak-plating steps on solid medium, the resistant bacteria showed 
positive spot test, which was not observed for the first two streak-plating steps. In a first 
glance, it seems to be due to lysogenic induction. However, the experiments of lysogenic 
induction showed no evidence of lysogeny (results of the mitomycin test) was observed 
during the phage addition experiments. Moreover, genes codifying to integrase were not 
detected in the phages genomes. This behavior can be due some genomic or phenotypic 
modifications in the resistant cells after phage-stress stop. More studies of the research 
group are ongoing in order to clarify this comportment. Previous results of research group 
(Pereira et al., 2016b) for S. Typhimurium and three specific phages showed that the 
phage-resistant bacteria did not recover sensitivity, phages did not adsorbed to phage-
resistant bacteria and after five streak-plating steps on solid medium these bacteria 
remained resistant. The authors compared the spectral changes of S. Typhimurium resistant 
and phage-sensitive cells, and observed relevant differences for peaks associated to amide I 
(1620 cm-1) and amide II (1515 cm-1) from proteins and from carbohydrates and 
phosphates region (1080-1000 cm-1). This results suggested that the bacteria have evolved 
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a range of barriers apparently irreversible (associated to amide I and amide II form 
proteins, carbohydrates and phosphates) to prevent phage adsorption and, consequently, 
prevent infection. 
 
 
3.6. Conclusion 
The results of the present work suggest that phage therapy using phages individually 
or combined in cocktails, can be an effective alternative to reduce the concentration of E. 
coli, particularly if combined in a phage cocktail. Although phage ECA2 presents a higher 
burst size and a shorter latent period, inactivating E. coli sooner than phage phT4A, the 
latter is less inducer of resistance to phage infection. Consequently, to select phages to be 
used in cocktails, it is necessary to take into account not only phage efficacy but also its 
propensity to develop phage-resistant mutants. 
 
3.7. Supplementary material  
 
Table 3.1S Coding sequences identified in phT4A phage of E. coli strain. 
Location Gene name Organism evidence Identity Evalue Function 
202_969 
hypothetical protein KP-
KP15_gp117 
Citrobacter phage IME-CF2 73% 6e-128 Thioredoxin, phage-associated 
966_1211 
hypothetical protein 
CPT_Matisse125 
Klebsiella phage Matisse 99% 0.0 hypothetical protein 
1211_1468 
hypothetical protein 
KP27_138 
Klebsiella phage KP27 100% 2-e54 Phage protein 
1465_2388 
cytosine-specific 
methyltransferase 
Klebsiella phage Miro 99% 0.0 
DNA-cytosine methyltransferase (EC 
2.1.1.37) 
2370_2903 
putative homing 
endonuclease RB16 6 
Enterobacteria phage RB16 45% 5e-59 Phage-associated homing endonuclease 
2962_3240 
hypothetical protein 
GAP161_115 
Cronobacter phage 
vB_CsaM_GAP161 
100% 4e-63 Phage protein 
3969_4484 
hypothetical protein 
KP-KP15_gp111 
Klebsiella phage KP15 98% 8e-126 Phage protein 
4484_4804 
hypothetical protein 
CPT_Miro118 
Klebsiella phage Miro 100% 2e-71 hypothetical protein 
4812_7028 
hypothetical protein 
KP-KP15_gp109 
Klebsiella phage KP15 100% 0.0 Phage protein 
7065_7715 
hypothetical protein 
CPT_Miro116 
Klebsiella phage Miro 100% 5e-158 Phage protein 
7712_7870 
hypothetical protein 
CPT_Miro115 
Klebsiella phage Miro 100% 7e-28 hypothetical protein 
7867_8337 
hypothetical protein 
CPT_Miro114 
Klebsiella phage Miro 100% 2e-109 Phage protein 
8353_8637 
hypothetical protein 
KP-KP15_gp105 
Klebsiella phage KP15 100% 3e-62 Phage protein 
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8739_8993 
hypothetical protein 
CPT_Matisse111 
Klebsiella phage Matisse 100% 2e-54 hypothetical protein 
8995_9219 
hypothetical protein 
CPT_Matisse110 
Klebsiella phage Matisse 100% 9e-48 Phage protein 
9254_9682 
hypothetical protein 
ADS69_00109 
Enterobacter phage phiEap-3 100% 2e-101 Phage protein 
10109_9717 
baseplate wedge 
subunit 
Klebsiella phage KP15 100% 5e-90 Phage baseplate wedge subunit (T4-like gp25) 
10664_10110 baseplate hub subunit Klebsiella phage KP27 100% 5e-135 Phage baseplate hub 
11404_10661 
gp51 baseplate hub 
assembly protein 
Klebsiella phage KP15 100% 4e-180 Phage baseplate 
12296_11433 gp54 baseplate subunit Klebsiella phage KP15 100% 0.0 Phage baseplate tail tube initiator 
13379_12306 
tail-tube assembly 
protein 
Klebsiella phage Matisse 100% 0.0 Phage baseplate tail tube cap (T4-like gp48) 
14985_13390 
hypothetical protein 
KP-KP15_gp096 
Klebsiella phage KP15 99% 0.0 Phage protein 
15742_15167 
baseplate distal hub 
subunit 
Klebsiella phage KP15 100% 2e-137 
Phage baseplate distal hub subunit (T4-like 
gp28) 
15812_16921 baseplate hub subunit Klebsiella phage KP27 100% 0.0 Phage baseplate hub 
17295_16918 
hypothetical protein 
KP-KP15_gp093 
Klebsiella phage KP15 100% 1e-87 Phage protein 
17593_17282 
hypothetical protein 
CPT_Matisse99 
Klebsiella phage Matisse 99% 2e-68 Phage protein 
17894_17604 
hypothetical protein 
CPT_Matisse98 
Klebsiella phage Matisse 100% 4e-64 Phage protein 
18555_17986 
hypothetical protein 
ADS69_00091 
Enterobacter phage phiEap-3 99% 4e-138 hypothetical protein 
20161_18632 gp30 DNA ligase Klebsiella phage KP15 100% 0.0 DNA ligase, phage-associated 
20756_20142 
hypothetical protein 
KP27_104 
Klebsiella phage KP27 100% 7e-152 Phage protein 
20974_20753 
hypothetical protein 
KP27_103 
Klebsiella phage KP27 100% 9e-47 Phage protein 
21212_20976 
hypothetical protein 
KP-KP15_gp085 
Klebsiella phage KP15 100% 2e-48 Phage protein 
21565_21248 
putative homing 
endonuclease 
Klebsiella phage KP27 58% 7e-34 Phage-associated homing endonuclease 
22068_21763 
hypothetical protein 
CPT_Margaery94 
Citrobacter phage Margaery 93% 6e-55 T4-like phage protein, T4 GC1630 
22451_22299 
hypothetical protein 
CPT_Margaery91 
Citrobacter phage Margaery 96% 3e-26 Phage protein 
22618_22448 
hypothetical protein 
ADS69_00084 
Enterobacter phage phiEap-3 98% 5e-34 hypothetical protein 
22842_22603 
hypothetical protein 
KP-KP15_gp081 
Klebsiella phage KP15 100% 8e-53 hypothetical protein 
23138_22845 
hypothetical protein 
KP-KP15_gp080 
Klebsiella phage KP15 100% 3e-64 hypothetical protein 
23533_23264 
hypothetical protein 
KP27_095 
Klebsiella phage KP27 100% 6e-58 Phage protein 
23895_23533 Vs.6 Klebsiella phage KP15 100% 3e-82 Pyruvate formate-lyase (EC 2.3.1.54) 
24331_23906 
hypothetical protein 
KP27_093 
Klebsiella phage KP27 100% 4e-101 Phage protein 
24933_24514 
hypothetical protein 
CPT_Miro82 
Klebsiella phage Miro 99% 1e-95 Phage protein 
25224_24943 
hypothetical protein 
CPT_Miro81 
Klebsiella phage Miro 99% 1e-62 Phage protein 
25532_25459 tRNA -- -- -- tRNA-Met-CAT 
25791_25540 
hypothetical protein 
KP-KP15_gp074 
Klebsiella phage KP15 100% 1e-53 Phage protein 
26143_25802 
head assembly 
chaperone with GroEL 
Klebsiella phage Miro 100% 2e-76 Phage capsid assembly chaperone 
26665_26159 cytidine deaminase- Klebsiella phage Matisse 99% 6e-125 dCMP deaminase (EC 3.5.4.12) 
26939_26655 
hypothetical protein 
KP-KP15_gp071 
Klebsiella phage KP15 100% 6e-64 hypothetical protein 
27183_26932 
hypothetical protein 
KP-KP15_gp070 
Klebsiella phage KP15 100% 1e-52 hypothetical protein 
27467_27180 
hypothetical protein  
ADS69_00071 
Enterobacter phage phiEap-3 100% 2e-64 hypothetical protein 
27642_27520 
PseT 3' phosphatase 
and 5' polynucleotide 
kinase 
Klebsiella phage KP15 98% 7e-20 
3'-phosphatase, 5'-polynucleotide kinase, 
phage-associated 
486_85 
hypothetical protein 
JD18_241 
Klebsiella phage JD18 88% 1e-77 hypothetical protein 
4314_529 
L-shaped tail fiber 
protein 
Enterobacter phage phiEap-3 87% 0.0 Phage tail fiber protein 
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78_2120 
rIIA protector from 
prophage-induced early 
lysis 
Klebsiella phage KP27 99% 0.0 Phage rIIA lysis inhibitor 
2120_3019 
host membrane ATPase 
affecting protein 
Klebsiella phage KP15 100% 0.0 
Phage lysis inhibitor # T4-like rIIA-rIIB 
membrane associated #T4 GC1698 
3065_3439 
hypothetical protein 
KP-KP15_gp257 
Klebsiella phage KP15 100% 6e-85 hypothetical protein 
3471_3851 
nucleoid disruption 
protein 
Klebsiella phage KP27 100% 2e-89 Phage protein 
3888_4136 
hypothetical protein 
CPT_Matisse278 
Klebsiella phage Matisse 100% 1e-50 Phage protein 
4181_4411 
hypothetical protein 
GAP161_268 
Cronobacter phage 
vB_CsaM_GAP161 
99% 1e-46 Phage protein 
4408_4545 
hypothetical protein 
GAP161_267 
Cronobacter phage 
vB_CsaM_GAP161 
100% 1e-24 hypothetical protein 
4520_4849 
hypothetical protein 
KP27_293 
Klebsiella phage KP27 100% 4e-75 Phage protein 
4846_5073 
hypothetical protein 
KP27_292 
Klebsiella phage KP27 100% 3e-50 hypothetical protein 
5154_5951 
hypothetical protein 
KP27_291 
Klebsiella phage KP27 100% 0.0 Phage protein 
5951_6241 
hypothetical protein 
KP27_290 
Klebsiella phage KP27 99% 2e-65 Phage protein 
6349_6507 
hypothetical protein 
KP-KP15_gp251 
Klebsiella phage KP15 94% 2e-29 hypothetical protein 
7155_6508 T holin lysis mediator Klebsiella phage KP27 98% 1e-156 Phage holin 
880_353 
distal long tail fiber 
assembly catalyst 
Klebsiella phage KP27 91% 6e-117 Phage tail fibers 
4801_920 
L-shaped tail fiber 
protein 
Klebsiella phage KP15 80% 0.0 Phage tail fiber protein 
1495_32 
NrdA ribonucleotide 
reductase A subunit 
Klebsiella phage KP15 100% 0.0 
Ribonucleotide reductase of class Ia (aerobic), 
alpha subunit (EC 1.17.4.1) 
2410_1535 
Td thymidylate 
synthetase 
Klebsiella phage KP15 99% 0.0 Thymidylate synthase (EC 2.1.1.45) 
2990_2412 dihydrofolate reductase Klebsiella phage Matisse 99% 3e-139 Dihydrofolate reductase (EC 1.5.1.3) 
3244_2987 
hypothetical protein 
KP-KP15_gp058 
Klebsiella phage KP15 100% 4e-56 Phage protein 
3471_3241 
hypothetical protein 
KP-KP15_gp057 
Klebsiella phage KP15 100% 4e-48 Phage protein 
3758_3468 
hypothetical protein 
KP27_068 
Klebsiella phage KP27 100% 3e-65 Phage protein 
5527_3818 
hypothetical protein 
ADS69_00056 
Enterobacter phage phiEap-3 99% 0.0 Phage protein 
5795_5601 
hypothetical protein 
KP-KP15_gp054 
Klebsiella phage KP15 95% 9e-36 Phage protein 
5852_6571 
putative Mob-like HNH 
homing endonuclease 
Cronobacter phage 
vB_CsaM_GAP161 
64% 2e-115 Phage-associated homing endonuclease 
8249_6558 
recombination 
endonuclease subunit  
Klebsiella phage KP27 99% 0.0 
Phage recombination-related endonuclease 
Gp46 
8520_8233 
hypothetical protein 
KP-KP15_gp052 
Klebsiella phage KP15 100% 9e-63 hypothetical protein 
9538_8507 
gp47 recombination 
endonuclease subunit 
Klebsiella phage KP15 99% 0.0 
Phage recombination-related endonuclease 
Gp47 
9916_9590 
hypothetical protein 
KP-KP15_gp050 
Klebsiella phage KP15 100% 8e-73 Phage protein 
10124_9909 
hypothetical protein 
KP-KP15_gp049 
Klebsiella phage KP15 100% 6e-42 Phage protein 
10648_10121 
gp55 RNA polymerase 
sigma factor 
Klebsiella phage KP15 100% 1e-128 
T4-like phage RNA polymerase sigma factor 
for late transcription 
10953_11888 RnaseH Klebsiella phage KP15 100% 0.0 Phage ribonuclease H (EC 3.1.26.4) 
11898_12161 DsbA dsDNA binding Klebsiella phage KP15 100% 7e-56 
Phage double-stranded DNA binding protein 
#T4-like dsbA, late transcriptional regulation 
#T4 GC1668 
12165_12410 
gp33 late promoter 
transcription 
Klebsiella phage KP15 100% 9e-53 Phage transcriptional regulator 
12407_13066 
helicase assembly 
protein 
Klebsiella phage Matisse 100% 2e-155 Phage DNA helicase loader 
13082_14053 ssDNA binding protein Enterobacter phage phiEap-3 100% 0.0 
Single stranded DNA-binding protein, phage-
associated 
14109_14378 
RpbA RNA polymerase 
binding protein 
Klebsiella phage KP15 100% 9e-58 Phage RNA polymerase binding protein 
14405_15070 
gp45 sliding clamp 
DNA polymerase 
Klebsiella phage KP15 100% 
3e-
156 
Sliding clamp DNA polymerase accessory 
protein, phage associated 
15129_16127 
gp44 clamp-loader 
subunit 
Klebsiella phage KP15 100% 0.0 
Replication factor C small subunit / Phage 
DNA polymerase clamp loader subunit 
16130_16693 
gp62 clamp-loader 
subunit 
Klebsiella phage KP15 99% 5e-133 
Phage DNA polymerase clamp loader subunit 
Gp62 
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16697_17059 RegA Klebsiella phage KP27 100% 4e-83 
Phage endoribonulcease translational 
repressor of early genes, regA 
17128_17415 
hypothetical protein 
CPT_Matisse40 
Klebsiella phage Matisse 100% 2e-64 Phage protein 
17412_17741 
hypothetical protein 
CPT_Miro40 
Klebsiella phage Miro 100% 3e-73 hypothetical protein 
329_12 
gp49 recombination 
endonuclease VII  
Klebsiella phage KP15 99% 7e-72 Phage endonuclease 
801_526 NrdC thioredoxin Klebsiella phage KP15 100% 8e-62 Thioredoxin, phage-associated 
1661_810 
DNA adenine 
methylase 
Enterobacter phage phiEap-3 99% 0.0 DNA adenine methylase (EC 2.1.1.72) 
1960_1658 
hypothetical protein 
KP27_266 
Klebsiella phage KP27 100% 9e-67 Phage protein 
3380_1947 
nicotinamide 
phosphoribosyl 
transferase 
Klebsiella phage KP15 100% 0.0 
Nicotinamide phosphoribosyltransferase (EC 
2.4.2.12) 
3857_3408 
hypothetical protein 
KP27_264 
Klebsiella phage KP27 100% 5e-106 Phage protein 
4127_3867 
hypothetical protein 
KP27_263 
Klebsiella phage KP27 100% 2e-55 Phage protein 
4648_4205 
hypothetical protein 
KP-KP15_gp224 
Klebsiella phage KP15 100% 4e-106 hypothetical protein 
5298_4717 
hypothetical protein 
ADS69_00241 
Enterobacter phage phiEap-3 99% 1e-139 Phage protein 
6307_5288 RNA ligase 2 Enterobacter phage phiEap-3 100% 0.0 RNA ligase, phage-associated 
6835_6311 
postulated decoy of 
host sigma70 or sigmaS 
Klebsiella phage KP27 100% 2e-126 
Srd postulated decoy of host sigma70 or 
sigmaS 
7191_6835 
hypothetical protein 
KP-KP15_gp220 
Klebsiella phage KP15 100% 2e-80 Phage protein 
7519_7193 
hypothetical protein 
CPT_Miro237 
Klebsiella phage Miro 100% 1e-72 Phage protein 
7692_7516 
hypothetical protein 
KP-KP15_gp218 
Klebsiella phage KP15 100% 4e-33 Phage protein 
8006_7689 
hypothetical protein 
KP-KP15_gp217 
Klebsiella phage KP15 99% 1e-72 Phage protein 
8914_8039 
hypothetical protein 
CPT_Miro234 
Klebsiella phage Miro 99% 0.0 Phage protein 
9029_9868 
hypothetical protein 
KP-KP15_gp215 
Klebsiella phage KP15 100% 0.0 Phage protein 
9918_10382 
hypothetical protein 
KP-KP15_gp214 
Klebsiella phage KP15 100% 4e-108 Phage protein 
10933_10415 
hypothetical protein 
KP27_250 
Klebsiella phage KP27 99% 1e-124 Phage protein 
11222_10947 
Hoc large outer capsid 
protein 
Klebsiella phage KP15 100% 1e-60 Phage capsid and scaffold 
11766_11233 
Hoc head outer capsid 
protein 
Klebsiella phage KP15 100% 5e-125 Phage capsid and scaffold 
12064_11795 
hypothetical protein 
KP27_247 
Klebsiella phage KP27 100% 5e-59 Phage protein 
12715_12404 
hypothetical protein 
KP-KP15_gp209 
Klebsiella phage KP15 100% 1e-71 Phage protein 
13431_12808 
inhibitor of prohead 
protease 
Klebsiella phage Miro 97% 1e-147 Protein inhbitor 
13502_15001 Helicase Klebsiella phage KP27 100% 0.0 DNA helicase, phage-associated 
15088_15243 
UvsW.1 hypothetical 
protein 
Klebsiella phage KP15 100% 6e-27 DNA helicase, phage-associated 
15694_15518 UvsY.-2 Klebsiella phage KP15 100% 2e-34 Phage protein 
16113_15694 UvsY Klebsiella phage KP15 100% 9e-97 
Single stranded DNA-binding protein, phage-
associated 
17707_16418 capsid vertex protein Klebsiella phage KP27 100% 0.0 Phage capsid vertex 
18375_17740 
SegD homing 
endonuclease 
Klebsiella phage KP15 99% 1e-152 Phage-associated homing endonuclease 
20029_18461 major capsid protein Klebsiella phage Miro 99% 0.0 Phage major capsid protein 
20837_20049 
gp22 prohead core 
protein 
Klebsiella phage KP15 100% 0.0 Phage prohead assembly (scaffolding) protein 
21517_20870 
prohead core scaffold 
protein and protease 
Klebsiella phage Matisse 100% 7e-153 Phage prohead assembly (scaffolding) protein 
21924_21520 
gp68 prohead core 
protein 
Klebsiella phage KP15 100% 3e-89 Phage capsid and scaffold 
22106_21933 prohead core protein Klebsiella phage Matisse 98% 1e-27 Phage prohead core protein 
23750_22176 
gp20 portal vertex 
protein 
Klebsiella phage KP15 100% 0.0 Phage portal vertex of the head 
24291_23806 gp19 tail tube protein Klebsiella phage KP15 100% 4e-117 Phage tail fibers 
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26331_24340 tail sheath protein Klebsiella phage Miro 99% 0.0 Phage tail sheath monomer 
28180_26351 large terminase protein Enterobacter phage phiEap-3 100% 0.0 Phage terminase, large subunit 
28691_28149 
gp16 small terminase 
protein 
Klebsiella phage KP15 100% 2e-128 Phage terminase, small subunit 
29512_28688 
gp15 tail sheath 
stabilizer and 
completion protein 
Klebsiella phage KP15 100% 0.0 Proximal tail sheath stabilization protein 
30339_29593 gp14 neck protein Klebsiella phage KP15 96% 7e-175 
T4-like phage head completion, neck hetero-
dimeric protein (T4-like gp14) 
30946_30332 putative endonuclease Escherichia phage MX01 57% 8e-68 Phage-associated homing endonuclease 
31882_30956 gp13 neck protein Klebsiella phage KP15 99% 0.0 
T4-like phage head completion, neck hetero-
dimeric protein (T4-like gp13) 
33363_31921 whisker protein Klebsiella phage KP15 99% 0.0 Phage neck whiskers 
33673_33368 whisker protein Klebsiella phage Matisse 100% 2e-60 Phage neck whiskers 
35072_33687 short tail fiber protein Klebsiella phage Matisse 99% 0.0 Phage tail fibers 
35750_35082 
gp11 baseplate wedge 
subunit and tail pin 
Klebsiella phage KP15 100% 2e-162 
Phage baseplate wedge subunit and tail pin 
(T4-like gp11) # T4 GC 1597 
37567_35750 
baseplate wedge 
subunit and tail pin 
Klebsiella phage KP27 99% 0.0 
Phage baseplate wedge subunit and tail pin 
(T4-like gp10) 
38427_37564 
baseplate wedge tail 
fiber connector 
Klebsiella phage KP27 99% 0.0 
Phage baseplate wedge tail fiber connector 
(T4-like gp9) 
39429_38437 
baseplate wedge 
subunit 
Klebsiella phage Matisse 100% 0.0 Phage baseplate wedge subunit (T4-like gp8) 
42516_39430 
baseplate wedge 
initiator 
Klebsiella phage Matisse 99% 0.0 Phage baseplate wedge subunit #T4-like gp7 
44522_42597 
baseplate wedge 
subunit 
Klebsiella phage Miro 99% 0.0 Phage baseplate wedge subunit (T4-like gp6) 
46011_44554 
hypothetical protein 
CPT_Miro198 
Klebsiella phage Miro 99% 0.0 Phage protein 
1824_55 
baseplate hub subunit 
and tail lysozyme 
Enterobacter phage phiEap-3 100% 0.0 Phage baseplate hub 
2375_1821 
baseplate wedge 
subunit 
Klebsiella phage KP27 100% 2e-134 Phage baseplate wedge subunit #T4-like gp53 
2426_2893 
gp4 head completion 
protein 
Klebsiella phage KP15 100% 2e-112 Phage head completion protein 
2909_3763 
DNA end protector 
protein 
Klebsiella phage KP27 100% 0.0 Phage DNA end protector during packaging 
4522_3800 
hypothetical protein 
KP27_206 
Klebsiella phage KP27 100% 1e-170 Phage protein 
4610_4494 
hypothetical protein 
KP27_206 
Klebsiella phage KP27 100% 2e-09 hypothetical protein 
4959_5489 
gp3 tail completion and 
sheath stabilizer protein 
Klebsiella phage KP15 100% 4e-129 Phage tail completion protein 
5489_6184 
deoxynucleoside 
monophosphate kinase 
Klebsiella phage KP27 98% 3e-168 
Deoxynucleotide monophosphate kinase (EC 
2.7.4.13) #T4-like phage gp1 #T4 GC1586 
6199_6459 
chaperone for tail fiber 
formation 
Klebsiella phage KP27 99% 3e-52 Phage protein 
6511_7134 
hypothetical protein 
KP27_202 
Klebsiella phage KP27 99% 1e-150 T4-like phage protein, T4 GC1584 
7142_7681 
hypothetical protein 
KP27_201 
Klebsiella phage KP27 100% 4e-131 Phage protein 
7747_7887 
hypothetical protein 
ADS69_00187 
Enterobacter phage phiEap-3 100% 3e-27 Phage protein 
7989_8117 
hypothetical protein 
KP-KP15_gp168 
Klebsiella phage KP15 100% 4e-20 hypothetical protein 
8128_8463 
hypothetical protein 
CPT_Matisse187 
Klebsiella phage Matisse 100% 9e-78 Phage protein 
8460_8753 
hypothetical protein 
KP-KP15_gp167 
Klebsiella phage KP15 100% 2e-67 Phage protein 
8746_8997 
hypothetical protein 
CPT_Miro182 
Klebsiella phage Miro 99% 6e-56 hypothetical protein 
8994_9239 
hypothetical protein 
KP27_195 
Klebsiella phage KP27 96% 7e-50 hypothetical protein 
9240_9647 nudix hydrolase Enterobacter phage phiEap-3 100% 7e-97 Nudix hydrolase, phage-associated 
9658_10041 
hypothetical protein 
KP27_193 
Klebsiella phage KP27 98% 9e-89 Phage protein 
10043_10300 
hypothetical protein 
KP-KP15_gp164 
Klebsiella phage KP15 99% 2e-55 Phage protein 
10329_10652 
hypothetical protein 
KP-KP15_gp163 
Klebsiella phage KP15 100% 4e-74 Phage protein 
10652_11179 
hypothetical protein 
KP-KP15_gp162 
Klebsiella phage KP15 100% 1e-129 Phage protein 
11176_12090 
hypothetical protein 
KP27_188 
Klebsiella phage KP27 99% 0.0 hypothetical protein 
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12167_12370 
hypothetical protein 
KP27_187 
Klebsiella phage KP27 100% 1e-40 Phage protein 
12380_12514 
hypothetical protein 
M975_1922 
Buttiauxella brennerae ATCC 
51605 
81% 5e-17 hypothetical protein 
12689_13087 
hypothetical protein 
ADS69_00174 
Enterobacter phage phiEap-3 99% 4e-94 hypothetical protein 
13095_13670 
hypothetical protein 
ADS69_00173 
Enterobacter phage phiEap-3 98% 1e-139 Phage protein 
14014_14292 
hypothetical protein 
CPT_Miro170 
Klebsiella phage Miro 99% 5e-61 Phage protein 
14364_14615 
hypothetical protein 
RB16p161 
Enterobacteria phage RB16 100% 3e-54 hypothetical protein 
14612_14758 
hypothetical protein 
RB16p160 
Enterobacteria phage RB16 100% 2e-26 hypothetical protein 
14755_14955 
hypothetical protein 
GAP161_158 
Cronobacter phage 
vB_CsaM_GAP161 
95% 2e-37 hypothetical protein 
15022_15276 
hypothetical protein 
Lw1_gp163 
Escherichia phage Lw1 96% 2e-53 Phage protein 
15997_15269 
hypothetical protein 
CPT_Miro165 
Klebsiella phage Miro 95% 1e-172 hypothetical protein 
16010_17164 
radical SAM 
superfamily protein 
Klebsiella phage Miro 96% 0.0 Phage protein 
17161_17457 
hypothetical protein 
ADS69_00160 
Enterobacter phage phiEap-3 98% 4e-64 hypothetical protein 
17454_17795 
hypothetical protein 
ADS69_00159 
Enterobacter phage phiEap-3 98% 1e-77 Phage protein 
17776_18123 
hypothetical protein 
KP27_173 
Klebsiella phage KP27 100% 1e-78 Phage protein 
18120_18293 
hypothetical protein 
KP27_172 
Klebsiella phage KP27 100% 3e-34 hypothetical protein 
18304_18735 
hypothetical protein 
KP27_171 
Klebsiella phage KP27 100% 1e-103 Phage protein 
18737_18997 
hypothetical protein 
KP27_170 
Klebsiella phage KP27 100% 1e-56 Phage protein 
19067_19330 
hypothetical protein 
KP27_169 
Klebsiella phage KP27 99% 3e-57 Phage protein 
19370_19693 
hypothetical protein 
CPT_Matisse156 
Klebsiella phage Matisse 99% 2e-72 Phage protein 
19748_20158 
hypothetical protein 
KP27_167 
Klebsiella phage KP27 94% 6e-90 Phage protein 
20226_20621 
hypothetical protein 
KP27_166 
Klebsiella phage KP27 100% 1e-90 Phage endolysin 
21111_21635 homing endonuclease Klebsiella phage Miro 99% 4e-126 Phage-associated homing endonuclease 
21645_22991 PhoH domain protein Klebsiella phage Matisse 100% 0.0 
Predicted ATPase related to phosphate 
starvation-inducible protein PhoH 
23234_23416 hypothetical protein Citrobacter phage IME-CF2 27% 2e-26 hypothetical protein 
23418_23972 
hypothetical protein 
KP-KP15_gp137 
Klebsiella phage KP15 100% 8e-134 Phage protein 
24037_24678 
hypothetical protein 
ADS69_00146 
Enterobacter phage phiEap-3 100% 2e-156 T4-like phage protein, T4 GC1559 
24746_24892 
hypothetical protein 
KP-KP15_gp134 
Klebsiella phage KP15 98% 2e-27 hypothetical protein 
24910_25479 
hypothetical protein 
KP-KP15_gp133 
Klebsiella phage KP15 99% 8e-140 Phage protein 
25489_25812 
hypothetical protein 
KP-KP15_gp132 
Klebsiella phage KP15 100% 1e-73 Phage protein 
25812_25928 
hypothetical protein 
CPT_Matisse143 
Klebsiella phage Matisse 100% 9e-20 hypothetical protein 
25879_26034 
hypothetical protein 
KP27_156 
Klebsiella phage KP27 100% 2e-28 hypothetical protein 
26119_26592 
hypothetical protein 
KP27_155 
Klebsiella phage KP27 100% 8e-112 Phage protein 
26595_26882 
hypothetical protein 
KP27_154 
Klebsiella phage KP27 99% 8e-62 hypothetical protein 
26875_27090 
hypothetical protein 
KP27_153 
Klebsiella phage KP27 100% 2e-46 hypothetical protein 
27273_27881 Tk thymidine kinase Enterobacter phage phiEap-3 99% 4e-148 Thymidine kinase (EC 2.7.1.21) 
27898_28290 
hypothetical protein 
KP27_150 
Klebsiella phage KP27 100% 3e-92 Phage protein 
28844_29071 
hypothetical protein 
KP27_148 
Klebsiella phage KP27 100% 5e-47 Phage protein 
29143_30057 
hypothetical protein 
KP-KP15_gp124 
Klebsiella phage KP15 100% 0.0 Phage protein 
30303_30722 
hypothetical protein 
KP27_146 
Klebsiella phage KP27 99% 8e-91 hypothetical protein 
30716_31294 
bifunctional protein 
NMN 
adenylyltransferase/NU
Klebsiella phage Matisse 99% 4e-141 
Nicotinamide-nucleotide adenylyltransferase, 
NadM family (EC 2.7.7.1) / ADP-ribose 
pyrophosphatase (EC 3.6.1.13) 
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DIX hydrolase 
31468_31662 
hypothetical protein 
RB16p128 
Enterobacteria phage RB16 100% 4e-38 hypothetical protein 
31659_31931 
hypothetical protein 
KP-KP15_gp121 
Klebsiella phage KP15 99% 5e-61 Phage protein 
24_1181 
UvsX RecA-like 
recombination protein 
Klebsiella phage KP15 100% 0.0 Phage recombination protein 
1219_1539 
membrane-associated 
initiation of head vertex 
Klebsiella phage KP15 100% 8e-71 
Phage membrane-associated initiation of head 
vertex 
1549_2985 
gp41 replication and 
recombination DNA 
helicase 
Klebsiella phage KP15 100% 0.0 DNA primase/helicase, phage-associated 
3029_3298 
hypothetical protein 
KP27_040 
Klebsiella phage KP27 100% 4e-55 hypothetical protein 
3378_3632 
hypothetical protein 
KP-KP15_gp030 
Klebsiella phage KP15 100% 2e-53 Phage protein 
3725_3961 
hypothetical protein 
KP-KP15_gp029 
Klebsiella phage KP15 100% 3e-46 hypothetical protein 
3958_4350 
hypothetical protein 
KP27_036 
Klebsiella phage KP27 100% 3e-92 Phage protein 
4331_5062 
hypothetical protein 
KP-KP15_gp027 
Klebsiella phage KP15 100% 0.0 Phage protein 
5068_5556 
gp61.1 hypothetical 
protein 
Klebsiella phage KP15 100% 1e-116 T4-like phage protein, T4 GC1491 
5553_5771 
hypothetical protein 
KP-KP15_gp025 
Klebsiella phage KP15 100% 5e-47 hypothetical protein 
5827_6087 
hypothetical protein 
KP27_032 
Klebsiella phage KP27 100% 9e-58 Hypothetical Zinc-finger containing protein 
6091_7116 DNA primase subunit Klebsiella phage KP27 100% 0.0 
DNA primase (EC 2.7.7.-) / DNA helicase 
(EC 3.6.1.-), phage-associated 
7124_7660 dCTP pyrophosphatase Klebsiella phage KP15 96% 3e-127 
dCTP pyrophosphatase (EC 3.6.1.12), phage-
associated 
8313_7654 Homing endonuclease Enterobacteria phage JSE 45% 2e-72 Phage-associated homing endonuclease 
8714_9004 
hypothetical protein 
KP-KP15_gp021 
Klebsiella phage KP15 100% 1e-63 Phage protein 
9001_10329 DNA helicase Klebsiella phage KP27 100% 0.0 DNA helicase (EC 3.6.1.-), phage-associated 
10354_10662 
hypothetical protein 
KP-KP15_gp019 
Klebsiella phage KP15 100% 7e-68 Phage protein 
10663_10947 
hypothetical protein 
CPT_Matisse20 
Klebsiella phage Matisse 100% 3e-64 Phage protein 
10944_11615 DexA exonuclease A Klebsiella phage KP15 100% 3e-165 
T4-like phage DexA exonuclease A #T4 
GC1472 
11612_11893 
hypothetical protein 
KP27_024 
Klebsiella phage KP27 100% 6e-61 Phage protein 
12334_12633 
hypothetical protein 
KP-KP15_gp013 
Klebsiella phage KP15 100% 6e-66 hypothetical protein 
12722_12985 
hypothetical protein 
KP-KP15_gp012 
Klebsiella phage KP15 100% 5e-57 hypothetical protein 
13059_13283 
hypothetical protein 
KP27_016 
Klebsiella phage KP27 100% 9e-47 Phage protein 
13343_13672 
hypothetical protein 
KP27_014 
Klebsiella phage KP27 100% 1e-75 Phage protein 
13712_14308 
hypothetical protein 
CPT_Matisse11 
Klebsiella phage Matisse] 100% 3e-147 Phage protein 
14272_14583 
hypothetical protein 
KP-KP15_gp008 
Klebsiella phage KP15 98% 1e-71 Phage protein 
14570_15163 
hypothetical protein 
ADS69_00008 
Enterobacter phage phiEap-3 97% 2e-140 Phage protein 
15186_15626 
hypothetical protein 
KP-KP15_gp006 
Klebsiella phage KP15 99% 2e-105 Transcriptional regulator 
15677_15790 
hypothetical protein 
KP27_008 
Klebsiella phage KP27 100% 6e-19 Phage protein 
15858_17756 
DNA topoisomerase 
large subunit 
Klebsiella phage KP27 99% 0.0 
Phage DNA topoisomerase large subunit (EC 
5.99.1.3) #T4-like gp60 #T4 GC1464 
4710_937 
long tail fiber proximal 
subunit 
Enterobacter phage phiEap-3 96% 0.0 Phage long tail fiber proximal subunit 
5089_4790 
hypothetical protein 
KP-KP15_gp244 
Klebsiella phage KP15 100% 5e-67 Phage protein 
5367_5086 Glutaredoxin Klebsiella phage KP27 100% 2e-62 Glutaredoxin 
5995_5327 
hypothetical protein 
KP-KP15_gp242 
Klebsiella phage KP15 100% 3e-160 Phage protein 
7006_6038 
hypothetical protein 
CPT_Matisse262 
Klebsiella phage Matisse 97% 0.0 Phage protein 
297_437 DenA endonuclease II Klebsiella phage KP15 100% 3e-25 Phage endonuclease 
418_1575 RNA ligase Klebsiella phage Miro 99% 0.0 
RNA ligase, phage-associated #T4-like RnlA 
#T4 GC1653 
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1908_2108 homing endonuclease Klebsiella phage Miro 100% 9e-38 Phage endonuclease 
2221_2412 i-spanin Klebsiella phage Matisse 98% 2e-36 Phage protein 
2409_2726 o-spanin Klebsiella phage Matisse 99% 9e-70 Phage outer membrane lipoprotein Rz1 
2711_2884 
hypothetical protein 
KP27_081 
Klebsiella phage KP27 100% 3e-32 hypothetical protein 
 
 
Table 3.2S Coding sequences identified in ECA2 phage of E. coli strain. 
Location Gene name Organism evidence Ident E-value Function 
120_353 tail protein Citrobacter phage SH2 97% 3e-42 Phage major tail protein 
467_1057 tail fiber protein Enterobacter phage E-3 100% 3e-143 
Phage tail fiber protein / T7-like tail tubular 
protein A 
1073_3478 tail tubular protein B Citrobacter phage SH1 99% 0.0 
Phage tail fiber protein / T7-like tail tubular 
protein B 
3551_3961 gp13 Salmonella phage phiSG-JL2 100% 1e-97 Phage protein inside capsid A 
3964_4557 protein inside capsid B Enterobacter phage E-3 98% 5e-137 Phage protein inside capsid B 
4560_6803 internal (core) protein Enterobacter phage E-3 98% 0.0 Phage internal (core) protein 
6822_10784 internal (core) protein Enterobacter phage E-2 99% 0.0 Phage internal (core) protein 
10856_12544 tail fibers protein Enterobacter phage E-2 67% 7e-123 Phage tail fibers 
12585_12788 holin class II Enterobacter phage E-3 100% 9e-41 Phage holin, class II 
12792_13058 gp18 Salmonella phage phiSG-JL2 99% 3e-56 DNA packaging protein A, T7-like gp18 
13148_13621 endopeptidase Citrobacter phage SH2 59% 9e-55 Phage endopeptidase (EC 3.4.-.-) Rz 
13621_14046 gp13.5 Enterobacteria phage EcoDS1 49% 1e-32 Phage endonuclease VII 
14039_15802 
DNA packaging protein 
B 
Yersinia phage phiYeO3-12 99% 0.0 Phage DNA packaging 
16047_16196 
hypothetical protein 
vBYenPAB5_0045 
Yersinia phage vB_YenP_AP5 100% 7e-26 Phage protein 
17482_17847 
hypothetical protein 
RU52_00001 
Citrobacter phage phiCFP-1 98% 2e-80 Phage protein kinase 
17847_17999 
hypothetical protein 
RU52_00002 
Citrobacter phage phiCFP-1 96% 2e-28 Phage protein 
18068_18352 hypothetical protein Enterobacter phage E-4 88% 2e-55 hypothetical protein 
18374_18496 
hypothetical protein 
phiYe-F10_00004 
Yersinia phage phiYe-F10 95% 1e-16 hypothetical protein 
18493_18690 
hypothetical protein 
phiYe-F10_00005 
Yersinia phage phiYe-F10 95% 7e-39 Phage protein 
18712_19821 protein kinase Enterobacteria phage T3 92% 0.0 Phage protein kinase (EC 2.7.11.1) 
19892_22546 
DNA-directed RNA 
polymerase 
Enterobacter phage E-2 99% 0.0 DNA-directed RNA polymerase (EC 2.7.7.6) 
22633_22905 gene 1.05 protein [ Enterobacteria phage T3 98% 2e-59 Phage protein 
22998_23138 1.1 protein Yersinia phage phiYeO3-12 100% 3e-24 Phage protein 
23138_23416 gp1.2 Salmonella phage phiSG-JL2 98% 1e-61 dGTP triphosphohydrolase inhibitor 
23443_23859 hypothetical protein Enterobacter phage E-2 100% 4e-100 Phage protein 
23856_24872 DNA ligase Enterobacter phage E-2 100% 0.0 DNA ligase, phage-associated 
25042_25299 1.6 protein Yersinia phage phiYeO3-12 100% 1e-54 Phage protein 
25299_25778 hypothetical protein Enterobacter phage E-2 100% 2e-116 Phage protein 
25765_25902 1.8 protein Yersinia phage phiYeO3-12 100% 4e-24 Phage protein 
25899_26135 
host RNA polymerase 
inhibitor 
Yersinia phage vB_YenP_AP5 100% 3e-52 Host RNA polymerase inhibitor, T7-like gp2 
26188_26886 ssDNA-binding protein Enterobacter phage E-2 99% 2e-169 T7-like phage ssDNA-binding protein 
26886_27347 endonuclease Enterobacter phage E-3 100% 1e-107 T7-like phage endonuclease (EC 3.1.21.2) 
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27340_27795 
N-acetylmuramoyl-L-
alanine amidase 
Yersinia phage phiYeO3-12 99% 6e-109 
Phage lysin, N-acetylmuramoyl-L-alanine 
amidase (EC 3.5.1.28) 
28162_29676 helicase Yersinia phage phiYeO3-12 99% 0.0 T7-like phage primase/helicase protein 
29776_29988 4.3 protein Yersinia phage phiYeO3-12 100% 8e-40 Phage protein 
30001_30285 4.5 protein Yersinia phage phiYeO3-12 100% 9e-64 Phage protein 
30353_32467 DNA polymerase Enterobacter phage E-3 99% 0.0 
DNA polymerase (EC 2.7.7.7), phage-
associated 
32487_32786 HNS binding protein Enterobacter phage E-3 97% 1e-63 Phage HNS binding protein 
32786_32995 5.7 protein Yersinia phage phiYeO3-12 100% 6e-43 Phage HNS binding protein 
32992_33174 
host recBCD nuclease 
inhibitor [ 
Yersinia phage vB_YenP_AP5 97% 2e-35 Phage inihibitor of recBCD nuclease 
33171_34082 exonuclease Yersinia phage phiYeO3-12 99% 0.0 T7-like phage exonuclease (EC 3.1.11.3) 
34064_34177 gene 6.3 protein Enterobacteria phage T3 92% 2e-14 Phage protein 
34270_34515 gene 6.5 protein Enterobacteria phage T3 100% 3e-53 Phage protein 
34520_34771 
hypothetical protein 
vBYenPAB5_0027 
Yersinia phage vB_YenP_AP5 100% 8e-51 Phage protein 
34799_35119 
host specificity protein 
B 
Yersinia phage phiYeO3-12 100% 4e-64 Phage protein 
35130_36737 
collar / head-to-tail 
joining protein 
Enterobacter phage E-3 99% 0.0 
Phage collar / T7-like phage head-to-tail 
joining protein 
36839_37771 capsid assembly protein Yersinia phage phiYe-F10 99% 0.0 Phage capsid and scaffold 
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4.1. Abstract 
The present study investigated the potential application of the bacteriophage (or 
phage) phT4A, ECA2 and the phage cocktail phT4A/ECA2 to decrease the concentration 
of Escherichia coli during the depuration of natural and artificially contaminated cockles. 
Depuration in static seawater at MOI 1 with single phage suspensions of phT4A and ECA2 
was the best condition, as it decreased by ~2.0 log CFU/g the concentration of E. coli in 
artificially contaminated cockles after a 4 h of treatment. When naturally contaminated 
cockles were treated in static seawater with single phage suspensions and the phage 
cocktail, similar decreases in the concentration of E. coli (~ 0.7 log CFU/g) were achieved. 
However, when employing the phage cocktail, a longer treatment time was required to 
obtain comparable results to those achieved when using single phage suspensions. When 
naturally contaminated cockles were depurated with phage phT4A in a recirculated 
seawater system (mimicking industrial depuration conditions), a 0.6 log CFU/g reduction 
of E. coli was achieved after a 2 h of treatment. When the depuration process was 
performed without phage addition, a 4 h treatment was necessary to obtain a similar 
decrease. By combining phage therapy and depuration procedures, a reduction in the 
depuration period can be achieved for marine bivalves, thus decreasing the potential costs 
associated with depuration and, possibly, even enhance the quality and safety of depurated 
bivalves destined for human consumption. 
 
Keywords: phages, cockles, Cerastoderma edule, food safety 
z 
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4.2. Introduction 
Enteric pathogen strains of Escherichia coli are widely distributed in coastal areas 
and are a causative agent of gastroenteritis in humans after consumption of contaminated 
seafood (Kanayama et al., 2015; Potasman et al., 2002). Cockles (Cerastoderma edule) are 
filter feeder bivalve molluscs that accumulate food particles and small organisms by 
circulating large volumes of seawater; consequently, microorganisms, including human 
pathogens, are retained and accumulate in their tissues (Lees, 2000). Moreover, as bivalves 
are often consumed raw or lightly cooked, they are potential vectors for pathogenic E. coli. 
Depuration is a method applied to reduce and eliminate human pathogens from 
bivalves. Briefly it consists of a flow-through or recirculation system operating with 
chemically (chlorine, ozone, iodophores or activated oxygen) or physically (UV-C light) 
disinfected water that allow bivalve purification under controlled conditions (Croci et al., 
2002; Wang et al., 2010). After depuration, bivalves may be destined for human 
consumption if they display less than 230 most probable number (MPN) E. coli per 100 g 
of flesh and intra-valvular liquid (FIL), as well as no detectable levels of Salmonella spp. 
(FAO, 2008). However, some pathogenic microorganisms are known to be resistant to this 
process and remain in bivalves after depuration (FAO, 2008; Martínez et al., 2009; Rong et 
al., 2014). 
In order to reduce the risk of infections by microbial pathogens through the 
consumption of bivalves, it is essential to develop alternative approaches to conventional 
depuration practices. One of the most promising approaches is to combine bivalve 
depuration with phage therapy (the application of lytic phages to prevent and/or to treat 
bacterial infections). The use of lytic phages to reduce food-borne pathogens has emerged 
as a promising tool for food safety (Denes and Wiedmann, 2014; Endersen et al., 2014). 
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These viruses are target-specific, self-replicating, rapid bactericides and do not modify 
normal food properties. A few publications have demonstrated that phages can be used to 
successfully decrease the load of E. coli in food, especially in meat and poultry products 
(Atterbury et al., 2007; Goodridge and Bisha, 2011; Raya et al., 2006; Sillankorva et al., 
2012). However, the combination of depuration and phage therapy to eliminate pathogenic 
bacteria in bivalves is an innovative approach which is still being investigated. A previous 
study by Rong et al. (2014) already reported the combined use of these two processes to 
eliminate Vibrio parahaemolyticus from artificially contaminated oysters. However, this 
study did not replicate industrial depuration procedures, neither tested the suitability of this 
approach on naturally contaminated bivalves.  
The aim of the present study was to evaluate, for the first time, the efficiency of two 
new phages of E. coli (phT4A and ECA2), individually or combined in a cocktail, to 
control E. coli in natural and artificially contaminated cockles in static water and during 
depuration mimicking industrial procedures currently employed. 
 
4.3. Material and Methods 
4.3.1. Bacterial strains 
E. coli (ATCC 13706), a microbiological indicator of shellfish depuration 
efficiency, was used to contaminate cockles. Fresh plate bacterial cultures were maintained 
in solid Tryptic Soy Agar (TSA; Liofilchem, Italy) at 4 °C. Before each assay, one isolated 
colony was aseptically transferred to 10 mL of Tryptic Soy Broth (TSB; Liofilchem, Italy) 
and was grown overnight at 37 ºC. An aliquot of this culture (100 μL) was aseptically 
transferred to 10 mL of fresh TSB and grown overnight at 37 °C to reach an optical density 
(O.D600 = 0.8), corresponding to about 109 cells per mL. 
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4.3.2. Phage preparation 
The phages phT4A and ECA2, two lytic phages previously isolated from sewage 
samples, evidenced to be effective in lysing E. coli even at low multiplicity of infection 
(MOI) (tested range: 1 / 100) in studies in vitro. Two phages were prepared in SM buffer 
(0.1 M NaCl, 8 mM MgSO4, 20 mM Tris-HCl, 2% (w/v) gelatin, pH 7.5) at 37 °C during 
6 h, using E. coli as host (unpublished data). Double-plaque assays were performed as 
described by to determine the phage titer, with the phages being stored at 4 °C. The titer of 
both phages was approximately 109 plaque-forming units (PFU)/mL. 
Phage phT4A and ECA2 contained a linear double-stranded DNA with a size of 
170.698 bp and 61.915 bp, respectively (unpublished data). Morphologically, phage 
phT4A belongs to the family Myoviridae and is characterised by an icosahedral head with 
a diameter of 80 ± 2 nm 75 nm width and a long contractile tail of 107 ± 3 nm. ECA2 
phage has an icosahedral head with approximately 56 ± 2 nm of width and was identified 
as member of family Podoviridae. None of the genomes featured any lysogeny related 
genes and it can be securely assumed that the two phages feature a virulent lifestyle. No 
genes encoding toxins, virulence factors or antibiotic resistance were identified based on 
aminoacid sequence homology searches. The genome sequences were deposited in 
GenBank under the accession numbers KX130727 (phage phT4A) and KX130726 (phage 
EC2A).  
 
4.3.3. Collection of cockle samples  
Cockles were selected as biological models to test the efficacy of phage therapy 
against E. coli infections and were purchased from Falcamar Lda. (Vila do Conde, 
Portugal), a bivalve wholesaler, after being depurated according to industrial processing 
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protocols (48 h at 15-16 °C in seawater irradiated with UV-C). These specimens were later 
artificially contaminated with E. coli in the laboratory (see below). Naturally contaminated 
cockles were collected in Mira Channel (Ria de Aveiro, Portugal; 40º36’30”N, 
8º44’52”W), a bivalve production area ranked as B (230 – 4600 MPN E. coli per 100 g of 
FIL) (Despacho n.o 15264, 2013). Mira channel is a recreational area  subjected to 
anthropogenic contamination (Pereira et al., 2015). Cockles were collected in June, July, 
September and October 2015. 
Live cockles were dry transported to the laboratory by the research team in a 
controlled temperature container, under an oxygen saturated atmosphere. 
 
4.3.4. Phage application during cockles depuration in static seawater  
4.3.4.1. Accumulation of E. coli in cockles 
Non contaminated cockles were maintained in independent tanks (10 cm length x 9 
cm width x 15 cm height), acting as static systems, filled with sterile synthetic seawater 
(0.6 L) and equipped with its own aerator, during 12h before being infected with E. coli. 
Temperature was maintained at 16 ± 1 °C, pH 8.0 ± 0.2, salinity 35 and dissolved oxygen 
above 5.5 mg/L during the whole trial. Synthetic seawater was prepared by mixing a 
synthetic salt brand (Tropic Marin Pro Reef salt – Tropic Marine, Germany) with water 
purified by a reverse osmosis system (Aqua-win RO-6080, Thailand). After the immersion 
period cockles were washed with sterile synthetic seawater and placed in independent 
tanks with sterile synthetic seawater. 
A total of 5 groups of cockles were randomly formed, each group with three 
replicates of 30 cockles (a total of 5 groups x 3 replicates x 30 cockles = 450 cockles). 
Four groups were infected with E. coli (test tanks), with the fifth group being used as the 
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uninfected group (control cockles - CC). The 3 replicates from each of the 5 groups were 
maintained in independent tanks as described above. A fresh culture of E. coli was added 
to the four test groups to obtain final concentrations of 105, 106, 107 and 108 colonies-
forming units (CFU)/mL. Cockles were sampled at 0, 6, 12 and 24 h during the 
accumulation process to determine cultivable bacteria concentrations. E. coli concentration 
was determined in chromocult coliform agar (Merck, Germany) at the start of the assays 
(time 0). At each sampling time, four cockles were randomly selected from each tank and 
their FIL was homogenized with a Bag Mixer 400 (Interscience, France). Ten grams were 
blended in 90 mL of alkaline peptone water (Liofilchem, Italy). The homogenized samples 
were then ten-fold serially diluted and 1 mL from each dilution was spread on the non-
specific TSA plates. All plates were incubated at 37 °C for 24 h. The counts in TSA 
medium allows to detect added E. coli, as well as other cultivable bacteria already present 
in cockles (including other E. coli strains). This assay was repeated three times in different 
periods to secure independent replication. 
 
4.3.4.2. Depuration of artificially contaminated cockles in the presence of phages 
Cockles were maintained in independent tanks as described above. After the 
immersion period cockles were washed with sterile synthetic seawater and placed in 
independent tanks with sterile synthetic seawater (Figure 4.1). In these experiments 14 
groups of cockles were used. Each group included 3 replicates of 30 cockles each (for a 
total of 14 groups x 3 replicates x 30 specimens = 1260 cockles). Each replicate was 
stocked in an independent tank as described above. E. coli was added to 7 of the 14 groups 
to obtain a final concentration of 105 CFU/mL. In the other 7 groups no E. coli was added. 
Cockles from the 14 groups remained for 12 h in the tanks under the same conditions. 
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Following 12 h of incubation cockles were washed with sterilized artificial seawater and 
placed in clean tanks with no E. coli contamination. From the 7 groups of cockles infected 
with E. coli, 3 were inoculated with phages (single phage suspensions of phT4A and ECA2 
phage and of phT4A/ECA2 cocktail at MOI 1 (BP MOI 1 phT4A, BP MOI 1 ECA2 and 
BP MOI 1 phT4A/EC2), another three with the same phage suspensions at a MOI 100 (BP 
MOI 100 phT4A, BP MOI 100 ECA2 and BP MOI 100 phT4A/ECA2) and to the 
remaining infected group no phage was added (bacteria control - BC). In order to obtain a 
MOI of 1 and 100, 105 PFU/mL for MOI 1 and 107 PFU/mL for MOI 100 of the single 
phage suspensions (phT4A or ECA2) or phage cocktail (phT4/ECA2) were inoculated. 
Concerning the 7 groups of cockles not infected with E. coli, 3 were inoculated with 
phages (single phage suspensions of phT4A and ECA2 phage and of phT4A/ECA2 
cocktail at MOI 1 (PC MOI 1 phT4A, PC MOI 1 ECA2 and PC MOI 1 phT4A/ECA2), 
three groups with the same phage suspensions at a MOI 100 (PC MOI 100 phT4A, PC 
MOI 100 ECA2 and PC MOI 100 phT4A/ECA2) and the remaining group was not 
inoculated with phages. All 14 groups were incubated exactly under the same conditions. 
Cockles of test tanks and controls were sampled at 0, 2, 4, 6, 8, 10 and 12 h of incubation. 
Four cockles were randomly selected from each tank to determine bacterial and phage 
concentration, homogenized as described above and 10 g were blended in 90 mL alkaline 
peptone water (Liofilchem, Italy). The phage titer was determined in duplicate for all 
assays through the double agar layer method after an incubation period of 8 - 12 h at 37 °C. 
Cultivable bacterial concentration was determined by the spread method in duplicate in 
TSA medium after an incubation period of 24 h at 37 °C. E. coli concentration was 
determined in chromocult coliform agar (Merck, Germany) at the start of the assays (time 
130 
 
0). All plates were incubated at 37 ºC for 24 h. This assay was repeated three times in 
different periods to secure independent replication. 
 
Figure 4.1 Schematic representation of the depuration experiments of cockles employing phages. 
(a) Depuration of artificially contaminated cockles with E. coli with phT4A, ECA2 phages and 
phT4A/ECA2 cocktail in static system (see section 4.3.4.2), (b) Depuration of naturally 
contaminated cockles with phT4A, ECA2 phages and phT4A/ECA2 cocktail in static system (see 
section 4.3.5), (c) Depuration of naturally contaminated cockles with phT4A phage in a 
recirculating system (see section 4.3.7). 
 
4.3.5. Depuration of naturally contaminated cockles in the presence of phages  
Naturally contaminated cockles were washed with sterile synthetic seawater and 
placed in clean water tanks with sterile synthetic seawater as described above (see also 
Figure 4.1). In these experiments 4 groups of cockles were used. Each group included 3 
replicates of 30 cockles each (a total of 4 groups x 3 replicates x 30 specimens = 360 
cockles). All replicates were maintained in independent tanks as described above. Three of 
the groups were inoculated with phages (single phage suspensions of phT4A and ECA2 
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phage and of phT4A/ECA2 cocktail), while the remaining group was not inoculated with 
any phages. The phage suspensions were inoculated as described above, with an initial 
concentration of 105 PFU/mL (selected according to the results of previous tests in 
artificially contaminated cockles). All replicates were incubated exactly under the same 
conditions. Cockles were collected after 0, 2, 4, 6, 8, 10 and 12 h of incubation. Four 
cockles were randomly selected from each tank to determine bacterial and phage 
concentration, homogenized as described above and 10 g were blended in 90 mL alkaline 
peptone water. The phage titer, cultivable bacterial concentration and E. coli concentration 
was determined as described above. This assay was repeated three times in different 
periods to secure independent replication. 
 
4.3.6. Effect of ultraviolet (UV) irradiation on phages 
In these experiments the effect of UV irradiation on phages was investigated by 
inoculating 105 PFU/mL of phT4A phage on 14 L of aerated synthetic seawater and 
irradiating it with UV light during 12 h (phT4A UV). A control treatment was prepared by 
replicating this procedure, with the exception of UV irradiation (CphT4A). Each group 
included 3 replicates, with temperature being maintained at 16 ± 1 °C, pH 8.0 ± 0.2, 
salinity 35, and dissolved oxygen above 5.5 mg/L, during the whole trial. Aliquots of each 
group were collected after 0, 2, 4, 6, 8, 10 and 12 h of incubation. In each group, the phage 
titre was determined in duplicate through the double agar layer method after an incubation 
period of 4 – 8 h at 37 °C. This assay was repeated three times in different periods to 
secure independent replication. 
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4.3.7. Depuration of naturally contaminated cockles with phT4A phage in a recirculating 
system 
The efficacy of the phT4A phage (selected according to the results of the tests 
described above) was evaluated during depuration in a recirculating system mimicking an 
industrial depuration process (Figure 4.1 and 4.2). The rationale for this trial was to 
evaluate if this approach could be successfully employed in industrial depuration facilities 
to inactivate E. coli. Cockles were washed with sterile synthetic seawater and placed in 
clean water tanks with sterile synthetic seawater as described above. In this experiment 2 
groups of cockles were formed, each with 3 replicates of 30 cockles each (for a total of 2 
groups x 3 replicates x 30 cockles = 180 cockles). All replicates were maintained in 
independent tanks with a volume of 0.6 L. Only one of the groups was inoculated with 105 
PFU/mL of phT4A phage. Tanks from each group were connected in parallel to twin 
recirculated water systems mimicking an industrial depuration facility. Each recirculated 
system was equipped with a 14 L tank holding a submerged water pump (Eheim Compact+ 
3000, Germany), a protein skimmer (RedSea Berlin Air-Lift 60, Israel) equipped with air 
pump (API Rena Air 200, USA) and UV filter (TMC V2 Vecton 120 Nano, UK) with a 
recirculating submerged water pump (Eheim Compact 1000, Germany) (Figure 4.2). 
Temperature was controlled by using a common 120 L water bath connected to a cooling 
unit (Hailea HC 500-A, China) through a submerged water pump (Eheim Compact+ 3000, 
Germany) (Figure 4.2). To avoid the effect of UV irradiation on the phages, the UV light 
was only switched on 2 h after the beginning of the depuration process (the time required 
for cockles to filtrate and accumulate the phages). All replicates were incubated exactly 
under the same conditions. Aliquots of test samples and controls were collected after 0, 2, 
4, 6, 8, 10 and 12 h of incubation. Four cockles were randomly selected from each tank to 
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determine bacterial and phage concentration, homogenized as described above and 10 g 
were blended in 90 mL alkaline peptone water. The phage titer, cultivable bacterial 
concentration and E. coli concentration was determined as described above. This assay was 
repeated three times in different periods to secure independent replication. 
 
Figure 4.2 Front view (A) and schematic representation of the lateral view (B) of the depuration 
system. 1 - Submerged water pump (Eheim Compact+ 3000), 2 - cooling unit (Hailea HC 500-A), 
3 – independent tanks, 4 – water reservoir, 5 – water bath for temperature control, 6 - air pump 
(API Rena Air 200), 7 - protein skimmer (RedSea Berlin Air-Lift 60), 8- UV filter (TMC V2 
Vecton 120 Nano) with a recirculating submerged water pump,            water circulation system,       
cooling system,       depuration system. 
 
4.3.8. Statistical analysis 
Statistical analysis was performed using GraphPad Prism 6. Normal distributions 
were assessed by Kolmogorov–Smirnov test and homogeneity of variances was assessed 
by Levene’s test. Two-way analysis of variance (ANOVA) was used to compare 
significant differences among the accumulation different concentrations of E. coli in 
cockles and control at different times. The significance differences on bacterial and viral 
concentration in cockles artificially contaminated was analysed using a three-way ANOVA 
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with MOIs (1 and 100), phages used in treatment (phT4A, ECA2 and phT4A and ECA2) 
and treatment times being used as fixed factors. The existence of significant differences of 
the phage treatment in cockles naturally contaminated and treatment time on bacterial and 
viral concentration was analyzed using a two-way ANOVA. For each situation, the 
significance of differences was evaluated by comparing the results obtained in the test 
samples and control samples for the different times of each of the three independent 
assays. The significance of the effect of UV-C irradiation on the phT4A phage and 
irradiation time on phage inactivation was assessed by one-way analysis of variance 
(ANOVA) model. A value of p < 0.05 was considered statistically significant and in these 
cases. Tukey's multiple comparison test was used for a pairwise comparison of the means. 
 
4.4. Results 
4.4.1. Phage application during cockles depuration in a static system 
4.4.1.1. Accumulation of E. coli in cockles  
The total number of cultivable bacteria and E. coli concentration present in the 
cockles at the start of the assay was 3.1 log CFU/g and 1.5 log CFU/g, respectively. Live 
cockles were assessed after 24 h of incubation in the presence of E. coli at 16 ± 1 °C 
(Figure 4.3). Accumulation of E. coli in cockles increased rapidly during the first 6 h, with 
counts decreasing in all four infected groups until they remained comparatively steady 
after 12 h and onward. Following 12 h of incubation, the mean values of bacteria in 
cockles were 5.0, 5.9, 7.1 and 8.0 log CFU/g in infected groups with 105, 106,107 and 108 
CFU/mL of E. coli, respectively (Figure 4.3). The abundance of cultivable bacteria in 
contaminated groups (105, 106,107 and 108 CFU/mL) after 6, 12 and 24 h, was statistically 
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different (ANOVA, p < 0.05; Figure 4.3). Incubation by immersion during 12 h in an E. 
coli culture with 105 CFU/mL was the selected procedure for follow-up experiments. 
 
Figure 4.3 Accumulation of E. coli in cockles in different infected groups after 24 h. Final 
concentrations of E. coli (log CFU/g) in groups of cockles initially contaminated with 105 CFU/mL; 
106 CFU/mL, 107 CFU/mL and 108 CFU/mL, as well as the uninfected group (control cockles - 
CC). 
 
4.4.1.2. Depuration of artificially contaminated cockles in the presence of phages  
The total number of cultivable bacteria and E. coli concentration present in the 
cockles at the start of the assay was 2.6 log CFU/g and 1.2 log CFU/g, respectively 
Bacterial density in the BC and CC remained constant (ANOVA, p > 0.05) during the 12 h 
of treatment. 
At a MOI of 1, the maximum of cultivable bacterial inactivation in cockles treated 
with phT4A phage relatively to the bacterial control was 2.0 log CFU/g, which was 
achieved after 4 h of phage therapy, and significantly higher than the one obtained with the 
phT4A/ECA2 (0.4 log CFU/g) (Figure 4.4A). Phage inactivation with phT4A phage at 
MOI 1 was significantly higher from that MOI 100 (ANOVA, p < 0.05) after 4 h, 6 h, 8 h 
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and 10 h of treatment. However, after 2 and 12 h of treatment, the rate of inactivation for 
both MOI was similar (ANOVA, p > 0.05). Increasing the MOI to a value of 100 enhanced 
the highest inactivation rate (1.0 log CFU/g) was achieved after 6 h of treatment, and after 
4 h it was 0.6 log CFU/g after 4 h of treatment (Figure 4.4A). 
The maximum rate of bacterial inactivation in cockles treated with ECA2 phage 
relatively to the bacterial control  was 1.9 log CFU/g achieved after 4 h of treatment at a 
MOI of 1 (ANOVA, p < 0.05) and significantly higher than the one obtained with the 
phT4A/ECA2 (0.4 log CFU/g) (Figure 4.4A). However, after 2 h, the inactivation rate was 
considerably higher for the MOI 1 (1.2 log CFU/g) and significantly higher (ANOVA, p < 
0.05) than the one obtained with the phT4A phage (0.6 log CFU/g; ANOVA, p < 0.05) and 
PhT4A/ECA2 cocktail phage (0.5 log CFU/g; ANOVA, p < 0.05) for MOI 1. At 12 h of 
treatment the inactivation rate remained quite high (1.6 log CFU/g) (ANOVA, p < 0.05) 
(Figure 4.4A). Phage inactivation with EC2 phage at MOI 1 was significantly higher from 
that MOI 100 (ANOVA, p < 0.05) at the different times. At the highest MOI value (100), 
the maximum value of inactivation was 1.1 log CFU/g after 6 h of treatment. 
The maximum of cultivable bacteria inactivation in cockles treated with phT4A/EC2 
cocktail phage was 1.8 log CFU/g achieved after 8 h treatment (ANOVA, p < 0.05; Figure 
4.4A). Phage inactivation at MOI 1 was only significantly different from that of MOI 100 
after 6 h and 8 h of treatment (ANOVA, p < 0.05). Increasing the MOI to a value of 100 
enhanced the highest inactivation rate (1.0 log CFU/g), which was achieved after 10 h of 
treatment, and after 6 h it was 0.8 log CFU/g (Figure 4.4A). At a MOI of 100, the rate of 
inactivation with the single suspensions of phT4A and ECA2 phage was similar (ANOVA, 
p > 0.05) than the obtained with the phT4A/ECA2 cocktail phage. 
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The abundance of phT4A and ECA2 single phage suspensions and of phT4A/ECA2 
phage cocktail in cockles, both in the absence (PC) and in the presence of the host E. coli 
(BP, Figure 4.4 B) increased during the first 2 h treatment, and then remained constant 
until the end of the treatment (ANOVA, p > 0.05). 
 
Figure 4.4 Inactivation of E. coli of artificially contaminated cockles by the two single phage 
suspensions (phT4A and ECA2) and the phage cocktail (phT4A/ECA2) at a MOI of 1 and 100 
during 12 h. A. Bacterial concentration: CC - uninfected group (control cockles); BC — bacteria 
control; BP — bacteria plus phage. B. Phage concentration: PC — phage control; BP — bacteria 
plus phage. Values represent the mean of three experiments; error bars represent the standard 
deviation. 
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4.4.1.3. Depuration of naturally contaminated cockles in the presence of phages 
The total number of cultivable bacteria and E. coli concentration present initially in 
naturally contaminated cockles was 3.4 log CFU/g (CC) and 1.5 log CFU/g, respectively. 
Bacterial density in the CC remained constant (ANOVA, p > 0.05) during the 12 h of 
treatment (Figure 4.5A).  
 
Figure 4.5 Inactivation of E. coli of naturally contaminated cockles by the two single phage 
suspensions (phT4A and ECA2) and the phage cocktail (phT4A/ECA2) during 12 h. A. Bacterial 
concentration: CC - uninfected group (control cockles), ECA2— cockles treated with ECA2 phage, 
phT4A – cockles treated with phT4A phage, phT4A/ECA2 – cockles treated with phT4A/ECA2 
cocktail. B. Phage concentration: PC- phage control. Values represent the mean of three 
experiments; error bars represent the standard deviation. 
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The maximum reduction of cultivable bacteria in cockles treated with phT4A and 
ECA2 phage was 0.8 and 0.7 log CFU/g, respectively, after 6 h of treatment, being 
statistically different from the untreated group (ANOVA, p < 0.05; Figure 4.5A). The 
highest inactivation rate (0.7 log CFU/g) was achieved after 10 h of treatment with 
phT4A/ECA2, and after 6 h it was 0.6 log CFU/g after 6 h of treatment (ANOVA, p < 
0.05; Figure 4.5A). Phage inactivation with phT4A, ECA2 phage and phT4A/ECA2 
cocktail phage was similar (ANOVA, p > 0.05) at the different times. 
The abundance of phT4A and ECA2 phage and phT4A/ECA2 phage cocktail in 
cockles increased during the first 2 h of treatment, and then remained constant until the end 
of the treatment (ANOVA, p > 0.05; Figure 4.5B). 
 
4.4.2. Effect of ultraviolet (UV-C) irradiation on phages 
Significant reductions (ANOVA, p < 0.05) in phT4A phage counts exposed to UV-C 
irradiation (phT4A UV) were observed after 2 h of incubation with a reduction of 
approximately 4.5 log PFU/mL, which was statistically different from the untreated group 
(C phT4A) (Figure 4.6). The phT4A phage was inactivated to the limit of detection (5.0 
log PFU/mL of reduction) by UV-C irradiation after 4 h of treatment (Figure 4.6). The 
abundance of phT4A in untreated group (C phT4A) remained constant until the end of the 
treatment (ANOVA, p > 0.05).  
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Figure 4.6 Effect of UV-C irradiation on the phT4A phage and synthetic seawater recirculation 
during 12 h. (C phT4) synthetic water with phT4A phage but not purified by UV-C irradiation 
(phT4A UV) synthetic seawater with phT4A phage and purified by UV-C light. 
 
4.4.3. Depuration of naturally contaminated cockles with phT4 phage in a recirculating 
system 
Total cultivable bacteria and E. coli density present initially in naturally 
contaminated cockles depurated was 4.6 log CFU/g (CC, Figure 4.7A) and 1.5 log CFU/g, 
respectively. Significant reductions (ANOVA, p < 0.05) in cultivable bacteria counts were 
also observed with the phT4A phage after 2 h of treatment with a reduction of 
approximately 0.6 log CFU/g, which was statistically different from the untreated group 
(Figure 4.7A). However, after 4 h of depuration, the concentration of the bacteria was 
similar (ANOVA, p > 0.05; Figure 4.7A) in the treatment with phT4A phage and in the 
cockles control. 
The abundance of phT4A phage in cockles increased during the first 2 h treatment, 
then decreased by one log of magnitude between 2 and 6 h, and then remained constant 
until the end of the treatment (ANOVA, p > 0.05; Figure 4.7B). 
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Figure 4.7 Inactivation of E. coli during depuration with recirculating water of natural 
contaminated cockles with and without phT4A phage suspension during 12 h. A. Bacterial 
concentration: CC - uninfected group (control cockles), phT4A— cockles treated with phT4A 
phage, B. Phage concentration: PC phT4A — Phage control Values represent the mean of three 
experiments; error bars represent the standard deviation. 
 
4.5. Discussion 
The elimination of E. coli in cockles is of extreme importance for public health, as 
some pathogenic strains of this species, used also as indicator of faecal pollution to classify 
bivalve production zones and to evaluate the depuration efficiency, can easily be 
accumulated in raw bivalves and pose a serious threat to human health (Kanayama et al., 
2015; Potasman et al., 2002). Although, bacterial elimination mostly depends on the 
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depuration process that is achieved by filtering cockles (Croci et al., 2002; Wang et al., 
2010),  this process is not always efficient to eliminate pathogenic microorganisms from 
their tissues (FAO, 2008; Martínez et al., 2009; Rong et al., 2014). Although many studies 
have demonstrated that phages can be used to successfully decrease the concentration of E. 
coli in food, especially in meat and poultry products (Atterbury et al., 2007; Goodridge and 
Bisha, 2011; Raya et al., 2006; Sillankorva et al., 2012), to date, no research on 
inactivation of E.coli with phages during depuration has been reported in the literature. 
Rong et al. (2014) reported the effectiveness of phage application to reduce the population 
of V. parahaemolyticus in the oyster depuration. However, these studies focused only on 
the depuration application of a phage in artificially contaminated oysters without water 
circulation. The experiments did not replicate industrial depuration procedures and neither 
tested the suitability of this approach on naturally contaminated bivalves. In the present 
study, we evaluated the inactivation of E. coli in artificially and naturally contaminated 
cockles by applying phage therapy during the depuration process, both with and without 
water circulation. 
One of the current challenges to phage therapy studies is to demonstrate its feasibility 
in vivo, according to several authors (S. Pereira et al., 2016; Silva et al., 2016, 2014b; 
Vieira et al., 2012), the assays in vitro are not sufficient to understand the interactions 
phage–bacteria in vivo. Tsonos et al. (2014) obtained similar results, as the efficiency of 
the phage cocktail used in treating CH2- infected chickens in vivo was negligible, even 
though, in vitro, the phages in the cocktail were able to efficiently lyse the APEC strain 
CH2. However, Park and Nakai (2003), which obtained similar results in vitro and in vivo, 
reported that the efficiency of the phage cocktail (PPpW-3 and PPpw-4) was higher than 
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that of the phages PPpW-3 and PPpW-4 when used individually in treating Pseudomonas 
plecoglossicida in both assays. 
 E. coli concentrations in cockles increased rapidly during the first 6 h and then the 
concentration remained stable. Similar results have been observed by Rong et al. (2014) 
during accumulation of V. parahemolyticus in oysters.  Although there is no consensus in 
the literature on the process of filtration in bivalves, many studies have shown that it is a 
physiological process regulated by many ecological factors, primarily by temperature, but 
also by salinity, particle size and concentration (Shumway and Rodrick, 2009; WHO, 
2010). 
Seafood is considered as the most difficult food to treat with phages since it has an 
uneven and large surface area, which physically limits the distribution of phage particles to 
reach bacterial targets (Guenther et al., 2009). However, some studies report the efficiency 
of phages for bacterial inactivation in bivalves (Jun et al., 2014; Rong et al., 2014). Also, 
Pelon et al. (2005) tested, in vitro, the use of Vibrio vulnificus specific bacteriophage and a 
bactericidal (antimicrobial component existing in oysters and designed by anti–V. 
vulnificus factor) for V. vulnificus, and observed that although each treatment alone can 
reduce V. vulnificus numbers, the simultaneous use of both treatments, was more efficient 
(decrease more 2 log CFU/mL when using only bactericidal 1%) (Pelon et al., 2005). In the 
current study, both single phage suspensions and the phage cocktail tested can be used to 
inactivate E. coli (inactivation of 2.0 log CFU/g, 1.9 log CFU/g and 1.8 log CFU/g, 
respectively, for single phage suspensions of phages phT4A and ECA2 and for phage 
cocktail phT4A/ECA2 in artificially contaminated cockles during the depuration process). 
For the two single phage suspensions (ECA2 and phT4A), after 4 h of treatment, all added 
bacteria were inactivated by the phages. The bacterial concentration in the contaminated 
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cockle groups reached values similar to those observed for the control group that was 
neither added of E. coli nor treated with phages. The phage cocktail was, however, less 
efficient than the single phage suspensions and needs a longer time (8 h) to attain a similar 
level of E. coli reduction. 
According to Rong et al. (2014), the successful application of phages for the 
treatment of artificial V. parahaemolyticus infections in oyster depend on many factors, 
such as time of incubation with phages during depuration without water circulation; 
temperature of depuration; bacterial concentration used to infect target bivalves and 
concentration of phage administered to inactivate the bacteria in the bivalves, that is, the 
multiplicity of infection (MOI) (Rong et al., 2014). The MOI has been referred as an 
important factor influencing phage therapy efficiency, differing among various animals 
used in vivo experiments namely due to the complex physicochemical environment and 
host defences ( Rong et al., 2014) but differing also from results obtained in in vitro assays 
(Kim et al., 2015; Tsonos et al., 2014). As stated before and contrarily to the case of 
chemicals and other substances, precise initial doses of phages may not be essential to 
inactivate in vitro important aquaculture pathogenic bacteria due to their self-perpetuating 
nature (Nakai, 2010). Rong et al. (2014) concluded that the application of phage (VPp1) 
could reduce the population of V. parahaemolyticus in infected oysters (105 CFU/mL) 
during depuration, with decreases, after 36 h of depuration, of 1.24, 1.99, 1.74 and 2.35 log 
CFU/g, respectively, in the negative control (oysters infected V. parahaemolyticus and not 
treated with phage) and in oysters treated with phage VPp1 at MOI 10, 1 and 0.1. Martínez 
and Hipólito-Morales (2013) reported that the phage Vpms1 was effective in eliminating 
the adverse effects of V. parahaemolyticus in brine shrimp with a MOI of 45, 4.2, 2.25 and 
0.45. These authors demonstrated that the reduction in the dosage of phages does not 
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induce a significant reduction in the efficacy of Vpms1, not being detected significant 
differences between the doses of Vpms1. In our study, the low dose of phage (MOI 1, 105 
PFU/mL) had a significantly higher effect on bacterial reduction in cockles than the high 
dose (MOI 100, 107 PFU/mL). All treated cockle groups (treatment with phage phT4A, 
ECA2 and the phage cocktail phT4A/ECA2) revealed a significantly decrease in the rate of 
E.coli inactivation in cockles (0.8 - 1.0 log CFU/g) during treatment when MOI was 
increased from 1 to 100. However, the application of a low phage titer is cost-effective, as 
theoretically, a low MOI ratio is advantageous for large scale production and 
commercialisation of phage products, since it would reduce the cost of preparation, 
purification and application of phage products. 
Studies on the removal of bacteria during “traditional” depuration (without phage 
addition) using bivalves artificially challenged with bacterial cultures show a greater 
degree of removal than studies using naturally contaminated shellfish (FAO, 2008). The 
type and quantity of initial contamination is also related with depuration efficiency, as 
more contaminated bivalves require longer depuration times and different microorganisms 
respond differently to the purification process (Croci et al., 2002; Jones et al., 1991; 
Richards, 1988). In this study, when naturally contaminated cockles (using 0.6 L of 
seawater added with phages, but without water recirculation) were depurated with the 
single suspensions of the two phages tested and the phage cocktail, the maximum reduction 
of cultivable bacteria (0.7 - 0.8 log CFU/g) was less than that observed in artificially 
contaminated cockles (reductions 1.8 - 2.0 log CFU/g). However, E. coli concentration 
used in contaminated cockles experiments was significantly higher (about 3.5 log CFU/g) 
than that observed in naturally contaminated cockles (about 1.5 log CFU/g). This indicates 
that naturally occurring E. coli in cockles can be effectively removed using depuration in 
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the presence of phages. Moreover, the two phages tested in this study (produced on a 
specific strain of E. coli) can inactivate the natural bacteria belonging to the E. coli species 
which are present in cockles with a similar efficiency than that observed for the E. coli 
specific host used to produce both phage suspensions.  
In the current study it was also tested the depuration in the presence of phages in 
conditions similar to those used in industrial depuration facilities, and phage phT4A was 
selected to be used for depuration of natural contaminated cockles in a circulating system. 
A 0.6 log CFU/g reduction of cultivable bacteria in cockles was achieved after a 2 h 
treatment (using 14 L seawater treated with UV-C light and supplemented with phages). 
However, when depuration occurred without the supply of phages (control group, using 14 
L seawater treated with UV-C light and without addition of phages) 4 h of treatment were 
necessary to obtain the same level of bacterial reduction. In the control group, the 
reduction occurred only during the 2 - 4 h time frame of treatment. After 4 h, no reduction 
of bacterial concentration was observed, which indicated that no E. coli, or other bacteria, 
were removed from the cockles after this period. 
Using the specific medium to detect E. coli initial concentration in the cockles it was 
obtained a value of 1.5 CFU/mL. Taking this into account, some bacteria detected with this 
medium (chromocult coliform agar) are not inactivated by the phage during the depuration 
process. Further studies, using a higher concentration of E. coli, using cockles naturally 
contaminated with a higher content of E. coli or artificially contaminated cockles with E. 
coli, in conditions similar to those used in industrial depuration facilities, that is in the 
recirculating system, are needed. In the control samples, without phage addition, after 4 h, 
the concentration of bacteria was constant, which means that a high concentration of 
bacteria, including E coli and other than bacteria, were not removed by depuration. Further 
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studies in the recirculating system, using cocktails of phages targeted for different genera 
of the main pathogenic bacteria transmitted by bivalve consumption, such as V. 
parahaemolyticus, Salmonella enterica serovar Enteritidis and serovar Typhimurium (Butt 
et al., 2004; Feldhusen, 2000), are also needed to evaluate the efficacy of phage therapy 
during depuration to inactivate the main pathogenic bacteria not removed by simple 
depuration. 
The success of phage therapy to control pathogenic bacteria in bivalves depends on 
viral survival and viability in seawater during depuration. After the accumulation period of 
phages in the cockles, their concentration remained relatively stable during the treatment 
period in the artificially and naturally contaminated cockles, which indicate that the tested 
phages are adequate to be used during the depuration. Whenever seawater is disinfected 
with UV-C light, the UV-C light application must be done before phage application, this 
because the phage concentration was affected by UV-C irradiation. However, the phages 
and bacteria accumulated inside the cockles were not affected by UV-C irradiation, 
because there was no decrease in the concentration of the phage and bacteria after 4 h of 
treatment. UV radiation kills viruses by chemically modifying their genetic material, DNA 
and RNA. The nucleic acid within the virus particle plays a crucial role in the absorption of 
UV radiation and in virus inactivation (Lytle and Sagripanti, 2005). 
In 2006, the Food and Drug Administration (FDA) approved the use of a commercial 
phage cocktail (such as List-Shield and Intralytix.) as suitable to be included on both raw 
and ready-to-eat food products. Having this approval into account and bearing in mind that 
phages are naturally found in all food products (Soni et al., 2010), we do not foresee major 
regulatory difficulties preventing the use of phages phT4A and EC2A during cockles 
depuration process. 
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4.6. Conclusion 
Overall, application of single phage suspensions and phage cocktails was found to 
be effective for the control of E. coli in artificial/natural contaminated cockles during 
depuration. Among all of the treatment groups, artificially contaminated cockles depurated 
with the phT4A and ECA2 phage at a MOI of 0.1 was the most efficient condition. This 
approach holds the potential to reduce the depuration time. We can also envisage that an 
increase in the efficiency of this process can be achieved, through the use of phage 
cocktails treating multiple pathogens transmitted to humans through bivalve consumption, 
broadening the spectrum of action of phage therapy. However, further studies on this topic 
are required to confirm this potential break through. 
By combining phage therapy and depuration a reduction in the depuration period 
can be achieved for marine bivalves, thus decreasing the potential costs associated with 
depuration and, possibly, even enhance the quality and safety of depurated bivalves 
destined for human consumption. 
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5.1. Abstract 
The aim of this study was to compare the dynamics of three previously isolated 
bacteriophages (or phages) individually (phSE-1, phSE-2 and phSE-5) or combined in 
cocktails of two or three phages (phSE-1/phSE-2, phSE-1/phSE-5, phSE-2/phSE-5 and 
phSE-1/phSE-2/phSE-5) to control Salmonella enterica serovar Typhimurium (Salmonella 
Typhimurium) in order to evaluate their potential application during depuration. Phages 
were assigned to the family Siphoviridae and revealed identical restriction digest profiles, 
although they showed a different phage adsorption, host range, burst size, explosion time 
and survival in seawater. The three phages were effective against S. Typhimurium 
(reduction of ~ 2.0 log CFU/mL after 4 h treatment). The use of cocktails was not 
significantly more effective than the use of single phages. A big fraction of the remained 
bacteria are phage-resistant mutants (frequency of phage-resistant mutants 9.19 x10-5 - 
5.11 x10-4) but phage-resistant bacterial mutants was lower for the cocktail phages than for 
the single phage suspensions and the phage phSE-1 presented the highest rate of resistance 
and phage phSE-5 the lowest one. The spectral changes of S. Typhimurium resistant and 
phage-sensitive cells were compared and revealed relevant differences for peaks associated 
to amide I (1620 cm-1) and amide II (1515 cm-1) from proteins and from carbohydrates and 
phosphates region (1080-1000 cm-1). Despite the similar efficiency of individual phages, 
the development of lower resistance indicates that phage cocktails might be the most 
promising choice to be used during the bivalve depuration to control the transmission of 
salmonellosis 
 
Keywords: Bacterial-phage inactivation, phage cocktails, Salmonella Typhimurium, 
salmonellosis, phenotypic resistance  
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5.2. Introduction 
Enteric pathogen strains of Salmonella spp. are widely distributed in coastal areas 
and are a causative agent of gastroenteritis in humans after consumption of contaminated 
seafood (Kanayama et al., 2015; Potasman et al., 2002). Salmonella introduced into marine 
environments readily contaminates the fauna, especially bivalves, which concentrate the 
marine microbiota via filter feeding, being even used as an indicator of the depuration 
efficiency of bivalves (FAO, 2008). Bivalve molluscs that accumulate food particles and 
small organisms by circulating large volumes of seawater; consequently, microorganisms, 
including human pathogens, are retained and accumulate in their tissues (Brands et al., 
2005; Butt et al., 2004; FAO, 2004; Huss et al., 2000; Muniain-Mujika et al., 2003; 
Robertson, 2007). Moreover, as bivalves are often consumed raw or lightly cooked, they 
are potential vectors for pathogenic Salmonella sp.. Although more than 2500 serovars of 
Salmonella enterica have been identified, the human infections are caused by a limited 
number of serovars (Grimont and Weill, 1997). Salmonella enterica serovar Enteritidis and 
serovar Typhimurium belong to the most common serovars isolated during outbreaks of 
foodborne salmonellosis in the United States and European Union (Finstad et al., 2012). 
Salmonella most commonly causes acute gastroenteritis, with symptoms including 
diarrhea, abdominal cramps, and fever. Other clinical manifestations can include enteric 
fever, urinary tract infections, bacteremia, and severe fecal infections. 
Depuration is a useful method to reduce microorganisms from bivalves when 
conducted under conditions that maximize the natural filtering activity, which results in 
expulsion of intestinal contents. However, some pathogenic microorganisms are resistant 
to this process (FAO, 2008; Martínez et al., 2009; Rong et al., 2014). In order to reduce the 
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risk of transmission of infections caused by microbial pathogens, including multidrug-
resistant bacteria, it is essential to develop alternative approaches. One of the most 
promising is the association of phage therapy (application of lytic phages to prevent and/or 
to treat bacterial infections) to the depuration process. This association will contribute to 
the improvement of the decontamination efficiency, likely reducing the time required for 
the depuration, and consequently, the production costs, with additional benefits in bivalve 
safety and quality. After depuration, the bivalves may be intended for consumption if they 
have a level of less than 230 Escherichia coli in 100 g of flesh bivalve and intra-valvular 
liquid (FIL), and absence of Salmonella sp. (FAO, 2008). 
The use of phages to control bacterial infections has been reported across numerous 
fields by many researchers (Bueno et al., 2012; Hooton et al., 2011; Karunasagar et al., 
2007; Lim et al., 2012; Mateus et al., 2014; Park and Nakai, 2003; Pereira et al., 2011a; 
Rong et al., 2014; Silva et al., 2016, 2014a; Viazis et al., 2011; Vinod et al., 2006). As 
specific pathogen-killers, phages are effective agents for controlling bacterial infections, 
without affecting the normal microbiota (Hawkins et al., 2010; Park and Nakai, 2003a; 
Pereira et al., 2011a). Despite of phage therapy can be an eco-friendly alternative to 
prevent and control pathogenic bacteria, there is a major concern regarding the use of 
phages in the treatment of infectious diseases due to the emergence of phage-resistant 
mutants (Gill and Hyman, 2010; Silva et al., 2014a). Resistance may arise due to the 
alteration or loss of the bacterial cell surface receptors, blocking of the receptors by the 
bacterial extracellular matrix, inhibition of phage DNA penetration, production of modified 
restriction endonucleases that degrade the phage DNA, or due to the inhibition of the 
phage intracellular development (Labrie et al., 2010). Genetic mutations affecting phage 
receptors represent the most frequent cause of bacterial phage resistance (Heller, 1992; 
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Labrie et al., 2010). However, nowadays, there is a growing recognition that the emergence 
of phage-resistant mutants can be due to tolerance to phage exposure. In this situation 
bacterial populations may maintain their viability in the presence of phages, remaining 
genetically sensitive to them (Bull et al., 2014; Vieira et al., 2012). Phenotypic resistance 
may be i) induced – the products of phage-lysed bacteria result in a change in uninfected 
bacterial gene expression, reducing adsorption; ii) intrinsic - reduced adsorption is due to a 
physiological or gene expression state that exists prior to the phage introduction; and iii) 
dynamic - degradation or blocking of bacterial receptors by phage proteins released during 
cell lysis (Bull et al., 2014).  
Although the development of phage-resistance, when only one phage is used, has 
already been reported (Levin and Bull, 2004; Nakai, 2010; Sandeep, 2006; Scott et al., 
2007; Silva-aciares et al., 2013; Skurnik and Strauch, 2006; Tanji et al., 2005; Vieira et al., 
2012), this limitation can be overcame by the combined use of more than one phage at the 
same time, that can be achieved, by the use of phage cocktails (Chan et al., 2013; Crothers-
Stomps et al., 2010; Mateus et al., 2014). Phage cocktails not only potentially provide 
means to circumvent resistance to the presence of a single phage, but they also allow the 
treatment of multiple pathogens simultaneously (Cairns et al., 2009; Kunisaki and Tanji, 
2010; Merabishvili et al., 2009). Therefore, the high specificity of phages, that sometimes 
can be considered to be a disadvantage of phage therapy, namely when the pathogenic 
bacteria are not known, may be circumvented by the use of phage cocktails, which broaden 
the spectrum of action (Chan et al., 2013; Sulakvelidze et al., 2001). 
The aim of this study was to evaluate the efficiency of three new phages of S. 
Typhimurium (phSE-1, phSE-2 and phSE-5), individually or combined in cocktails of two 
or three phages, to control S. Typhimurium growth. As the selection of appropriate phages 
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is a key factor in the success of phage mediated control of bivalves infections, the three 
phages were characterized in terms of survival in the marine environment, host range, 
latent period, burst size and adsorption to the host. Nowadays, a major concern regarding 
the use of phages to control infections is the emergency of phage-resistant mutants and it 
has been stated that resistance can be overcome by the combined use of two or more 
phages. In this sense, phage cocktails were tested, and the development of phage-resistant 
mutants was evaluated after exposition to single phage suspensions and to phage cocktails. 
 
5.3. Material and Methods 
5.3.1. Bacterial strains and growth conditions 
The bacterial strains used in this study are listed in Table 5.1. S. Typhimurium 
(ATCC 13311 and ATCC14028), Escherichia coli (ATCC 25922 and 13706), Aeromonas 
hydrophila (ATCC 7966), Vibrio fischeri (ATCC 49387), Vibrio parahaemolyticus (DSM 
27657), Vibrio anguillarum (DSM 21597), Photobacterium damselae damselae (DSM 
7482), Shigella flexneri Listeria innocua (NCTC 11288), Listeria monocytogenes 
(NCTC1194) and Aeromonas salmonicida (CECT 894) were purchased from ATCC, 
DSM, NCTC and CECT collection, respectively. Five strains S. Enteriditis were isolated 
from food and gently provided by Controlvet Laboratory. The other bacterial strains used 
in this study were isolated in previous works from water samples collected in Ria de 
Aveiro (Alves et al., 2008; Louvado et al., 2012; Pereira et al., 2016a). Fresh plate bacterial 
cultures were maintained in solid Tryptic Soy Agar medium (TSA; Liofilchem, Italy) at 4 
°C. Before each assay, one isolated colony was aseptically transferred to 10 mL of Tryptic 
Soy Broth medium (TSB; Liofilchem, Italy) and was grown overnight at 37 ºC. An aliquot 
of this culture (100 μL) was aseptically transferred to 10 mL of fresh TSB medium and 
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grown overnight at 37 °C to reach an optical density (O.D. 600) of 0.8, corresponding to 
about 109 cells per mL. 
 
5.3.2. Phage isolation and purification 
Three phages (phSE-1, phSE-2 and phSE-5) were isolated from sewage network of 
Aveiro (station EEIS9 of SIMRIA Multi Sanitation System of Ria de Aveiro) collected in 
different places at different times (January 2014, April 2014 and June 2014). Sewage water 
was filtered through 0.45 µm pore size polycarbonate membranes (Millipore, Bedford, 
MA, USA). The filtrate was added to double-concentrated TSB medium with 1 mL of 
fresh culture of the host, S. Typhimurium (ATCC 13311). The mixtures were incubated at 
37 ˚C for 18 h at 80 rpm, and then filtered through a 0.2 µm membrane (Millipore Bedford, 
MA, USA). Chloroform (final volume of 1%) was added to the supernatants and phage 
concentration was determined as described before. Plates were incubated at 37 ˚C and 
examined for the presence of lytic plaques after 12 h. One single plaque was removed from 
the agar, diluted in TSB, and then chloroform (final volume of 1%) was added to eliminate 
bacteria. The sample was centrifuged and the supernatant was used as a phage source for a 
second isolation procedure. Three successive single-plaque isolation cycles were 
performed to obtain pure phage stocks for both bacteria. All lysates were centrifuged at 
10.000 g for 10 min at 4 ˚C, to remove intact bacteria or bacterial debris. The phage stocks 
were stored at 4 °C and 1% chloroform (final volume) (Scharlau, Spain) was added. The 
phages were designated as phSE-1, phSE-2 and phSE-5. The phage suspension titers were 
determined by the double-layer agar method using TSA as culture medium (Adams, 1959). 
The plates were incubated at 37 °C for 4 – 8 h and the number of lysis plaques was 
counted. The results were expressed as plaque forming units per millilitre (PFU/mL). 
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5.3.3. Electron microscope examination 
Phage particles of a highly concentrated suspension (109 PFU/mL) were negatively 
stained with 2% uranyl acetate (Electron Microscopy Sciences, Hatfield, UK) and electron 
micrographs were taken using a JEOL 1011 transmission electron microscope (JEDL USA 
Inc, Peabody, MA, USA) operating at 100 kV and images were acquired with a Gatan 
CCD-Erlangshen ES100W.  
 
5.3.4. DNA extraction and restriction enzyme digestion 
Phage suspensions (109 PFU/mL) of the three phages (phSE-1, phSE-2 and phSE-5) 
were centrifuged 3 times at 13.000 g for 10 min. The phage lysates were ultracentrifuged 
(Beckman, Optima LE-80K) at 100.000 g for 2 h at 10 °C. The extraction of nucleic acid 
from phage particles was performed using the phage DNA isolation kit (Norgen Biotek 
Corp, Canadan), as indicated by the instructions provided by the manufacturer. Nucleic 
acid yield was quantified in the Qubit 2.0 Fluorometer (Invitrogen, Carlsbad, CA, USA). 
The resulting product was electrophoresed through 0.8% agarose gel at 80 V for 40 min. 
The extracted phage nucleic acid was analysed on a standard 0.8% (w/v) 1X Tris–acetate–
EDTA (TAE) agarose gel. It was then digested with DNase Ι (Thermo Scientific, USA), 
RNase A (Thermo Scientific, USA) and EcoRI (Thermo Scientific, USA) following the 
manufacturer´s recommendations. 
 
5.3.5. Whole genome sequencing and bioinformatics analyses 
The genome of the two most effective (individually and in cocktail) phage 
suspensions (phSE-2 and phSE-5) were sequenced. Phage DNA samples were firstly 
fragmented using NEB Next dsDNA Fragmentase (New England Biolabs) and digested 
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DNA further processed for libraries construction, using reagents from KAPA Library 
Preparation Kit for Ion Torrent according to manufacturers' protocol. High quality libraries 
were further used for template preparation using Ion PGM Hi-Q Template Kit and 
sequencing on Ion Torrent PGM machine using the chip316 v2 and Ion PGM HiQ 
Sequencing Kit according to manufacturers' protocol.  
The generated raw sequence data were analyzed with CLC Genomics Workbench 
8.5.1 (CLC Bio-Qiagen, Aarhus, Denmark). After quality trimming, the sequence reads 
were de novo assembled and the consensus sequence of the most represented contigs of 
both genomes, was generated. The annotation for both genomes was performed using the 
phage/plasmid pipeline from the RAST server Version 2.0 (Aziz et al., 2008). The 
nucleotide sequences were compared with those of other genes in GenBank using BLAST. 
Open reading frames (ORFs) were identified using the NCBI ORF Finder. A conserved 
protein domain analysis was performed using BLASTP and the NCBI Conserved Domains 
Database. The homology level between the two phages was determined taking into account 
the values correspond to percent nucleotide identity, using blast (bl2seq) on NCBI home-
page. The genome sequences were deposited in GenBank under the accession numbers 
KX015770 (phage phSE-2) and KX015771 (phage phSE-5). 
 
5.3.6. Phage host range and efficiency of plating (EOP) analysis  
 As a first approach, phage host range was determined by spot testing according to 
Adams (1959). The plates were incubated at 37 °C and examined for plaques after 8 - 12 h. 
Bacterial sensitivity to a phage was established by a lysis cleared zone at the spot. 
According to the clarity of the spot, bacteria were differentiated into three categories: clear 
lysis zone (+), no lysis zone (-). The efficiency of plating (EOP) was determined for 
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bacteria with positive spot tests (occurrence of a clear lysis zone), using the double-layer 
agar method (Adams, 1959). The EOP was calculated (average PFU on target bacteria / 
average PFU on host bacteria) (Kutter, 2009) along with the standard deviation for the 
three measurements. For each phage, three independent experiments were done. 
 
5.3.7. Phage adsorption 
Ten microliters of the phage suspensions (final concentration 106 PFU/mL) were 
added to 10 mL of the bacterial culture [cell density of 109 colonies forming units per 
millilitre (CFU/mL), corresponding to a O.D600=0.8] to obtain a multiplicity of infection 
(MOI) of 0.001 (Stuer-Lauridsen et al., 2003) and incubate at 25ºC. Aliquots of mixture 
were collected after 0, 5, 10, 15, 20, 25, 30, 40, 50, 60 and 70 min of incubation and 
chloroform (final volume 1%) was added. The mixture was centrifuged at 12.000 g for 
5min and supernatants were immediately filtered by using 0.2 µm membrane (Millipore 
Bedford, MA, USA). The filtrates containing unadsorbed phages were diluted and titrated. 
The plates were incubated at 37 °C and examined for plaques after 4-8 h. Adsorption was 
expressed as the percentage decrease of the phage titre in the supernatant, as compared to 
the time zero. Suspensions of phages without any cells were used as no-adsorption 
standard for calculations (Stuer-Lauridsen et al., 2003). Three independent assays were 
done. 
 
5.3.8. One step growth assays 
Exponential host bacterial cultures of S. Typhimurium were adjusted to a 0.8 O.D. at 
600 nm (corresponding to a cell density of 109 CFU/mL). Ten microliters of the phage 
suspensions (final concentration: 106 PFU/mL) were added to 10 mL of the bacterial 
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culture in order to have a MOI of 0.001 and incubated at 25 °C (Mateus et al., 2014).The 
mixture was centrifuged at 12.000 g for 5 min, the pellet was re-suspended in 10 mL of 
TSB at 37 °C and then were diluted and titrated. The plates were incubated at 37 °C and 
examined for plaques after 4-8 h (Mateus et al., 2014). Three independent assays were 
done. 
 
5.3.9. Phage survival determination 
The survival of S. Typhimurium phages was tested in seawater. Water samples were 
collected in August 2014 at the Mira Channel in the estuarine system Ria de Aveiro 
(latitude: 40°37′51.44′′N, longitude 8°40′31.75′′W), which is located on the northwestern 
coast of Portugal (Almeida and Alcantara, 1992; Almeida et al., 2002). Mira Channel 
(40°36′30″N, 8°44′52″W) is one of the authorized harvesting area classified as a statute B 
[230 – 4600 most probable number (MPN) E. coli per 100 g of flesh bivalve and intra-
valvular liquid (FIL)] (Pereira et al., 2015). Fifty millilitres of water was filtered through 
0.45 μm and then by 0.22 μm pore-size membranes (Poretics, USA), which was followed 
by the addition of phage suspensions of about 107 PFU/mL. The samples were then 
incubated at 25 °C without shaking, in the dark. Phage titre was determined at time zero 
and at intervals of 14 days by the double-layer agar method. The plates were incubated at 
37 °C and examined for lysis plaques after 4 - 8 h. For each phage, three independent 
experiments were done. 
 
5.3.10. Bacterial kill curves 
Bacterial inactivation was determined using one phage alone (phSE-1, phSE-2 or 
phSE-5) and with phage cocktails (two or all the three phages mixed together, each phage 
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at the same concentration) using the bacterium S. Typhimurium as host, at a MOI of 100. 
The tested phage cocktails were: phSE-1/phSE-2, phSE-1/phSE-5, phSE-2/phSE-5 and 
phSE-1/phSE-2/phSE-5 phages. For each assay, two control samples were included: the 
bacterial control (BC) and the phage control (PC). The bacterial control was inoculated 
with S. Typhimurium but not with phages and the phage controls were inoculated with 
phages but not with bacteria. Controls and test samples were incubated exactly in the same 
conditions. Aliquots of test samples and of the bacterial and phage controls were collected 
after 0, 2, 4, 6, 8, 10, 12 and 24 h of incubation. In all assays, the phage titre was 
determined in duplicate through the double agar layer method after an incubation period of 
4 – 8 h at 37 °C. Bacterial concentration was determined in duplicate in TSA medium after 
an incubation period of 24 h at 37 °C. Three independent experiments were performed for 
each condition. 
 
5.3.11. Statistical analysis 
The statistical analysis of data was performed using the IBM SPSS Statistics 22.0 
software. Normal distributions were checked by Kolmorov-Smirnov test and homogeneity 
of variances by Levene test. The significance of bacterial and viral concentrations between 
treatments and along the experiments was tested using two-way ANOVA and Bonferrori 
post-hoc test. For different treatments, the significance of differences was evaluated by 
comparing the result obtained in the test samples with the results obtained for the 
correspondent control samples, for the different times. A value of p<0.05 was considered 
to be statistically significant.  
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5.3.12. Determination of the rate of emergence of bacterial mutants 
In order to determinate the mutation frequencies per cell, ten isolated colonies were 
picked and inoculated into ten tubes with TSB medium, grown at 37 °C for 24 h. Aliquots 
of 0.1 mL from the 100 –10-3 dilutions were inoculated on TSA plates which were 
incubated at 37 °C for five days (because some of the phage-resistant mutants grow very 
slowly). Simultaneously, 0.1 mL aliquots of 10-5, 10-6 and 10-7 dilutions were plated on 
TSA medium without phage, for determination of CFU numbers. The averaged colony 
number of mutants (obtained from the ten isolated colonies) in 1 mL of culture (prepared 
from the culture with phages) was divided by the averaged colony number of the control 
(prepared from the culture without phages  (Filippov et al., 2011). Three independent 
assays were performed. 
 
5.3.13. Prophage detection in the host bacterium after phage addition 
In order to evaluate if the phage was capable of lysogenic induction (i.e. has the 
ability to incorporate its own genome in the bacterial genome), a test using mitomycin C 
was applied (Mendes, 2009; Pereira et al., 2016a) The petri plates used to determine the 
spontaneous S. Typhimurium mutants resistant to phages were used. An isolated colony 
was picked out from the lysis plaque, inoculated into tubes with TSB medium and stress-
induced with mitomycin C (Sigma Chemical, St. Louis, MO, USA) at a final concentration 
of 1 μg/mL. Cells with temperate phages usually result in the release of the phage (after 
inducing it by mitomycin C). The samples were incubated overnight at 37 °C and 
centrifuged (10.000 g, 10 min). The supernatant was checked for the presence of phages by 
applying the spot test. The presence of a clear zone after stress inducing indicates that 
bacteria have prophages in their genome. Three independent assays were performed. 
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5.3.14. Detection of host sensitivity to phages after one cycle of phage contact  
 The petri plates used to determine the spontaneous S. Typhimurium mutants resistant 
to phages were used. Ten isolated colony was picked out from the lysis plaque, inoculated 
in TSB medium and incubated for 24 h. After incubation the culture was used to do the 
spot test and was also streak-plated on TSA solid medium. An isolated colony in TSA was 
selected and the procedure was repeated more 4 times. Overall 5 streak-plating steps on 
solid medium were done (Pereira et al., 2016a). After to be done 5 streak-plating steps on 
solid medium was determined efficacy of plating and adsorption of phages to resistant 
bacteria as described in Section 5.3.6 and 5.3.7, respectively. Three independent assays 
were done. 
 
5.3.15. Spectral characterization of S. Typhimurium phage resistant and susceptible 
colonies  
In order to assess the spectral differences of spontaneous S. Typhimurium mutants 
resistant to phages, mid-infrared spectroscopy was performed, as previously described 
(Moreirinha et al., 2015). The petri plates used to determine the spontaneous S. 
Typhimurium mutants resistant to phages were used. Ten isolated colonies was picked out 
from the lysis plaque inoculated on SS medium (Liofilchem, Italy). After 24 h of 
incubation at 37 °C, the colonies were examined by infrared spectroscopy. Colonies were 
collected with a loop and placed directly on the crystal of a horizontal single reflection 
platinum ATR accessory. The colonies were air-dried and then measured. Control S. 
Typhimurium and mutants resistant to individual and cocktail phages were analysed. 
Spectroscopic acquisition was carried out in a MIR (Bruker ALPHA FTIR Spectrometer) 
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with a resolution of 4 cm-1 and 32 scans, in the mid-infrared (region between 4000 and 600 
cm-1). At least three replicate spectra were obtained for each sample. 
Mid-infrared spectra, obtained in OPUS format (OPUS version 6.5 software, Bruker, 
Germany), were transferred via JCAMP.DX format to an in-house developed data analysis 
package (CATS build 97) (Barros, 1999). Principal component analysis (PCA) was used to 
find the major sources of variability in data, detect outliers and detect the probable 
presence of clusters. Previous to PCA, the spectra were standard normal deviate (SNV) 
corrected. 
 
5.4. Results 
5.4.1. Phage isolation and enrichment 
Phages phSE-1, phSE-2 and phSE-5, isolated from Aveiro municipal sewage using S. 
Typhimurium (ATCC 13311) as host, formed clear plaques on the host strain with a 
diameter of 0.5 - 2 mm, of 1 - 3 mm and of  2 - 5 mm, respectively (Figure 5.1). High titre 
suspensions (2-4 x 109 PFU/mL) were obtained for the three phages. 
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Figure 5.1 Examples of phage plaque morphologies and electron micrographs of Salmonella 
phages. (A) Phage phSE-1. (B) Phage phSE-2. (C) Phage phSE-5. The bars represent 50 nm. 
 
5.4.2. Virion morphology 
Based on the morphological analysis by TEM (Figure 5.1), all three phages were 
identified as order Caudovirales and family Siphoviridae of double-stranded DNA phages. 
The three phages have an icosahedric head with approximately 67 ± 3nm. Phages phSE-1, 
phSE-2 and phSE-5 displayed binary symmetry and a long and flexible tail with a length of 
approximately 152 ± 2 nm, 177 ± 2nm and 160 ± 2 nm, respectively (Figure 5.1) 
 
5.4.3. Phage genomic characterisation 
The analysis of nucleic acid type suggested that phSE-1, phSE-2 and phSE-5 are 
DNA phages as the genome was completely digested by DNase Ι, but refractory to the 
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activities of RNase A. The three phages presented indistinguishable restriction digest 
profiles and estimated genome size was approximately 50 kbp. 
 
5.4.4. Genome Analysis 
The phage genomes were sequenced with an Ion Torrent PGM semiconductor 
sequencing approach. A total of 331.839 reads were produced, with 376 bp average read 
length, resulting in a total of 121.880.159 bases. Specifically, 38.487 sequence reads were 
obtained for phSE-2 and 293. 352 sequence reads for phSE-5 phage. Phage genomes were 
de novo assembled using CLC Genomics Workbench 8.5.1. For phSE-2 phage 49.167-fold 
coverage was obtained, 49.167 bp genome and a G+C content of 42.89%. For phSE-5 
phage, 9.490- fold coverage, 49.178 bp genome and 45.18% G+C content. The sequence 
analysis revealed the presence of 83 potential number of Coding Sequences (CDS) in both 
phages (Table 5.1S and 5.2S). In general, the genes of phSE-2 and phSE-5 can be roughly 
classified into three classes of clusters. The early (Class I), the class comprising gene 
clusters dealing with DNA metabolism (Class II) and finally the third group (Class III) 
with structural proteins of virion, helpers for assembly, and responsible for host lysis 
(Table 5.1S and 5.2S). None of the genomes featured any lysogenic related genes and it 
can be safety assumed that the two phages feature a lytic lifestyle. No genes encoding 
toxins, virulence factors or antibiotic resistance genes were identified based on amino acid 
sequence homology searches. All two genomes (phSE-2 and phSE-5) were very similar on 
nucleotide level (99% similarity). Overall, the genome sequence of phSE-2 phage had the 
highest similarity with two of the Siphoviridae phages: 95% with Citrobacter phage Stevie 
(accession number KM236241.1) and 94% with Salmonella phage 36 (accession number 
KR296690.1). However, the genome sequence of phSE-5 phage feature 94% similarity 
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with other two of the Siphoviridae phages, Phage TLS (accession number AY308796.1) 
and Salmonella phage FSL SP-126 ( accession number KC139513.1). 
 
5.4.5. Phage host range and efficiency of plating analysis (EOP) 
Spot test indicated that phage phSE-1 and phSE-2 had the capacity to form 
completely cleared zones on 27 of the 42 strains, and the phSE-5 phage form cleared zones 
on 25 of the 42 strains (Table 5.1). However, efficiency of plating (EOP) results indicated 
that the three phages formed phage lysis plates only in 3 strains (E. coli AE11, 
Bioluminescent E. coli and Citrobacter freundii 10I) of the 42 strains (14% strains) tested 
(Table 5.1). Phage phSE-1 infected E. coli AE11, Bioluminescent E. coli and C. freundii 
10I, presenting an efficacy of 1.70x10-6, 22.25 and 1.74x10-3%, respectively. The phSE-2 
phage infected E. coli AE11, Bioluminescent E. coli and C. freundii 10I with an efficacy of 
4.73x10-6, 34.50 and 2.28x10-3 %. The phSE-5 phage also infected E. coli AE11, 
Bioluminescent E. coli and C. freundii 10I, presenting an efficacy of 1.41x10-5, 68.22 and 
5.89x10-4 % respectively (Table 5.1). 
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Table 5.1 Host range and efficiency of plating of three Salmonella phages isolates determined on 
47 bacterial strains included in eight genera. Clear lysis zone (+), not lysis zone (-) 
Species 
Infectivity of phage Efficacy of plating (%) 
phSE-1 phSE-2 phSE-5 phSE-1 phSE-2 phSE-5 
Salmonella. Typhimurium ATCC 13311 + + + 100 100 100 
Salmonella Typhimurium ATCC 14028 + + + 0 0 0 
Salmonella Typhimurium WG49 + + + 0 0 0 
Salmonella Enteriditis CVA + + + 0 0 0 
Salmonella Enteriditis CVB + + + 0 0 0 
Salmonella Enteriditis CVC + + + 0 0 0 
Salmonella Enteriditis CVD + + + 0 0 0 
Salmonella  Enteriditis CVE + + + 0 0 0 
Escherichia coli ATCC 25922 + + + 0 0 0 
Escherichia coli ATCC 13706 + + + 0 0 0 
Escherichia  coli BC30 + + + 0 0 0 
Escherichia coli AE11 + + + 1.70x10-6 4.73x10-6 1.41x10-5 
Escherichia coli AD6 + + + 0 0 0 
Escherichia coli AF15 - - - 0 0 0 
Escherichia coli AN19 + + - 0 0 0 
Escherichia coli AC5 + + + 0 0 0 
Escherichia coli AJ23 + + + 0 0 0 
Escherichia coli BN65 + + + 0 0 0 
Escherichia coli BM62 + + + 0 0 0 
Bioluminescent Escherichia coli  + + + 22.3 34.5 68.2 
Shigella flexneri DSM 4782 - - - 0 0 0 
Citrobacter freundii 6F + + + 0 0 0 
Citrobacter freundii 10I + + + 1.74x10-3 2.28x10-3 5.89x10-4 
Providencia sp. + + + 0 0 0 
Providencia vermicola  + + + 0 0 0 
Providencia vulgaris  + + + 0 0 0 
Providencia mirabilis + + + 0 0 0 
Klebsiella pneumonia + + + 0 0 0 
Enterobacter cloacae + + - 0 0 0 
Listeria innocua NCTC 11288 - - - 0 0 0 
Listeria monocytogenes NCTC 1194 - - - 0 0 0 
Vibrio parahaemolyticus DSM 27657 - - - 0 0 0 
Vibrio anguillarum DSM 21597 - - - 0 0 0 
Vibrio fischeri ATCC 49387 - - - 0 0 0 
Photobacterium damselae damselae DSM 7482 - - - 0 0 0 
Aeromonas hydrophilla ATCC 7966 - - - 0 0 0 
Aeromonas salmonicida CECT 894 - - - 0 0 0 
Pseudomonas aeruginosa - - - 0 0 0 
Pseudomonas fluorescens - - - 0 0 0 
Pseudomonas putida - - - 0 0 0 
Pseudomonas segetis - - - 0 0 0 
Pseudomonas gingeri - - - 0 0 0 
Total number of strains infected 27 27 25    
 
 
5.4.6. Phage adsorption 
Phage adsorption assays with phSE-1 showed that approximately 55% of the phage 
particles adsorb to S. Typhimurium after 40 min and 85% adsorbed after 50 min (Figure 
5.2). For phage phSE-2, 55% of particles adsorbs to S. Typhimurium within 50 min and 
169 
 
65% after 60 min (Figure 5.2). Phage adsorption of phSE-5 was approximately 55% of 
particles adsorbs to S. Typhimurium within 40 min and about 90% after 60 min (Figure 
5.2). 
 
Figure 5.2 Adsorption of bacteriophages phSE-1, phSE-2 and phSE-5 to S. Typhimurium. The 
percent of unadsorbed phage is the ratio between the PFU in the supernatant to the initial sample 
and in an equivalent dilution of the phage in the absence of host cells. Values represent the mean of 
three experiments; error bars represent the standard. 
 
5.4.7. Burst size and explosion time 
Growth curve for phages phSE-1, phSE-2 and phSE-5 was determined in TSB at 25 
ºC (Figure 5.3). From the triphasic curves obtained, an eclipse period of 20 min, a latent 
period of 30 min and a burst size of 28±3 PFU/host cell were calculated for phSE-1. The 
phSE-2 phage is characterized by an eclipse time of 20 min, a latent period of 40 min and 
each infected bacteria produced 53±5 PFU/host cell. phSE-5 is characterized by an eclipse 
period of 15min, a short latency of 30 min and burst size of 149±14 PFU/host cell. 
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Figure 5.3 One-step growth curves of phSE-1, phSE-2 and phSE-5 phages in the presence 
of S. Typhimurium as host. Values represent the mean of three experiments; error bars 
represent the standard deviation. 
 
5.4.8. Phage survival in seawater 
The experiments of phage survival in the seawater samples revealed that all the three 
phages maintained their viability during long periods in seawater (Figure 5.4). All of the 
studied phages persisted viable for at least 8 months at 25 °C. The abundance of phSE-1 
phage remained constant during 28th days, then decreased by three orders of magnitude 
between 42 and 126th day (ANOVA, p < 0.05), and reached a plateau until the 168th day. 
After 168th days, the abundance of phSE-1 phage decreased by two orders of magnitude. 
The phSE-2 phage abundance remained constant during 28th days, then decreased by two 
orders of magnitude between 42 and 112th day (ANOVA, p < 0.05) and reached a plateau 
until the 140th day. Afterwards, the phage titer decreased by two orders of magnitude until 
the 252th day. The phSE-5 phage abundance remained constant during 70th days, then 
decreased by 2.5 log between 84th and 126th day and reached a plateau until the 168th day. 
Afterwards, the phage titer decreased by one order of magnitude until the 252th day. 
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Between 126 and 168th days, the abundance of phSE-1 phage was similar (ANOVA, p > 
0.05) to the obtained by phSE-2 and phSE-5 phages. The abundance of phSE-1, phSE-2 
and phSE-5 phages at the end of the experiment was statistically different. 
 
Figure 5.4 Survival of phSE-1, phSE-2 and phSE-5 phages in seawater. Values represent the mean 
of three experiments; error bars represent the standard deviation. 
 
5.4.9. Bacterial killing curves 
5.4.9.1. Bacterial killing curves using single-phage suspensions 
According to Figure 5.5, after 4 h of treatment there was a significant reduction in S. 
Typhimurium counts with phSE-1, phSE-2 and phSE-5 phage of 1.8, 1.7 and 1.9 log 
CFU/mL, respectively (ANOVA, p < 0.05) (Figure 5.5A) when compared with those of the 
bacterial control (BC). The rates of inactivation after 4 h treatment, were statistically 
similar (ANOVA, p > 0.05) for the three phages. However, after 12 h, the rate of bacterial 
inactivation with the phSE-5 and phSE-2 phages (2.5 and 2.4 log, respectively) was similar 
(ANOVA, p > 0.05) and, twice higher (ANOVA, p < 0.05) than those obtained with the 
phSE-1 (Figure 5.5A). 
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Bacterial density in the BC increased by 3.5 log CFU/mL (ANOVA, p < 0.05) during 
the 12 h of incubation (Figure 5.5A).  
No decrease of the phage survival was observed during the 12 h of the experiments 
for the phage alone and for the phage in the presence of its host in different treatments 
(Figure 5.5B). The phage alone (PC) was constant during all time (ANOVA, p > 0.05) and 
when they were incubated in the presence of its host a significant increase (ANOVA, p < 
0.05) of 0.4, 0.5 and 0.35 log PFU/mL was observed for phSE-1, phSE-2 and phSE-5, 
respectively, after 2 h of incubation (Figure 5.5B). 
 
Figure 5.5 Inactivation of S. Typhimurium by the three phages (phSE-1, phSE-2 and phSE-5) at a 
MOI of 100 during 24 h. A. Bacterial concentration: BC — bacteria control; BP —bacteria plus 
phage. B. Phage concentration: PC — phage control; BP — bacteria plus phage. Values represent 
the mean of three experiments; error bars represent the standard deviation. 
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5.4.9.2. Bacterial killing curves using phage cocktails 
The rates of inactivation during the treatment, were statistically similar (ANOVA, p 
> 0.05) for the four phage cocktails (Figure 5.6A). 
The bacterial inactivation with the phSE-1/phSE-2 phage cocktail was already 1.7 
log CFU/mL (ANOVA, p < 0.05) after 4 h incubation, being statistically similar to those 
with single phage suspensions of phSE-1 and phSE-2 (Figure 5.6A). However, after 12 h 
incubation, the rate of bacterial inactivation with phSE-1/phSE-2 phage cocktail was 
statistically different from that obtained with the phSE-1 phage (ANOVA, p < 0.05) and 
similar to that obtained for the phage phSE-2 (ANOVA, p>0.05) (Figure 5.6A). The 
bacterial inactivation with the phSE-1/phSE-5 after 4 h incubation was also 1.7 log 
CFU/mL (ANOVA, p < 0.05) (Figure 5.6A). This value was not statistically different 
(ANOVA, p > 0.05) from the results of the phage therapy with the phSE-1 and phSE-5 
phages. However, after 12 h incubation, the rate of bacterial inactivation of the phSE-
1/phSE-5 were significantly different from those obtained in the assays of phage therapy 
with the phSE-1 phage alone (ANOVA, p < 0.05), but similar to those obtained with the 
phSE-5 phage alone (ANOVA, p > 0.05).  
In the phage treatment with the phage cocktail phSE-2/phSE-5, after 4 h of treatment, 
the rate of bacterial inactivation was 2.0 log CFU/mL (ANOVA, p < 0.05) (Figure 5.6A). 
The inactivation was not statistically different (ANOVA, p > 0.05) from those obtained 
with single phage suspension of phSE-2 and phSE-5. 
The bacterial inactivation with the phSE-1/phSE-2/phSE-5 phage cocktail was 1.8 
log CFU/mL (ANOVA, p < 0.05) (Figure 5.6A), which was not statistically different from 
the values obtained for the phage treatment with the three phages individually (ANOVA, p 
> 0.05). However, after 12 h incubation, the rate of bacterial inactivation with this cocktail 
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was statistically different (ANOVA, p < 0.05) from the experiments with the phSE-1 
phage, but was similar (ANOVA, p > 0.05) to those obtained in the assays with phages 
phSE-2 and phSE-5. 
 
Figure 5.6 Inactivation of S. Typhimurium by phage cocktails at a MOI of 100 during 24 h. A. 
Bacterial concentration: BC—bacteria control; BP—bacteria plus phage. B. Phage concentration: 
PC — phage control; BP — bacteria plus phage. phSE-1- phage phSE-1; phSE-2 - phage phSE-2; 
phSE-5 - phage phSE-5. Values represent the mean of three experiments; error bars represent the 
standard deviation. 
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Bacterial density in the BC increased by 3.6 log CFU/mL (ANOVA, p < 0.05) during 
the 12 h of incubation (Figure 5.6A). 
Phage concentration did not decrease significantly (ANOVA, p > 0.05) during the 12 
h of experiment for the phage cocktail controls (PC) (Figure 5.6B). The suspensions with 
the phage cocktails, when incubated in the presence of the host, presented a significant 
increase (ANOVA, p < 0.05). An increase of 0.4 log was observed after 4 h of incubation 
(ANOVA, p < 0.05) for the phage cocktails phSE-1/phSE-2, phSE-2/phSE-5 and phSE-
1/phSE-2/phSE-5 and after the concentration remained constant until 12 h (Figure 5.6B). 
When the phSE-1/phSE-2 was incubated in the presence of the host, phage started to 
increase sooner (0.4 log PFU/mL; ANOVA, p < 0.05), after only 2 h (Figure 5.6B). 
 
5.4.10. Determination of the rate of emergence of bacterial mutants 
S. Typhimurium showed different rates of phage-resistant mutants frequencies for 
single phage suspensions and for phage cocktails (Table 5.2). The bacterial colonies of the 
mutants were smaller than those of the non-phage added control and were visible only after 
6 days of incubation. In control, colonies were visible after 24 h of incubation in the same 
conditions. 
 
 Table 5.2 Frequency of S. Typhimurium spontaneous phage-resistant mutants. 
 Control sample 
(CFU mL-1) 
Sample treated 
with phages 
Frequency of 
mutants 
phSE-1 1.19  0.26 x109 6.06  0.51 x105 5.11 x10-4 
phSE-2 1.45  0.34 x109 3.53  0.84 x105 2.43 x10-4 
phSE-5 1.84  0.55 x109 2.34 0.53 x105 1.27 x10-4 
phSE-1/phSE-2 1.68  0.56 x109 1.54 0.40 x105 9.19 x10-5 
phSE-1/phSE-5 1.58  0.25 x109 1.75 0.32 x105 1.10 x10-4 
phSE-2/phSE-5 1.76  0.33 x109 1.80 0.39 x105 1.02 x10-4 
phSE-1/phSE-2/phSE-5 1.61  0.45 x109 1.99 0.56 x105 1.24 x10-4 
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5.4.11. Prophage detection in the host bacterium after phage addition  
No phages were detected in the supernatant of cultures of S. Typhimurium or in the 
mixture of bacteria and phages after treatment with mitomycin C (1µg/mL), demonstrating 
the absence of inducible prophages.  
 
5.4.12. Detection of host sensitivity to phages after one cycle of phage contact  
After incubation in the presence of single phages and phage cocktails and five streak-
plating steps on solid medium, host bacterium had the capacity to form completely cleared 
zones (positive spot test). However, EOP results indicated that the three phages and phage 
cocktails did not form phage lysis plates and cannot adsorb and replicate in the presence to 
the resistant strains bacteria after five streak-plating steps on solid medium.  
 
5.4.13. Spectral characterization of S. Typhimurium phage resistant and susceptible 
colonies  
Principal component analysis of the spectra showed that mutants resistant to single 
phage suspensions, as well as mutants resistant to phage cocktails (BP), were well 
discriminated from non-phage added control (BC) (Figure 5.7A). It was also observable 
that three distinct groups are formed: bacteria resistant to individual phages; bacteria 
resistant to phage cocktails and bacteria control. Figure 5.7B shows that the peaks that 
contribute to the discrimination of the sensitive bacteria (BC) from the resistant ones (BP) 
are: 2917, 1072, 1052 and 1020 cm-1 for the sensitive bacteria (positive PC1) and 1620 and 
1515 cm-1 for the resistant bacteria (negative PC1). It was performed a second PCA 
(Figure 5.8) with the spectra correspondent to bacteria sensitive to individual phages and 
bacteria resistant to phage cocktails, in order to observe whether these two groups 
remained discriminated and if the peaks that contributed to their discrimination were the 
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same that contributed for the discrimination in Figure 5.7. The bacteria resistant to 
individual phages were well discriminated from bacteria resistant to cocktails (Figure 
5.8A) and the peaks that characterized the bacteria resistant to individual phages were 
1693, 1620 and 1615 cm-1, while the peaks that characterized the bacteria resistant to 
phage cocktails were characterized by peaks at 2917, 1079 and 1020 cm-1. 
 
Figure 5.7 A - Scores scatter plot of the mid-infrared spectra of the bacteria in the spectral region 
between 3000-2800 cm-1 and 1800-980 cm-1. BC—bacteria control; BP—bacteria plus phage. 
phSE-1- phage phSE-1; phSE-2 - phage phSE-2; phSE-5 - phage phSE-5. B - Loadings plot profile 
of the mid-infrared spectra of the bacteria in the spectral region between 3000-2800 cm-1 and 
1800-980 cm-1. BC—bacteria control; BP—bacteria plus phage. phSE-1- phage phSE-1; phSE-2 - 
phage phSE-2; phSE-5 - phage phSE-5. 
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Figure 5.8 A - Scores scatter plot of the mid-infrared spectra of the bacteria in the spectral region 
between 3000-2800 cm-1 and 1800-980 cm-1. BP—bacteria plus phage. phSE-1- phage phSE-1; 
phSE-2 - phage phSE-2; phSE-5 - phage phSE-5. B - Loadings plot profile of the mid-infrared 
spectra of the bacteria in the spectral region between 3000-2800 cm-1 and 1800-980 cm-1. BC—
bacteria control; BP—bacteria plus phage. phSE-1- phage phSE-1; phSE-2 - phage phSE-2; phSE-
5 - phage phSE-5. 
 
5.5 Discussion 
Depuration is the unique treatment applied in order to reduce microbial 
contamination in bivalves, but some pathogenic microorganisms are resistant to this 
process. Therefore, the association of phage treatment during depuration can be an 
innovative and promising approach that is still in the initial stage, needing more work and 
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experiments. Just one study has reported the simultaneous use of the two processes in the 
elimination of V. parahaemolyticus (Rong et al., 2014), but, as far as we know, there are 
not any studies focused in the inactivation of the indicator of the depuration efficiency of 
bivalves and causal agent of a high number of enteric infections in the world, S. 
Typhimurium.  
The selection of appropriate phages to be used in phage therapy is a critical stage to 
achieve a successful phage-mediated control of pathogenic bacteria. Criteria such as the 
host range, adsorption rate, latent period,  burst size, survival in the environment and 
efficiency of bacterial inactivation must be evaluated (Mateus et al., 2014). 
The three dsDNA phages tested in this study (isolated on S. Typhimurium) 1) 
infected the same hosts (E. coli AE 11, bioluminescent E. coli and C. freundii), 2) 
presented high efficiency to inactivate the S. Typhimurium, 3) presented long periods of 
survival in marine water but  the concentration of phSE-5 phage decrease slowly in 
seawater, however, 4) the phSE -5 phage had a short latent period than the phSE-2 phage 
and higher burst size than the other two phages, adsorbing faster to its host.  
The three phages presented similar morphology and its restriction digest profiles 
were indistinguishable from each other.  However, there were evident differences between 
them, namely in their phage adsorption, host range, burst size, explosion time and survival 
in seawater are enough to consider all of them to evaluate their potential to inactivate S. 
Typhimurium as single suspensions or as cocktails. 
The phage burst size and latent period are important factors to consider when phages 
are selected. Phages with high burst sizes and short latent periods are more effective to 
inactivate bacteria (Abedon and Culler, 2007; Mateus et al., 2014). Phage phSE-5 
presented the highest burst size (149 ± 14 PFU/host cell) which was around 3 to 5 times 
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higher than those presented by phSE-2 and phSE-1 phages (53 ± 5 and 28 ± 3  PFU/host 
cell, respectively). The latent period was short, 30 min (30 and 40 min for phSE-2 and 
phSE-1, respectively). Having into account the number of phages produced by host cell 
(burst size) and the necessary time to replicate them (time of explosion), phage phSE-5 
should be the most adequate to be used during bivalve depuration. 
One of the major advantages of phage treatment is the phage specificity, although a 
therapeutic phage should be able to lyse the majority of the strains of a given bacterial 
species (Almeida et al., 2009). The three phages infect a similar host range, which can be 
explained by the fact that all of the phages were isolated using the same strain of S. 
Typhimurium as a host. Spot test indicated that phage phSE-1 and phSE-2 had the capacity 
to form completely cleared zones on 27 of the 42 strains, and the phSE-5 phage form 
cleared zones on 25 of the 42 strains. However, efficiency of plating (EOP) results 
indicated that the three phages formed phage lysis plates only in 3 strains (E. coli AE11, 
Bioluminescent E. coli and C. freundii 10I) of the 42 strains tested. Mirzaei and Nilsson 
(2015), obtained similar results, stating that spot test cannot be used for identification and 
selection of phages to a phage library and should be replaced by EOP assays. Lysis is a 
plausible mechanism which happens when an overload of phages simultaneously infects a 
bacterium leading to lysis either from the action of lysins or from rapid depletion of the 
cells resources (Abedon, 2011). In addition, as observed by Mirzaei and Nilsson (2015), 
high EOP was not correlated to the results from the spot tests. Further studies are needed to 
understand the different results obtained by both approaches. 
Before the application of phages to inactivate pathogenic bacteria, like S. 
Typhimurium, during bivalves depuration, it is important to characterize the in vitro the 
dynamics of phage-host replication. Both single phage suspensions and phage cocktails 
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isolated in this study can be used to inactivate Salmonella (reduction of bacterial 
concentration of almost 3 log CFU/mL). Unlike other studies (Mateus et al., 2014; O’Flynn 
et al., 2006; Wagner and Waldor, 2002), the efficiency of all phage cocktails tested (two or 
three phages mixed together) to inactivate S. Typhimurium was similar to the single phage 
suspensions. For instance, Mateus et al. (2014) showed that there is a faster and higher rate 
of bacterial inactivation by using phage cocktails, relatively to the use of single-phage 
suspensions. In this study, it was not detected an increase in efficiency due to the use of 
phage cocktails, even when the phage phSE-5, which present the more suitable 
characteristics to be used in phage treatment (a shorter latent period, bigger burst size and 
slower decrease in seawater) is in the mixture, comparatively to the use of the single phage 
suspensions. 
The emergence of phage-resistant mutants during phage infection has been reported 
in many other studies (Kudva et al., 1999; O’Flynn et al., 2006; Park and Nakai, 2003; 
Silva et al., 2016, 2014a; Tomat et al., 2013; Vieira et al., 2012) Other major challenge of 
bacterial inactivation by phages is the selection of phages that are unable to induce 
lysogeny. The experiments of lysogenic induction with mitomycin C (1 µg/mL) showed 
that no phages were detected in the supernatant of S. Typhimurium cultures or in the 
mixture of bacteria and phages after treatment with mitomycin C, demonstrating the 
absence of inducible prophages. Phages presented lytic cycles with no evidence of 
lysogeny induction. Moreover, genes codifying to integrase were not detected in the phSE-
2 and phSE-5 genomes.  
Phage resistance may result from mutations that alters cell surface receptors, 
restriction modification, or abortive infection associated with the presence of clustered 
regularly interspaced short palindromic repeats (CRISPRs) in the bacterial genome 
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(Allison and Klaenhammer, 1998; Barrangou et al., 2007). In this study, the frequency of 
phage-resistant mutation was 10-4-10-5 CFU/mL. With such a low mutation frequency, 
phage resistance should not hinder the use of phages as biocontrol agents against the 
pathogenic bacteria, as stated before by other authors (Flynn et al., 2004; Tanji et al., 
2004). In this study, the potential of using phage cocktails to minimize the development of 
phage resistant mutants was tested. Using a phage cocktail containing different phages 
against the same bacterial species can decrease the likelihood of selecting phage-resistant 
mutants (Carter et al., 2012; Flynn et al., 2004; Tanji et al., 2004; Tomat et al., 2013). 
Because different phages may attach to different receptors on the host, mutations in one 
phage receptor gene may not alter the mutant susceptibility to another phage that attaches 
to a different receptor on the bacterial cells (Tanji et al., 2004). However, the use of phage 
cocktails, as well as the use of single-phage suspensions, did not prevent the occurrence of 
phage-resistant mutants. The emergence of phage resistant mutants was slightly lower for 
phage cocktails than for single phage suspensions. Nevertheless, colonies of phage-
resistant mutants were smaller than colonies formed by the non-phage added control and 
were visible only after 5 days of incubation. In the non-phage added control, bacterial 
colonies were visible after 24 hour of incubation. These results suggest that the remaining 
bacterial mutants (forming small size colonies and showing slow growth) maintained their 
viability in the presence of phages but their phenotypes were affected. Similar results were 
already observed in other studies (Flynn et al., 2004; Mizoguchi et al., 2003; Pereira et al., 
2016a). These decrease in the bacterial growth after phage exposure could be fitness cost 
which can contribute to their elimination from the environment faster than their wild-type 
parents. Further studies are needed to confirm this hypothesis. 
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Phage-resistant bacteria did not recover sensitivity, phages did not adsorbed to 
phage-resistant bacteria and after five streak-plating steps on solid medium these bacteria 
remained resistant. In order to understand why the surviving viable bacteria did not 
recuperate their sensitivity to the phages, infrared spectroscopy was used to study the 
surface of the bacterial cells. The spectral changes of S. Typhimurium resistant and phage-
sensitive cells were compared. Spectral differences between resistant mutants and the 
controls were clear, being the differences more relevant for peaks associated to amide I 
(1620 cm-1) and amide II (1515 cm-1) from proteins and from carbohydrates and 
phosphates region (1080-1000 cm-1). Taking this into account, it is a possibility that the 
proteins present in the bacteria cellular envelope of the resistant cells, which can be used as 
receptors for phages, are someway modified, thus leading to the observed resistance. The 
peak at 2917 cm-1, which appears in the controls but not in the resistant cells, has been 
previously associated with methylene, which is associated with proteins and amino acids, 
evidencing that phages could have induced changes in protein composition. However, shall 
be taking in consideration that the cellular envelope contains also lipids which can arise 
signals in the same region (Santos et al., 2013). The alterations in the spectral region of 
1080-1000 cm-1 (Barth, 2007; Movasaghi et al., 2008) are more difficult to understand, as 
this region comprises not only vibrations of amino acids, but also signals due to sugars and 
phosphates, originating very complex bands. Comparing the group of resistant bacteria 
corresponding to exposition to single suspensions with that corresponding to resistant 
bacteria treated with phage cocktail, it is noticed that the peaks that separated these two 
groups were almost the same that separated resistant and controls for this spectral region. 
The more noticeable alteration is a peak at 1693 cm-1 (Barth, 2007; Movasaghi et al., 2008) 
observed in bacterial resistant cells treated with single phages, which seems to be related to 
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amide I β-linked to protein conformation. The peaks 2917 and 1020 cm-1, present in the 
controls, re-appear in the cells treated with the cocktails after five streak-plating steps on 
solid medium but not in the cells treated with the single suspensions. Overall, the results 
suggests that the bacteria have evolved a range of barriers apparently irreversible 
(associated to amide I and amide II form proteins, carbohydrates and phosphates) to 
prevent phage adsorption and, consequently, prevent infection. As infrared spectroscopy 
only allows to detect alterations on cell surface, external proteins seem to be greatly 
implied in this process. The bacterial resistance to the phages maybe mainly due to 
phenotypic alterations on bacterial surface. In order to better understand the spectral 
changes observed when the whole cells spectra is used and, it is important to analyze 
bacteria protein, DNA and lipids cellular fractions in separate with infrared spectroscopy 
(work in progress). Although all the phages, individually or combined in cocktails, 
inactivated the pathogenic bacterium S. Typhimurium with the same efficiency, the use of 
phage cocktails induce lower rates of resistance development. Therefore, phage cocktails 
might be the most promising choice to be used during the bivalve depuration to control the 
transmission of salmonellosis. However, it is essential to previously select the phages for 
the cocktails, having into account not only its efficacy and its propensity to develop phage-
resistant mutants, but also the growth characteristics. As phage phSE-5 present the shortest 
latent period, the largest burst size, the slowest decrease in seawater, and the highest 
sensitivity on surviving bacteria, this phage should be one to be used in the cocktails. 
Contrarily, as the phage phSE-1 increases the frequency of resistance of the cocktails, this 
must be avoided. Taking into account this information, the genome of the phSE-5 and 
phSE-2 were sequenced in order to use them in posterior in vivo tests during the depuration 
process. The genome sequence of phSE-2 and phSE-5 confirmed that they had similar 
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genome sequences (99% similarity) and no genes encoding products such as toxins, 
antibiotic resistance and integrase enzyme were detected by aminoacid sequence 
comparisons. Consequently, from our current state of knowledge, these phages can be 
considered safe to be used in phage therapy. 
 
5.6 Conclusion 
Bacterial inactivation efficiency with phSE-5 and phSE-2 phage suspension alone 
and combined in phage cocktails, associated with the safety of the phages and their long 
periods of survival, paves the way for depth studies, especially in vivo studies, concerning 
the control of Salmonella in bivalves. The results of this study highlight the importance of 
previously test the efficacy of phages to inactivate bacteria in vitro before moving on to in 
vivo experiments. 
 
5.7 Supplementary material 
Table 5.1S Coding sequences identified in phSE-2 phage of S. Typhimurium strain. 
ID Location Start Stop Strand Function 
1 1_576 1 576 + JK_59P 
2 657_854 657 854 + Phage protein 
3 856_1020 856 1020 + Phage protein 
4 1013_1195 1013 1195 + hypothetical protein 
5 1192_1437 1192 1437 + Phage protein 
6 1450_1962 1450 1962 + Phage protein 
7 2037_2246 2037 2246 + Phage protein 
8 2243_2500 2243 2500 + Phage protein 
9 2497_2823 2497 2823 + Phage protein 
10 2883_3011 2883 3011 + Phage protein 
11 3013_3240 3013 3240 + Phage protein 
12 3423_3584 3423 3584 + Phage protein 
13 3568_3750 3568 3750 + Phage protein 
14 3750_3980 3750 3980 + Phage protein 
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15 4070_4594 4070 4594 + Phage terminase, small subunit 
16 4606_6177 4606 6177 + Phage terminase, large subunit 
17 6231_7526 6231 7526 + Phage portal protein 
18 7523_8194 7523 8194 + Phage protein 
19 8191_9300 8191 9300 + Phage capsid and scaffold 
20 9313_9801 9313 9801 + Phage protein 
21 9845_10285 9845 10285 + Phage protein 
22 10375_11352 10375 11352 + hypothetical protein 
23 11414_11686 11414 11686 + JK_24P 
24 11732_12136 11732 12136 + JK_23P 
25 12133_12504 12133 12504 + JK_22P 
26 12497_12937 12497 12937 + Phage protein 
27 12927_13319 12927 13319 + Phage protein 
28 13334_13996 13334 13996 + Phage tail fibers 
29 14074_14388 14074 14388 + Phage protein 
30 14436_14705 14436 14705 + Phage protein 
31 14744_17653 14744 17653 + Phage tail length tape-measure protein 1 
32 17653_18000 17653 18000 + Phage minor tail protein 
33 18067_18825 18067 18825 + Phage minor tail protein 
34 18822_19544 18822 19544 + Phage tail assembly protein 
35 19537_20136 19537 20136 + Phage tail assembly protein 
36 20218_23994 20218 23994 + Phage tail fiber protein 
37 24455_25510 24455 25510 + Exodeoxyribonuclease VIII 
38 25586_25876 25586 25876 + Phage tail length tape-measure protein 
39 25923_26585 25923 26585 + Phage-associated recombinase 
40 26624_27049 26624 27049 + Single-stranded DNA-binding protein 
41 29494_27083 29494 27083 - Phage tail fibers 
42 30581_29655 30581 29655 - DNA primase/helicase, phage-associated 
43 31248_30640 31248 30640 - Phage protein 
44 31337_33310 31337 33310 + DNA helicase, phage-associated 
45 33313_33720 33313 33720 + Phage protein 
46 33792_34070 33792 34070 + Phage protein 
47 34072_34812 34072 34812 + DNA adenine methyltransferase, phage-associated 
48 34814_35044 34814 35044 + Phage protein 
49 35116_35280 35116 35280 + Phage protein 
50 35261_35503 35261 35503 + JK_65P 
51 35587_36702 35587 36702 + Phage protein 
52 36814_37038 36814 37038 + Phage holin 
53 37038_37529 37038 37529 + 
Phage lysin (EC 3.2.1.17) # Phage lysozyme or muramidase (EC 
3.2.1.17) 
54 37526_37915 37526 37915 + Phage protein 
55 38150_37929 38150 37929 - hypothetical protein 
56 38364_38227 38364 38227 - hypothetical protein 
187 
 
57 38740_38348 38740 38348 - Phage protein 
58 40323_38743 40323 38743 - Phage protein 
59 40639_40391 40639 40391 - Phage protein 
60 40998_40636 40998 40636 - Phage protein 
61 41766_41071 41766 41071 - Phage protein 
62 42189_41965 42189 41965 - Phage protein 
63 42412_42191 42412 42191 - Phage protein 
64 42638_42471 42638 42471 - Phage protein 
65 42868_42635 42868 42635 - Phage protein 
66 43149_42868 43149 42868 - Phage protein 
67 43521_43327 43521 43327 - Phage protein 
68 43754_43518 43754 43518 - Phage protein 
69 43969_43751 43969 43751 - Phage protein 
70 44328_44044 44328 44044 - Phage protein 
71 45091_44975 45091 44975 - hypothetical protein 
72 45054_45341 45054 45341 + hypothetical protein 
73 45353_45796 45353 45796 + JK_47P 
74 46035_45913 46035 45913 - hypothetical protein 
75 46104_46262 46104 46262 + Phage protein 
76 46246_46527 46246 46527 + Phage protein 
77 46533_46790 46533 46790 + Phage protein 
78 46940_47116 46940 47116 + hypothetical protein 
79 47190_47495 47190 47495 + hypothetical protein 
80 47679_48242 47679 48242 + 3'-phosphatase, 5'-polynucleotide kinase, phage-associated 
81 48223_48411 48223 48411 + Phage protein 
82 48422_48607 48422 48607 + Phage protein 
83 48685_48996 48685 48996 + hypothetical protein 
 
Table 5.2S Coding sequences identified in phSE-5 phage of S. Typhimurium strain 
CDS Location Start Stop Strand Function 
1 4318_542 4318 542 - Phage tail fiber protein 
2 4999_4400 4999 4400 - Phage tail assembly protein 
3 5714_4992 5714 4992 - Phage tail assembly protein 
4 6469_5711 6469 5711 - Phage minor tail protein 
5 6883_6536 6883 6536 - Phage minor tail protein 
6 9792_6883 9792 6883 - Phage tail length tape-measure protein 1 
7 10100_9831 10100 9831 - Phage protein 
8 10462_10148 10462 10148 - Phage protein 
9 11202_10540 11202 10540 - Phage tail fibers 
10 11609_11217 11609 11217 - Phage protein 
11 12039_11599 12039 11599 - Phage protein 
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12 12403_12032 12403 12032 - JK_22P 
13 12804_12400 12804 12400 - JK_23P 
14 13122_12850 13122 12850 - JK_24P 
15 14161_13184 14161 13184 - hypothetical protein 
16 14604_14251 14604 14251 - Phage protein 
17 15223_14735 15223 14735 - Phage protein 
18 16345_15236 16345 15236 - Phage capsid and scaffold 
19 17013_16342 17013 16342 - Phage protein 
20 18305_17010 18305 17010 - Phage portal protein 
21 19930_18359 19930 18359 - Phage terminase, large subunit 
22 20466_19942 20466 19942 - Phage terminase, small subunit 
23 20807_20556 20807 20556 - Phage protein 
24 20989_20807 20989 20807 - Phage protein 
25 21134_20973 21134 20973 - Phage protein 
26 21544_21317 21544 21317 - Phage protein 
27 21674_21546 21674 21546 - Phage protein 
28 22060_21734 22060 21734 - Phage protein 
29 22314_22057 22314 22057 - Phage protein 
30 22520_22311 22520 22311 - Phage protein 
31 23107_22595 23107 22595 - Phage protein 
32 23365_23120 23365 23120 - Phage protein 
33 23544_23362 23544 23362 - hypothetical protein 
34 23701_23537 23701 23537 - Phage protein 
35 23900_23703 23900 23703 - Phage protein 
36 24556_23981 24556 23981 - JK_59P 
37 24731_24549 24731 24549 - Phage protein 
38 25039_24728 25039 24728 - hypothetical protein 
39 25302_25117 25302 25117 - Phage protein 
40 25501_25313 25501 25313 - Phage protein 
41 26045_25482 26045 25482 - 3'-phosphatase, 5'-polynucleotide kinase, phage-associated 
42 26534_26229 26534 26229 - hypothetical protein 
43 26784_26608 26784 26608 - hypothetical protein 
44 27191_26934 27191 26934 - Phage protein 
45 S27478_27197 27478 27197 - Phage protein 
46 27620_27462 27620 27462 - Phage protein 
47 27689_27811 27689 27811 + hypothetical protein 
48 28371_27928 28371 27928 - JK_47P 
49 28670_28383 28670 28383 - hypothetical protein 
50 29396_29680 29396 29680 + Phage protein 
51 29755_29973 29755 29973 + Phage protein 
52 29970_30206 29970 30206 + Phage protein 
53 30203_30397 30203 30397 + Phage protein 
54 30575_30856 30575 30856 + Phage protein 
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55 30856_31089 30856 31089 + Phage protein 
56 31086_31253 31086 31253 + Phage protein 
57 31312_31533 31312 31533 + Phage protein 
58 31535_31759 31535 31759 + Phage protein 
59 31958_32653 31958 32653 + Phage protein 
60 32726_33088 32726 33088 + Phage protein 
61 33085_33333 33085 33333 + Phage protein 
62 33401_34981 33401 34981 + Phage protein 
63 34984_35376 34984 35376 + Phage protein 
64 35360_35497 35360 35497 + hypothetical protein 
65 35574_35795 35574 35795 + hypothetical protein 
66 36198_35809 36198 35809 - Phage protein 
67 36686_36195 36686 36195 - Phage lysin (EC 3.2.1.17) # Phage lysozyme or muramidase (EC 3.2.1.17) 
68 36910_36686 36910 36686 - Phage holin 
69 38137_37022 38137 37022 - Phage protein 
70 38463_38221 38463 38221 - JK_65P 
71 38608_38444 38608 38444 - Phage protein 
72 38910_38680 38910 38680 - Phage protein 
73 39652_38912 39652 38912 - DNA adenine methyltransferase, phage-associated 
74 39932_39654 39932 39654 - Phage protein 
75 40411_40004 40411 40004 - Phage protein 
76 42387_40414 42387 40414 - DNA helicase, phage-associated 
77 42476_43084 42476 43084 + Phage protein 
78 43143_44069 43143 44069 + DNA primase/helicase, phage-associated 
79 44230_46641 44230 46641 + Phage tail fibers 
80 47100_46675 47100 46675 - Single-stranded DNA-binding protein 
81 47801_47139 47801 47139 - Phage-associated recombinase 
82 48138_47848 48138 47848 - Phage tail length tape-measure protein 
83 48990_48214 48990 48214 - Phage exonuclease 
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6.1. Abstract 
As bivalve molluscs are filter feeder, often consumed raw or lightly cooked and are 
frequently cultivated in contaminated waters, they are implicated in food-borne disease 
transmission to human.  The present study investigated the potential application of the 
bacteriophage (or phage) phSE-5 and phSE-2/phSE-5 cocktail to decrease the load of 
Salmonella enterica serovar Typhimurium (Salmonella Typhimurium) during the 
depuration of natural and artificially contaminated cockles (Cerastoderma edule). 
Although a previous study reported the combined use of these two processes to eliminate 
Vibrio parahaemolyticus from artificially contaminated oysters, this study did not replicate 
industrial depuration procedures and did not test the suitability of this approach on 
naturally contaminated bivalves. Cockles were artificially infected with 105 and 106 
colony-forming units (CFU)/mL of S. Typhimurium in static seawater and each infected 
group was treated with four different MOI values: 0.1, 1, 10 and 100. Depuration in static 
seawater at MOI of 0.1 with single phage suspension of phSE-5 provided the best results, 
as it decreased by ~ 1.7 log CFU/g the load of S. Typhimurium after a 4 h treatment. At a 
MOI of 0.1, the rate of inactivation with phSE-5 phage was higher when compared with 
the results obtained using phSE-2/phSE-5 cocktail. However, in naturally contaminated 
cockles treated in static seawater with single phage suspensions and phage cocktail phSE-
2/phSE-5, similar decreases in S. Typhimurium concentration (~ 0.9 log CFU/g) were 
achieved. When artificially contaminated cockles were depurated with phSE-5 phage in a 
recirculated seawater system (mimicking industrial depuration conditions), a 0.9 and 2.0 
log CFU/g reduction of S. Typhimurium was reached after 4 and 6 h treatment, 
respectively, relatively to the bacterial control (BC). Once the depuration process was 
performed without phage, a 6 h treatment was needed to obtain a 1.1 log CFU/g reduction 
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of S. Typhimurium. Results indicated that combining phage therapy with depuration 
procedures enhance bivalve microbial safety for human consumption by improving 
decontamination efficiency, proving that this technology can be transposed to the bivalves 
industry.  Moreover, this approach also displays the advantage of reducing the time 
required for depuration and consequently its associated costs.  
 
Keywords: bacteriophage, cockles, Cerastoderma edule, food safety 
 
6.2. Introduction 
Seafood, particularly filter feeder bivalve molluscs, are well represented in food-
borne disease statistics (Potasman et al., 2002). As the majority of bivalves used for human 
consumption, cockles (Cerastoderma edule) accumulate food particles and small 
organisms by circulating large volumes of seawater; consequently, microorganisms, 
including human pathogens, are retained and can accumulate in their tissues (Brands et al., 
2005; Butt et al., 2004; FAO, 2004; Huss et al., 2000; Muniain-Mujika et al., 2003; 
Robertson, 2007). Moreover, as bivalves are often consumed raw or lightly cooked, they 
are potential vectors of pathogenic Salmonella enterica serovar Typhimurium (Salmonella 
Typhimurium) (Lees, 2000). Salmonella has long been recognized as an importance 
foodborne pathogen and a major public health burden worldwide (Hungaro et al., 2013). 
Salmonella enterica, namely Salmonella enterica serovar Enteritidis and serovar 
Typhimurium, has been considered the causal agent of a high number of enteric infections 
in the world, transmitted mainly by raw foods and cross-contamination of ready-to-eat 
products (Bell and Kyriakides, 2002). As Salmonella is introduced through a number of 
pathways into marine environments and readily contaminate existing fauna, especially 
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bivalves which concentrate marine microbiota via filter feeding, this microorganism is 
commonly used as a proxy to infer depuration efficiency of bivalves destined for human 
consumption (FAO, 2008).  
Depuration is a method applied to reduce and eliminate human pathogens from 
bivalves. Briefly, it consists of a flow-through or recirculation system of chemically 
(chlorine, ozone, iodophores and activated oxygen) or physically (UV-C irradiation) 
disinfected seawater to allow purification under controlled conditions (Croci et al., 2002; 
Wang et al., 2010). This process of depuration usually occurs in 2 days (Lees, 2000). After 
depuration, bivalves may be destined for consumption if they have a level of less than 230 
Escherichia coli in 100 g of flesh bivalve and intra-valvular liquid (FIL), and absence of 
Salmonella sp. (FAO, 2008). However, it is already well documented that a number of 
pathogenic microorganisms still persist in depurated bivalves (FAO, 2008; Martínez et al., 
2009; Rong et al., 2014). In order to reduce the risk of transmission of infections caused by 
microbial pathogens, including multidrug-resistant bacteria, it is essential to develop 
alternative and/or complementary approaches to “traditional” bivalve depuration practices. 
One of the most promising is the association of phage therapy (application of lytic phages 
to prevent and/or to treat bacterial infections) to the depuration process (Pereira et al., 
2016a; Rong et al., 2014). 
The use of lytic phages to reduce food-borne pathogens has emerged as a promising 
tool for food safety. These viruses are target-specific, self-replicating, rapidly bactericidal, 
and do not alter normal food properties (Galarce et al., 2014). A few publications have 
demonstrated that phages can be used to successfully reduce Salmonella spp. in foods, 
especially meat and poultry products (Bielke et al., 2007; Bigwood et al., 2008; Goode et 
al., 2003; Goodridge and Bisha, 2011; Guenther et al., 2009; Hooton et al., 2011). 
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However, the combination of depuration and phage therapy to eliminate pathogenic 
bacteria in bivalves is an innovative approach which is still being investigated. A previous 
study by Rong et al. (2014) already reported the combined use of these two processes to 
eliminate V. parahaemolyticus from artificially contaminated oysters. However, this study 
did not replicate industrial depuration procedures and did not test the suitability of this 
approach on naturally contaminated bivalves. 
The aim of the present study was to evaluate, for the first time, the efficiency of 
phSE-5 individually or combined in a cocktail (phSE-2/phSE-5), to control S. 
Typhimurium in natural and artificially contaminated cockles in static water and during 
depuration mimicking industrial procedures currently employed using artificially 
contaminated bivalves. 
 
6.3. Material and Methods 
6.3.1. Bacterial strains 
S. Typhimurium (ATCC 13311), a microbiological indicator of shellfish depuration 
efficiency (FAO, 2008), was used to infect cockles. Fresh plate bacterial cultures were 
maintained in solid Tryptic Soy Agar (TSA; Liofilchem, Italy) at 4 °C. Before each assay, 
one isolated colony was aseptically transferred to 10 mL of Tryptic Soy Broth (TSB; 
Liofilchem, Italy) and was grown overnight at 37 ºC. An aliquot of this culture (100 μL) 
was aseptically transferred to 10 mL of fresh TSB and grown overnight at 37 °C to reach 
an optical density (O.D. 600 nm = 0.8), corresponding to about 109 cells per mL. Counts of 
S. Typhimurium was performed using Brilliant green agar (BGE, Liofilchem, Italy) in 
artificially contaminated cockles , while TSA medium was used for naturally contaminated 
cockles. 
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6.3.2 Phage preparation 
The phages phSE-2 and phSE-5, two lytic phages previously isolated from sewage 
samples, evidenced to be effective in lysing S. Typhimurium even at multiplicity of 
infection (MOI) of 100 in studies in vitro (Pereira et al., 2016b). The two phage 
suspensions were prepared in SM buffer (0.1 M NaCl, 8 mM MgSO4, 20 mM Tris-HCl, 
2% (w/v) gelatin, pH 7.5) at 37 °C during 4-6 h, using S. Typhimurium as host. Double-
plaque assays were performed as described by Pereira et al. (2016b) to determine the phage 
titer, with the phages being stored at 4 °C. The titer of both phages was approximately 109 
plaque-forming units (PFU)/mL. 
Phage phSE-2 and phSE-5 belong to the family Siphoviridae and both are safe (no 
integrase and toxin codifying genes) to be used in bacterial control (Pereira et al., 2016b). 
The genome sequences were deposited in GenBank under the accession number 
KX015770 for phSE-2 and KX015771 for phSE-5. 
 
6.3.3. Collection of cockle samples  
Cockles were selected as biological models to test the efficacy of phage therapy 
against S. Typhimurium infections and purchased from Falcamar Lda. (Vila do Conde, 
Portugal), a bivalve wholesaler, after being depurated according to industrial processing 
protocols (48 h at 15-16 °C in seawater radiated with UV-C). These specimens were later 
artificially contaminated with S. Typhimurium in the laboratory (see below). Naturally 
contaminated cockles were collected in Mira Channel (Ria de Aveiro, Portugal; 
40º36’30”N, 8º44’52”W), a bivalve production area ranked as B (230 – 4600 MPN E. coli 
per 100 g of FIL) (Despacho n.o 15264, 2013). Mira channel is a recreational area 
subjected to anthropogenic contamination (Pereira et al., 2015). Cockles were collected in 
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February, March, April, July 2015 and January 2016.Live cockles were dry transported to 
the laboratory by the research team in a controlled temperature container, under an oxygen 
saturated atmosphere. 
 
6.3.4. Phage application during cockles depuration in static seawater  
6.3.4.1. Accumulation of S. Typhimurium in cockles 
Non contaminated cockles were maintained in independent tanks (10 cm length x 9 
cm width x 15 cm height), acting as static systems, filled with sterile synthetic seawater 
(0.6 L) and equipped with its own aerator, during 12 h before being infected with S. 
Typhimurium. Temperature was maintained at 16 ± 1 °C, pH 8.0 ± 0.2, salinity 35, and 
dissolved oxygen above 5.5 mg/L during the whole trial. Synthetic seawater was prepared 
by mixing a synthetic salt brand (Tropic Marin Pro Reef salt – Tropic Marine, Germany) 
with water purified by a reverse osmosis system (Aqua-win RO-6080, Thailand). After the 
immersion period cockles were washed with sterile synthetic seawater and placed in 
independent tanks filled with sterile synthetic seawater. 
A total of 5 groups of cockles were randomly formed, each group with three 
replicates of 30 cockles (a total of 5 groups x 3 replicates x 30 cockles = 450 cockles). 
Four groups were infected with S. Typhimurium (test tanks), with the fifth group being 
used as the cockles control. The 3 replicates from each of the 5 groups were maintained in 
independent tanks as described above. A fresh culture of S. Typhimurium was added to the 
four test groups obtain to obtain final concentrations of 105, 106, 107 and 108 CFU/mL. 
Cockles were sampled at 0, 6, 12 and 24 h during the accumulation process. This assay 
was repeated three times in different periods to secure independent replication. 
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6.3.4.2. Depuration of artificially contaminated cockles in the presence of phSE-5 phage 
Cockles were maintained in independent tanks as described above. After the 
immersion period, cockles were washed with sterile synthetic seawater and placed in tanks 
independents with sterile synthetic seawater (Figure 6.1). In these experiments, 21 groups 
of cockles were used. Each group included 3 replicates of 30 cockles each (19 groups x 3 
replicates x 30 specimens =1890). Each replicate was stocked in an independent tank as 
described above. S. Typhimurium was added to 6 of the 21 groups to obtain a final 
concentration of 105 CFU/mL, and was added to the other 5 groups to obtain a final 
concentration of 106 CFU/mL. In the other 9 groups no S. Typhimurium was added. 
Cockles from the 21 groups remained for 12 h in the tanks under the same conditions. 
Following 12 h of incubation, cockles were washed with sterilized artificial seawater and 
placed in clean tanks with no S. Typhimurium contamination. From the 11 groups of 
cockles infected with S. Typhimurium, 8 were inoculated with phSE-5 phage at a MOI of 
0.1, 1, 10 and 100 (BP MOI 0.1 phSE-5, BP MOI 1 phSE-5, BP MOI 10 phSE-5 and BP 
MOI 100 phSE-5), 1 was inoculated with cocktail phSE-2/phSE-2 at a MOI of 0.1 (BP 
phSE-2/ BPphSE-5) and no phage was added to the two remaining infected groups 
(bacteria control - BC). In groups infected with S. Typhimurium (final concentration of 105 
CFU/mL), the single phage suspension (phSE-5) was inoculated in order to obtain a MOI 
of 0.1, MOI of 1, MOI of 10 and 100, 104 PFU/mL for MOI of 0.1, 105 PFU/mL for MOI 
of 1, 106 PFU/mL for MOI of 10 and 107 PFU/mL for MOI of 100 and the cocktail 
suspension (phSE-2/phSE-5) was inoculated in order to obtain a MOI of 0.1. In groups 
infected with S. Typhimurium (final concentration of 106 CFU/mL), final concentrations of 
105 PFU/mL, 106 PFU/mL and 107 PFU/mL and 108 PFU/mL were inoculated in order to 
obtain a MOI of 0.1, 1, 10 and 100, respectively. Concerning the 10 groups of cockles not 
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infected with S. Typhimurium, 8 were inoculated with phSE-5 phage at a MOI of 0.1, 1, 10 
and 100 (PC MOI 0.1 phSE-5, PC MOI 1 phSE-5, PC MOI 10 phSE-5 and PC MOI 100 
phSE-5), 1 was inoculated with cocktail phSE-2/phSE-5 and the remaining group was not 
inoculated with phages (CC). All 21 groups were incubated exactly under the same 
conditions. Aliquots of test samples and controls were collected after 0, 2, 4, 6, 8, 10 and 
12 h of incubation. This assay was repeated three times in different dates to secure 
independent experiments. 
 
6.3.5. Depuration of naturally contaminated cockles in the presence of phages  
Naturally contaminated cockles were washed with sterile synthetic seawater and 
placed in clean water tanks with sterile synthetic seawater as described above (Figure 6.1). 
For each contaminated group, cockles were divided into four treatments groups (4 groups x 
3 samples x 30 specimens = 360 cockles): phage treatment with phSE-5 or cocktail phSE-
2/phSE-5 and no phage or cocktail treatment. The phage suspensions were inoculated as 
described above, with an initial concentration of 104 PFU/ mL (selected according to the 
results of previous tests in artificially contaminated cockles). After that, the procedure was 
similar to that described in section 6.3.4.2.Three independent experiments were done in 
different dates. 
 
6.3.6. Effect of ultraviolet (UV) irradiation on phages 
The effect of UV irradiation on phages was investigated by inoculating 105 PFU/ mL 
of phSE-5 phage on 14 L of aerated synthetic seawater and irradiating it with UV 
irradiation during 12 h (phSE-5 UV). A control treatment was prepared by replicating this 
procedure, with the exception of UV irradiation (CphSE-5). Each group included 3 
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replicates, with temperature being maintained at 16 ± 1 °C, pH 8.0 ± 0.2, salinity 35, and 
dissolved oxygen above 5.5 mg/L, during the whole trial. Aliquots of each group were 
collected after 0, 2, 4, 6, 8, 10 and 12 h of incubation. This assay was repeated three times 
in different periods to secure independent replication. 
 
Figure 6.1 Schematic representation of the depuration experiments of cockles employing phages. 
(a) Depuration of artificially contaminated cockles with S. Typhimurium with phSE-5 and phSE-
2/phSE-5 cocktail in static system (see sections 6.3.4.2), (b) Depuration of naturally contaminated 
cockles with phSE-5 and phSE-2/phSE-5 cocktail in static system (see section 6.3.5), (c) 
Depuration of artificially contaminated cockles with phSE-5 phage in a recirculating system (see 
section 6.3.7). 
 
6.3.7. Depuration of artificially contaminated cockles with phSE-5 phage in a recirculating 
system 
The efficacy of the phSE-5 phage (selected according to the results of the tests 
described above) was evaluated during depuration in a recirculating system mimicking the 
industrial depuration process. The rationale for this trial was to evaluate if this approach 
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could be successfully employed in industrial depuration facilities to inactivate S. 
Typhimurium. Tanks from each group were connected in parallel to twin recirculated 
water systems mimicking an industrial depuration facility. Each recirculated system was 
equipped with a 14 L tank holding a submerged water pump (Eheim Compact+ 3000, 
Germany), a protein skimmer (RedSea Berlin Air-Lift 60, Israel) equipped with air pump 
(API Rena Air 200, USA) and UV filter (TMC V2 Vecton 120 Nano, UK) with a 
recirculating submerged water pump (Eheim Compact 1000, Germany). Temperature was 
controlled by using a common 120 L water bath connected to a cooling unit (Hailea HC 
500-A, China) through a submerged water pump (Eheim Compact + 3000, Germany). 
Cockles were washed with sterile synthetic seawater and placed in clean water tanks with 
sterile synthetic seawater as described above (Figure 6.1). For each contaminated group, 
cockles were divided into four treatments groups (4 groups x 3 samples x 30 specimens = 
360 cockles): cockles treated with phage phSE-5 with 104 PFU/mL (BP), cockles 
inoculated with S. Typhimurium with 105 CFU/mL and no treated with phage, cockles not 
inoculated with bacteria and not treated with phage (CC), cockles no inoculated with 
bacteria but treated with phage (PC). To avoid the effect of UV irradiation on the phages, 
the UV irradiation was only switched on 2 h after the beginning of the depuration process 
(the time required for cockles to filtrate and accumulate the phages. After that, the 
procedure was similar to that described in section 6.3.4.2. This assay was repeated three 
times in different dates. 
 
6.3.8. Determination the concentration of bacteria and phage  
To determine the S. Typhimurium counts, oysters were sampled from treatment 
groups at different intervals during the accumulation and depuration process.  At each 
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sampling time, four cockles were randomly selected from each tank and were 
homogenized with Bag Mixer 400 (Interscience, France). Ten grams were blended in 90 
mL of alkaline peptone water (Liofilchem, Italy). The homogenized samples were then ten-
fold serially diluted and 1 mL from each dilution was spread on the specific BGE plates 
(for cockles during accumulation of S. Typhimurium and for artificially contaminated 
cockles) or TSA medium (for naturally contaminated cockles). All plates were incubated at 
37 °C for 24 h. The counts in BGE medium allows to detect added S. Typhimurium, as 
well as other Salmonella spp. already present in cockles. The phage titer was determined in 
duplicate for all assays through the double agar layer method after an incubation period of 
8 - 12h at 37 ºC. 
 
6.3.9. Statistical analysis 
Statistical analysis was performed using GraphPad Prism 6. Normal distributions 
were assessed by Kolmogorov–Smirnov test and homogeneity of variances was assessed 
by Levene’s test. Two-way analysis of variance (ANOVA) was used to test for significant 
differences among the accumulation of different concentrations of S. Typhimurium in 
cockles at different times. The existence of significant differences on bacterial and viral 
concentration in cockles artificially contaminated with 105 CFU/mL of S. Typhimurium 
was analysed using a three-way ANOVA with MOIs (0.1, 1, 10 and 100), phages (phSE-5, 
phSE-2/phSE-5) and treatment times being used as fixed factors. The significance of 
differences on bacterial and viral concentration in cockles artificially contaminated with 
106 CFU/mL of S. Typhimurium was analysed using a two-way ANOVA. The existence of 
significant differences between phage treatment in cockles naturally contaminated and 
treatment time on bacterial and viral concentration was analysed using a two-way 
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ANOVA. For each experiment, the significance of differences was evaluated by comparing 
the results obtained in the test and control samples for the different times of each of the 
three independent assays. The significance of the effect of UV-C irradiation on the phT4A 
phage and irradiation time on phage inactivation was assessed by one-way ANOVA. 
Whenever signiﬁcance was accepted, at p < 0.05, Tukey's multiple comparison test was 
used for a pairwise comparison of the means. 
 
6.4. Results 
6.4.1. Phage application during cockles depuration in static seawater  
6.4.1.1. Accumulation of S. Typhimurium in cockles 
 
Figure 6.2 Accumulation of S. Typhimurium in cockles in different infected groups after 24 h. 
Final concentrations of S. Typhimurium (log CFU/g) in groups of cockles initially contaminated 
with 105 CFU/mL; 106 CFU/mL, 107 CFU/mL and 108 CFU/mL, as well as the cockles control 
(CC). 
 
Live cockles were assessed after 24 h of incubation in the presence of S. 
Typhimurium at 16 ± 1 °C (Figure 6.2). Accumulation of S. Typhimurium in cockles 
increased rapidly during the first 6 h, with counts decreasing after this time in all four 
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infected groups until they remained comparatively steady after 12 h and onward. 
Following 12 h of incubation, the mean values of bacteria in cockles were 4.9, 6.0, 7.0 and 
7.9 log CFU/g in infected groups with 105, 106,107 and 108 CFU/mL of S. Typhimurium, 
respectively (Figure 6.2). The abundance of S. Typhimurium in contaminated groups (105, 
106,107 and 108 CFU/mL) after 6, 12 and 24 h, was statistically different (ANOVA, p < 
0.05; Figure 6.2). Incubation by immersion during 12 h in an S. Typhimurium culture with 
105 CFU/mL was the selected procedure for follow-up experiments. 
 
6.4.1.2. Depuration of artificially contaminated cockles in the presence of phSE-5 phage 
and phSE-2/phSE-5 cocktail phage 
At a MOI of 0.1 (the infected concentration of S. Typhimurium was 105 CFU/mL), 
the maximum of bacterial inactivation in cockles treated with phSE-5 phage relatively to 
the bacterial control was 1.7 log CFU/g (ANOVA, p < 0.05), which was achieved after 4 h 
of phage therapy (Figure 6.3A). Increasing the MOI to a value of 1 did not signiﬁcantly 
increase the rate of inactivation (1.0 log CFU/g) after the same period of time (ANOVA, p 
> 0.05). At higher values of MOI (10 and 100), it was shown that the rate of inactivation 
slightly decreases with the MOI, with maximum values of 1.0 log CFU/g for a MOI of 10 
and 0.6 log CFU/g of reduction at a MOI of 100, respectively, after 4 and 8 h of treatment 
(Figure 6.3A). However, this decrease in the rate of inactivation at MOI of 10 was not 
statistically signiﬁcant when compared with the MOI of 1 and 10 (ANOVA, p > 0.05) after 
6, 8, 10 and 12 h treatment. The results showed that phage treatment with phSE-5 phage in 
cockles infected with S. Typhimurium (105 CFU/mL at MOI of 0.1) could achieve 
significant reduction in less time of depuration.   
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Figure 6.3 Inactivation of S. Typhimurium in artificially contaminated cockles with concentration 
of S. Typhimurium was 105 CFU/mL, by phSE-5 phage at a MOI of 0.1, 1, 10 and 100 during 12 h. 
A. Bacterial concentration: CC – cockles control; BC — bacteria control; BP — bacteria plus 
phage. B. Phage concentration: PC — phage control; BP — bacteria plus phage. Values represent 
the mean of three experiments; error bars represent the standard deviation. 
 
The maximum of bacteria inactivation in cockles treated with phSE-2/SE-5 cocktail 
phage (MOI of 0.1) was 0.7 log CFU/g achieved after 6 h treatment (ANOVA, p < 0.05; 
Figure 6.3A). At a MOI of 0.1, the rate of inactivation with the single suspension of phSE-
5 phage was significantly higher (ANOVA, p > 0.05) than the obtained with the phSE-
2/phSE-5 cocktail phage after 2, 4 and 6 h of treatment. After 8 h of treatment, the rate of 
inactivation for phSE-5 phage and phSE-2/phSE-5 cocktail was similar (ANOVA, p > 
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0.05). The rate of inactivation with the phage cocktail was similar to the obtained with the 
phSE-5 phage at MOI of 1, 10 and 100 during 12 h of treatment (ANOVA, p > 0.05). 
Bacterial density in the bacterial control and cockles control remained constant (ANOVA, 
p > 0.05) during the 12 h of treatment (Figure 6.3A). The abundance of phSE-5 phage and 
phSE-2/phSE-5 in cockles, in the absence (PC) and in the presence of the host S. 
Typhimurium (BP, Figure 6.3B) increased during the first 2 h treatment, and then remained 
constant until the end of the treatment (ANOVA, p > 0.05). 
At a MOI of 0.1 (the infected concentration of S. Typhimurium was 106 CFU/mL) in 
cockles treated with phSE-5 phage was 1.4 log CFU/g, achieved after 4 h of treatment 
(Figure 6.4A). However, after 2 h, the inactivation rate was considerably higher for the 
MOI of 0.1 (1.3 log CFU/g) and significantly higher (ANOVA, p < 0.05) than the one 
obtained for the MOI of 1 (0.2 log CFU/g; ANOVA, p < 0.05) and for the MOI of 100 (0.1 
log CFU/g; ANOVA, p < 0.05). Increasing the MOI of 0.1 to 10 did not signiﬁcantly 
increase the rate of inactivation during 12 h of treatment (ANOVA, p > 0.05). After 6 h of 
treatment, the rate of inactivation for both MOIs was similar (ANOVA, p > 0.05). The rate 
of inactivation decreased with the MOI, with maximum values of 1.0 log CFU/g for a MOI 
of 1 and 10 and 1.2 log CFU/g of reduction at a MOI of 100, respectively, after 6 and 12 h 
of treatment (Figure 6.4A). Bacterial density in the bacterial control and cockles control 
remained constant (ANOVA, p > 0.05) during the 12 h of treatment (Figure 6.4A). Phage 
density in the PCs and in the presence of the host S. Typhimurium (BPs) increased during 
the first 2 h treatment, and then remained constant until the end of the treatment (ANOVA, 
p > 0.05; Figure 6.4B). 
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Figure 6.4. Inactivation of S. Typhimurium in artificially contaminated cockles with concentration 
of S. Typhimurium was 106 CFU/mL, by phSE-5 phage at a MOI of 0.1, 1, 10 and 100 during 12 h. 
A. Bacterial concentration: CC - cockles control; BC — bacteria control; BP — bacteria plus 
phage. B. Phage concentration: PC — phage control; BP — bacteria plus phage. Values represent 
the mean of three experiments; error bars represent the standard deviation. 
 
6.4.2. Depuration of naturally contaminated cockles in the presence of phages  
The maximum reduction of bacteria in cockles treated with phSE-5 was 0.9 log 
CFU/g after 6 h of treatment, being statistically different from the untreated group 
(ANOVA, p < 0.05), and similar than the one obtained with the phSE-2/phSE-5 (0.7 log 
CFU/g) (ANOVA, p > 0.05; Figure 6.5A). However after 2 h, the inactivation rate was 
considerably higher with phSE-5 phage (0.5 log CFU/g) and significantly higher than the 
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one obtained with the phSE-2/phSE-5. The highest inactivation rate (0.9 log CFU/g) was 
achieved after 4 h of treatment with phSE-2/SE-5, and after 6 h it was 0.8 log CFU/g 
(ANOVA, p < 0.05; Figure 6.5A). Phage inactivation with phSE-5 phage and phSE-
2/phSE-5 cocktail phage was similar (ANOVA, p > 0.05) after 2 h treatment. 
 
 
Figure 6.5 Inactivation of S. Typhimurium in natural contaminated cockles by phSE-5 phage and 
phSE-2/phSE-5 cocktail phage during 12 h. A. Bacterial concentration: CC - cockles control, 
phSE-5 — cockles treated with phSE-5 phage. B. Phage concentration: PCphSE-5- phage control. 
Values represent the mean of three experiments; error bars represent the standard deviation. 
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The abundance of phSE-5 phage and phSE-2/phSE-5 cocktail in cockles increased 
during the first 2 h of treatment, and then remained constant until the end of the treatment 
(ANOVA, p > 0.05; Figure 6.5B). 
 
6.4.3. Effect of ultraviolet (UV) irradiation on phages 
 
 
Figure 6.6 Effect of UV-C irradiation on the phSE-5 phage and synthetic seawater recirculation 
during 12 h. (C phSE-5) synthetic water with phSE-5 phage but not purified by UV-C irradiation 
(phSE-5 UV) synthetic seawater with phT4A phage and purified by UV-C irradiation. 
 
Significant reductions (ANOVA, p< 0.05) in phSE-5 phage counts exposed to UV-C 
irradiation (phSE-5 UV) were observed after 2 h of incubation with a reduction of 
approximately 4.3 log PFU/mL, which was statistically different from the untreated group 
(C phSE-5) (Figure 6.6). The phSE-5 phage was inactivated to the limit of detection (5.0 
log PFU/mL of reduction) by UV-C irradiation after 4 h of treatment (Figure 6.6). The 
abundance of phSE-5 in untreated group (C phSE-5) remained constant until the end of the 
treatment (ANOVA, p > 0.05).  
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6.4.4. Depuration of artificially contaminated cockles with phSE-5 phage in a recirculating 
system 
The maximum of bacteria inactivation in cockles with phSE-5 was 2.0 log CFU/g 
after a 6 h treatment (Figure 6.7A). After 2 and 4h of treatment, the rate of inactivation was 
0.7 log CFU/g and 0.9 log CFU/g, respectively, which was statistically different from the 
bacterial control (ANOVA, p < 0.05). Bacterial density in the bacterial control (BC) 
remained constant (ANOVA, p > 0.05) during the first 4 h of treatment, then decreased by 
1.1 log CFU/g after 6 h of treatment, compared with initial bacterial density (5.0 log 
CFU/g) (Figure 6.7A). After 6 h of treatment, the bacterial density remained constant until 
the end of the treatment. Bacterial density in cockles control (CC) remained constant 
(ANOVA, p > 0.05; Figure 6.7A) during the first 4 h of treatment, then decreased to the 
limit of detection (~ 0.6 log CFU/g). 
The abundance of phSE-5 in cockles, both in the absence (PC) and in the presence of 
the host S. Typhimurium (BP, Figure 6.7 B)  increased during the first 2 h of treatment, 
then decreased by 0.6 log PFU/g between 2 and 4 h treatment. After a 4 h treatment, the 
abundance of phSE-5 remained constant until the end of the treatment (ANOVA, p > 0.05). 
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Figure 6.7 Inactivation of S. Typhimurium during depuration of artificial contaminated cockles 
with phSE-5 phage and water recirculation during 12 h. A. Bacterial concentration: CC - cockles 
control, BPphSE-5 - cockles treated with phSE-5 phage, B. Phage concentration: PC - phage 
control; BP - bacteria plus phage. Values represent the mean of three experiments; error bars 
represent the standard deviation. 
 
6.5. Discussion 
Salmonella Typhimurium is the most frequent causative agent of human 
gastroenteritis (Butt et al., 2004; Oliveira et al., 2011a). Taking this into account, the 
elimination of S. Typhimurium in cockles is paramount for public health, as pathogenic 
strains of this species can easily accumulate in raw bivalves (Hungaro et al., 2013; WHO, 
2010). One of the current challenges faced when performing phage therapy studies is to 
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demonstrate its feasibility in vivo. According to several authors (Pereira et al., 2016a; Silva 
et al., 2014a, 2016; Vieira et al., 2012), in vitro tests are not sufficient to understand 
phage–bacteria interactions in vivo. While the use of lytic phages to reduce food-borne 
pathogens has already been suggested as a promising tool for food safety (Hungaro et al., 
2013; Sillankorva et al., 2012), to date, only a single study has addressed the potential use 
of phage therapy (during depuration in a system without water circulation) to inactivate 
pathogenic V. parahaemolyticus in artificially contaminated oyster (Rong et al., 2014). In 
the present study, we evaluated the inactivation of S. Typhimurium in artificially and 
naturally contaminated cockles by applying phage therapy during the depuration process, 
both with and without water circulation.  
An artificially infected cockles, using different concentrations of S. Typhimurium, 
was established to evaluate the effect of the single phage suspensions and phage cocktail 
on cockles depuration. S. Typhimurium counts in cockles decreased from 6 to 12 h of 
accumulation, which may have been due to the self-cleaning of cockles,  only a certain 
level of bacteria could colonize in the body after accumulation. Therefore, the 
accumulation of S. Typhimurium was performed for 12 h, when accumulated bacterial 
counts were comparatively steady. Similar results have been observed during the 
accumulation of V. parahemolyticus in oysters (Rong et al., 2014).  
Single phage suspension (phSE-5) tested in this study can be used to inactivate S. 
Typhimurium in artificially contaminated cockles contaminated with 105 CFU/mL and 
106CFU/mL. In general, increasing the concentration of S. Typhimurium in cockles (of 105 
CFU/mL for 106 CFU/mL), did not shift the rate of inactivation during a 12 h treatment 
using the same MOI. Rong et al. (2014)obtained similar results, since these authors 
observed that the application of phage (VPp1) could reduce the population of V. 
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parahaemolyticus in infected oysters (105-107 CFU/mL) during depuration; indeed similar 
decreases after 36 h of depuration were recorded in oysters treated with VPp1 at MOI of 
0.1,1 and 10. The phage cocktail (phSE-2/phSE-5) at MOI of 0.1 was, however, less 
efficient than the single phage suspensions and needed a longer time (6 h) to attain the 
maximum of inactivation for S. Typhimurium. Previous results using in vitro assays, in 
liquid medium at a MOI of 100, showed that the inactivation of S. Typhimurium with 
single suspensions of phSE-5 and with the phSE-2/phSE-5 phage cocktail was also 
effective  Pereira et al., 2016b). In the in vitro assays performed, the rate of inactivation for 
phSE-5 phage and phSE-2/phSE-5 phage cocktail were 1.9 and 2.0 CFU/mL, respectively, 
achieved after 4 h of phage therapy (Pereira et al., 2016b).  
Unlike in in vivo assays, previous trials in vitro displayed similar rates of bacterial 
inactivation with the phSE-5 phage and phSE-2/phSE-5 cocktail (reductions of 1.9 and 2.0 
CFU/mL, respectively, after a 4 h treatment) (Pereira et al., 2016b). Park and Nakai (2003) 
recorded similar results using in vitro and in vivo assays, and reported that the efficiency of 
the phage cocktail (PPpW-3/PPpw-4) was higher than that of the PPpW-3 and PPpW-4 
phages when used individually to treat Pseudomonas plecoglossicida. 
The phage concentration applied is another factor influencing the elimination of the 
target microorganism during depuration (Rong et al., 2014). The dynamics of phage-
bacterium interactions differ among various animal samples due to the complexity of the 
physicochemical environment, phage lysis activity, and host defenses (Clokie et al., 2011). 
Hence, the phage concentration used in a particular scenario can show dramatically 
different effects in other cases. In this study, the authors demonstrated that the application 
of phSE-5 phage at MOI of 0.1, 1, 10 and 100 in artificial contaminated cockles (105 
CFU/mL) could reduce the population of S. Typhimurium during depuration in s static 
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system, with decreases of 1.7 log CFU/g after 4 h, 1.0 log CFU/g after 4 h, 1.0 log CFU/g 
after 4 h and 0.6 log CFU/g after 8 h, respectively. In this study the low dose of phSE-5 
phage (MOI of 0.1, 104 PFU/mL) had a significantly higher effect on bacterial reduction in 
cockles than the highest dosage tested (MOI of 100, 107 PFU/mL). Rong et al.(2014) 
concluded that the application of the phage (VPp1) could reduce the population of V. 
parahaemolyticus in infected oysters (105 CFU/mL) during depuration, with decreases, 
after 36 h of depuration, of 1.24 log, 1.99, 1.74 and 2.35 log CFU/g, respectively, in the 
negative control (oysters infected V. parahaemolyticus and not treated with phage) and in 
oysters treated with phage VPp1 at MOI of 10, 1 and 0.1. Nakai et al. (1999) examined the 
protective effects of an anti-Lactococcus garvieae phage with a MOI < 1 by intraperitoneal 
injection or oral administration of phage against experimentally infected young yellowtails. 
Hooton et al. (2011) found that a high concentration (MOI > 10) of S. Typhimurium U288 
phage cocktail could achieve successful results on artificially contaminated pig skins. The 
application of a low phage titer is cost-effective, as theoretically, a low MOI ratio is 
advantageous for large scale production and commercialization of phage products, as it 
would reduce their cost of preparation, purification and application. 
Studies on the removal of bacteria during “traditional” depuration (without phage 
addition) using bivalves artificially challenged with bacterial cultures show a greater 
degree of removal than studies using naturally contaminated shellfish (FAO, 2008). In this 
study, when naturally contaminated cockles (using 0.6 L of seawater added with phages, 
but without water recirculation) were depurated with the phSE-5 phage, the maximum 
reduction of cultivable bacteria (reductions of 0.9 log CFU/g) was less than that observed 
in artificially contaminated cockles (reductions of 1.9 log CFU/g). However, when 
naturally contaminated cockles were depurated with the phSE-2/phSE-5 phage, the 
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maximum reduction of cultivable bacteria (0.9 log CFU/g) was similar to that observed in 
artificially contaminated cockles (0.7 log CFU/g). However, S. Typhimurium 
concentration used in contaminated cockles experiments was significantly higher (about 
3.2 log CFU/g) than that observed in naturally contaminated specimens (about 1.0 log 
CFU/g). This indicates that naturally occurring S. Typhimurium in cockles can be 
effectively removed if the bivalves are depurated in the presence of phages.  
While a maximum of 2.0 log CFU/g reduction of S. Typhimurium in cockles was 
achieved after a 6 h treatment (using 14 L of recirculated seawater treated with UV-C 
irradiation and supplemented with phages), after 2 h of treatment a bacterial reduction of 
0.7 log CFU/g log was already perceptible. However, when depuration occurred without 
the supply of phages (control group, using 14 L of recirculated seawater treated with UV-C 
irradiation and without addition of phages) a small reduction of 1.1 log CFU/g of S. 
Typhimurium was obtained only after 4 h of treatment. Using conventional depuration 
practices, bacterial concentration is reduced only after 4 h of treatment, while in the 
presence of phages the bacterial reduction is already significant after 2 h; this result 
indicates that cockles decontamination in the presence of phages can shorten the duration 
of the depuration period. It is worth stating that after 6 h of treatment the number of 
Salmonella, even in the presence of the phages, remained stable. This can be due to the 
development of resistance by bacteria. Further studies are needed in order to test this 
hypothesis. In vitro treatments revealed the frequency of phage-resistant mutation to be 
low (10-4-10-5 CFU/mL) and that these phage-resistant bacteria grow slowly. These 
findings will be also important to evaluate the growth of resistant bacteria isolated from 
phage treated cockles, as these bacteria frequently display altered surfaces and cell shapes, 
which reduce their fitness and attenuate their virulence (Carrillo et al., 2005; Flynn et al., 
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2004). The modification of Salmonella LPS structure is believed to be an important phage 
adsorption ligand and is likely to severely affect its pathogenicity (Kong et al., 2011). The 
development of resistance in the host could reduce the efficacy of phage treatment and, 
consequently, appropriate measures to decrease the likelihood of resistance development 
are needed. Among these measures should be considered the use of phage cocktails 
including phages with broad host range or the use of rotating treatment schemes employing 
different phages (Guenther et al., 2009; Kunisaki and Tanji, 2010).  
After the accumulation period of phages in cockles, their concentration remained 
relatively stable during the treatment period in artificially and naturally contaminated 
specimens, thus indicating that tested phages can be suitably employed during bivalve 
depuration. Whenever seawater is disinfected with UV-C irradiation, its application must 
be done before phage application, because the phage concentration is affected by UV-C 
irradiation. However, phages and bacteria that were accumulated inside the cockles were 
not affected by UV-C irradiation, because there was no decrease in the concentration of 
phage and bacteria after 4 h of treatment.  
 
6.6. Conclusion 
The application of phSE-5 phage and phSE-2/phSE-5 phage cocktails can be 
successfully employed to inactivate S. Typhimurium in cockles during depuration, 
especially if phSE-5 phage is used individually and a low MOI is employed. Overall, this 
approach holds the potential to reduce depuration time and increase the efficiency of this 
process, consequently holding the potential to reduce production costs and improve bivalve 
safety and quality for human consumption 
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Chapter 7. General conclusions and future perspectives 
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7.1 Conclusions 
 
In this work a series of experiments were conducted to assess the sustainability of 
phage therapy to control infections by microbial pathogens through the consumption of 
bivalves, during depuration. 
The main conclusions of this work are summarized in the following topics. 
 
For apply a successful phage therapy during depuration of bivalves it is essential to 
know the dynamics of the natural microbial community in the harvesting waters, 
with detail on the most important pathogenic bacteria of bivalves associated illness.  
 Enterobactereaceae family was the most abundant bacterial group.  
 The indigenous Vibrio and Aeromonas were also present at high concentrations 
 The harvesting waters from the Ílhavo channel (classified as a C area) were more 
contaminated than those from the Mira channel (classified as a B area). 
 The overall bacterial community and the disease-causing bacteria, as well as the 
indicator of microbiological water quality of two harvesting areas showed clear but 
distinct patterns of variation. 
 The seasonal variation of the bacterial community and specific groups that are 
responsible for the contamination of the bivalves, indicate that monitoring the 
seasonal variation should be done in order to select the more appropriate phages to 
inactive microbial pathogenic of the bivalves. 
 A higher complexity of the whole community and an increase of abundance of the 
main pathogenic bacteria in hot months, indicate that this season is the critical time 
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frame when phage therapy should be applied. However, could be necessary the 
application of phage therapy during the cold season. 
- The bacterial community structure in the hot months (June and August) was more 
diverse and distinct from that in cold months (December and February). 
- Non- and indigenous bacterial groups, as the total bacterial number, registered the 
highest values in summer.  
- Vibrio and Aeromonas genus also presented a seasonal pattern of variation, with 
values up to 20 times higher in the hot season, when compared to the cold season. 
 
The new phages of S. Typhimurium and of E. coli tested in this study are potential 
candidates to be used during depuration. Phage characterization is an important 
aspect to select the most adequate phages. 
 S. Typhimurium phages showed good survival time in seawater 
 Phages with high burst sizes and short lytic cycles increase the efficiency of phage 
therapy. 
- The E. coli phage EC2A presents the high burst size and the short lytic cycle and 
inactivate E. coli sooner than phage phT4A. 
 Efficiency of plating was not correlated to the results from the spot tests 
- Spot test indicated that the three phages of S. Typhimurium have capacity to form 
completely cleared zones on 25-27 of the 42 strains. However, EOP results 
indicated that the three phages form lysis plates only on 3 strains. 
- Spot test indicated that E. coli phages have the capacity to form completely cleared 
zones on 19-20 of the 40 strains, but EOP indicated that the two phages do not 
form phage lysis plates in none strain. 
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Phage-resistant bacteria tend to be less fit, so they can be expected to be eliminated 
from the environment fast than their wild-type relatives. Therefore, the evolution of 
resistance against phage might in this case promote bacterial mutants with reduced 
ability to cause shellfish disease. These results suggest that the emergence of phage-
resistant mutants should not be a major problem to the application of phages to 
control bacterial infections in aquaculture 
 The frequency of phage-resistant mutation was low (10-3-10-5 CFU/mL). 
 The use of phage cocktails, as well as the use of single-phage suspensions, did not 
prevent the occurrence of phage-resistant mutants. 
 The use of the phage cocktail containing different phages against the same bacterial 
species can decrease the likelihood of selecting phage-resistant mutants 
 The colonies of phage -resistant mutants were smaller than colonies formed by the 
non-phage added control and were visible only after 5 days of incubation. 
 Phage-resistant bacteria did not recover sensitivity, phages did not adsorb to phage-
resistant bacteria and after five streak-plating steps on solid medium these bacteria 
remained resistant by the spot test but not by the EOP technique. 
 The spectral changes of S. Typhimurium resistant and phage-sensitive cells were 
compared and revealed relevant differences for peaks associated to amide I (1620 
cm-1) and amide II (1515 cm-1) from proteins and from carbohydrates and 
phosphates region (1080-1000 cm-1). 
 
Precise initial doses may not be essential, due to the self-perpetuating nature of 
phages.  
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• The efficiency of phages phT4A and phage cocktail phT4A/EC2A in vitro 
increased in MOI from 1 to 100, but for phage EC2A the efficiency was similar for 
both MOI. 
 In vivo, low MOI were efficient to inactivate E. coli (MOI of 1) and S. 
Typhimurium (MOI of 0.1).The efficiency of inactivation with phages E. coli at a 
low MOI (MOI of 1, reduction ~2.0 CFU/g) was twice more higher using a high 
MOI (MOI of 100, reduction ~1.0 CFU/g). The rate inactivation using phSE-
2/phSE-5 was 1.7 and 0.6 log CFU/g at MOI 0.1 and 100, respectively, after 4 and 
8h treatment. 
 
In vivo studies are needed to transpose phage therapy for industry. Results in vivo 
were different from the results obtained in vitro. 
 The rate of E. coli inactivation, in vitro, using phages phT4A, ECA2 and phage 
cocktail phT4A/ECA2 was higher than the results recorded in vivo. 
 Unlike in vivo assays, in previous in vitro experiments, the use of the cocktail 
phT4A/ECA2 was significantly more effective than the use of single phage 
suspensions of phT4A and ECA2 
 The use of the cocktail phSE-2/phSE-5 in vitro assays was more effective than the 
when used in vivo assays. 
 
The use of phage cocktail does not always increase the efficiency of treatment 
 The phage cocktail phT4A/EC2A in vitro assays was more efficient than the single 
phage suspensions. 
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 In vivo assays, the phage cocktail was less efficient than the single phage 
suspensions and needs a longer time to attain a similar level of E. coli reduction. 
 In vitro, the inactivation rate of phage cocktails to control S. Typhimurium was 
similar to that  obtained using single phage suspensions 
 The inactivation rate of artificially contaminated cockles depurated with the phSE-
2/phSE-5 phage cocktail was lower than when phage phSE-5 was used 
individually. However, when naturally contaminated cockles were depurated with 
the phSE-2/phSE-5 phage cocktail, the maximum reduction of cultivable bacteria 
was similar than when the single phage phSE-5 suspension was used. 
The efficiency of bacterial inactivation in artificially contaminated cockles was higher 
than that observed in naturally contaminated cockles 
 In general, the rate of inactivation when artificially contaminated cockles were 
depurated with the phage/ phage cocktail E. coli and S. Typhimurium was higher 
than when naturally contaminated cockles were used 
The application E. coli and S. Typhimurium phages can be successfully employed 
during depuration. Overall, this approach holds the potential to reduce the 
depuration time and increase the efficiency of this process, consequently holding the 
potential to reduce production costs and improve bivalve safety and quality for 
human consumption. 
 During depuration mimicking industrial procedures using naturally contaminated 
cockles, the maximum reduction of cultivable bacteria in cockles was 0.6 log 
CFU/g after a 2 h of treatment with phage phT4A. However, when depuration 
occurred without the supply of phages, 4 h of treatment were necessary to obtain 
the same level of bacterial reduction. 
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 During depuration mimicking industrial procedures using artificially contaminated 
cockles, the maximum reduction of S. Typhimurium in cockles was achieved after a 
6 h treatment (2.0 log CFU/g), however, after 4 h of treatment a bacterial reduction 
of 0.7 log CFU/g log was already perceptible. When depuration occurred without 
the supply of phages the reduction was 1.1 log CFU/g after 6 h of treatment.  
 
 Whenever seawater is disinfected with UV-C light, the UV-C light application must 
be done before phage application because concentration phage was reduced after 
UV-C irradiation. 
 
7.2 Future work 
 
While successfully used in vitro and at laboratory scale, the feasibility of phage 
therapy at industrial large scale remains to be validated. This aspect will be of paramount 
importance for its rapid inclusion in depuration systems. The next step will be the 
evaluation of phage therapy at market scale, by testing it in industrial depuration systems 
with larger water volumes and higher bivalves stocking densities, employing phage 
concentrations suitable to control target bacteria, in real-case scenarios. Also, it is 
necessary to evaluate the efficiency of the isolated phages to inactivate bacteria in other 
species of bivalves. It is also important to isolate and characterize new phages to control 
other pathogenic bacteria transmitted to humans by bivalves (e.g. Vibrio parahaemolyticus, 
Aeromonas hydrophilla, Staphylococcus aureus, Shigella flexneri and Listeria 
monocytogenes). 
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The results of this and previous studies suggest that phage-resistant bacteria tend to 
be less fit or even lose their virulence properties, so they can be expected to be eliminated 
from the environment faster than their wild-type relatives and they can have a reduced 
ability of causing disease in shellfish. Further studies are needed in order to evaluate new 
phage-bacteria interactions and confirm these findings. It has been stated that phage-
resistance development can be overcome by the combined use of two or more phages 
(phage cocktails) and that the use of phage cocktails has the ability to treat multiple 
pathogens. This feature broadens the action spectrum of phage therapy. Further studies 
using phage cocktails, specific for different bacteria, are needed in order to evaluate and 
optimize their application during bivalve depuration. 
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